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Abstract
Responding to changes in the intra and extracellular environment is a fundamental pro-
perty of living organisms enabling them to adapt and survive. The information transfer
in cells is accomplished through complex networks of interacting proteins. Dysfunctions
in the transmission process can lead to various diseases, such as obesity or cancer. Thus,
gaining information on the interrelations of the components of signalling pathways has
become a focus in biomedical and drug development. The focus of this work is on cell sig-
nalling in the context of energy sensing, which is linked to glucose uptake and metabolism.
One pathway, which is an important energy sensor, is the AMPK signalling pathway
controlling various metabolic processes. In this work, a systems biology approach is pre-
sented that consists of iterative cycles between data-driven modelling and model-driven
experimentation. A mathematical model composed of ordinary differential equations is
established to investigate the AMPK pathway homologue in the yeast Saccharomyces
cerevisiae, the Snf1 pathway. Therefore, at first the definition of a glucose-regulated stim-
ulus is derived requiring information of the mechanisms of glucose transport across the
membrane. The data of the Snf1 pathway component Mig1 is generated by fluorescent
microscopy, which suffers from bleaching effects and background noise. The processing of
this data is realised through the development of a mathematical approach, which extracts
the GFP-tagged Mig1 data from background noises while taking account for bleaching
effects and predicting the dynamics of Mig1. The extracted information of the processed
fluorescent data, the derived glucose-regulated signal, and the Snf1 Western blot data
are then combined in order to compare those data to the simulations of the alternative
network structures suggested to underly the Snf1 pathway. The simulations indicate that
certain network structures can be excluded from the list of candidate structures describing
the dynamics of the Snf1 pathway.
In the second part of this thesis, signalling pathways are considered in a more general
setting using quantitative measures to characterise them. Quantitative measures have
become a useful tool to describe the dynamic properties of the components of signalling
pathways, such as the average time until activation or the average duration of remaining
in an activated state. An optimality criterion is defined, based on quantitative measures,
to analyse the characteristic design of a MAPK pathway and to compare the consequences
of model approximations. Comparisons with single and triple phosphorylated structures
showed that the design of a MAPK pathway is favourable for pathways that realise the
transmission of fast signals with short duration.

Zusammenfassung
Ein wichtiges Merkmal aller Lebensformen ist ihre Fa¨higkeit, intra- und extrazellula¨re
Vera¨nderungen in Form von Signalen, zum Beispiel in Ionenkonzentrationen, Hormonen
oder Na¨hrstoffen, zu erfassen und sich ihnen anpassen zu ko¨nnen. Dieser Prozess wird
durch biochemische Reaktionsnetzwerke bestehend aus interagierenden Proteinen real-
isiert. Ein Beispiel fu¨r ein solches Netzwerk ist der AMPK Signalweg, der eine bedeu-
tende Rolle im Gleichgewicht des Energiehaushalts spielt, indem er bei Energiemangel
katabolische Vorga¨nge mobilisiert, anabolische hingegen versucht einzusparen. Fehlfunk-
tionen dieses Signalwegs ko¨nnen zu Diabetes Typ 2 und Fettleibigkeit fu¨hren.
In dieser Arbeit wurde ein systembiologischer Ansatz, bestehend aus mehreren Itera-
tionen aus Modellierung und Experimenten, zur Untersuchung des Snf1 Signalwegs ver-
wendet. Dabei wurde zuerst ein glukoseinduziertes Eingangssignal zur Snf1 Regulation
hergeleitet. Zur Aufbereitung von Fluoreszenzmikroskopiedaten der Snf1 Signalwegkom-
ponente Mig1, wurde ein mathematisches Modell erstellt. Fluoreszenzmikroskopiedaten
sind mit unerwu¨nschten Nebeneffekten, wie Leuchten von Hintergrundmoleku¨len und Aus-
bleicheffekten behaftet. Das erstellte mathematische Modell ermo¨glicht es, die Fluoreszen-
zintensita¨t der Hintergrundmoleku¨le abzuziehen und die Ausbleichrate der Hintergrund-
moleku¨le und die der Mig1-GFP-Proteine zu bestimmen und zu kompensieren, so dass
Vorhersagen u¨ber die Dynamik von Mig1 gemacht werden ko¨nnen, wie sie ohne diese
Nebeneffekte auftreten wu¨rden. Die aufbereiteten Daten wurden zusammen mit dem
hergeleiteten Eingangssignal und Snf1 Western Blot Daten zur Analyse mehrerer alter-
nativer Snf1 Netzwerkstrukturen verwendet. Dabei wurde gezeigt, dass ein zusa¨tzlicher
glukoseregulierender Schritt fu¨r die Regulation des Snf1 Signalwegs erforderlich ist.
Quantitative Maße ko¨nnen zur Charakterisierung der Dynamik von Komponenten eines
Signalwegs angewendet werden. Beispiel sind die mittlere Dauer, die eine Komponente ak-
tiviert bleibt oder die mittlere Zeit, die sie braucht, um aktiviert zu werden. Die Beschrei-
bung solcher Eigenschaften ist nu¨tzlich, um Konsequenzen unterschiedlicher Netzwerk-
strukuturen aufdecken zu ko¨nnen. Bei Krankheit der Zelle sind solche Eigenschaften unter
Umsta¨nden vera¨ndert. Im zweiten Teil dieser Arbeit werden ausgehend von der charak-
teristischen Kaskadenstruktur eines MAPK Signalweges, bestehend aus drei Ebenen und
zwei Doppelphosphorylierungen, Signalwegsstrukturen mit Hilfe von quantitativen Maßen
untersucht und verglichen. Dabei wurde unter Beru¨cksichtigung der MAPK spezifischen
Versta¨rkung gezeigt, dass die Struktur der MAPK Kaskade daraufhin ausgerichtet sein
ko¨nnte, ein Eingangssignal mit schneller Aktivita¨tszeit und kurzer Dauer zu u¨bertragen.
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1. Introduction
All cells, whether they live as individuals or in multicellular organisms, are exposed to a
diversity of signals, such as light, odours, nutrients, temperature, hormones, or changes in
ion concentrations [Hancock 2010]. The potential to sense and to respond to them in an
appropriate manner is crucial to survival. Therefore, cells must be able to detect signals
and to transmit that information, a process termed cellular signalling or signal transduc-
tion [Asthagiri and Lauffenburger 2000]. The focus of this work lies in signalling in the
context of energy sensing, which is linked to glucose uptake and metabolism. The AMPK
pathway acts as a main energy sensor controlling metabolic pathways and appears to be
highly conserved between vertebrates, plants, and yeasts [Woods et al. 1994; Mitchelhill
et al. 1994; Carling 2004; Hedbacker and Carlson 2008]. In this thesis, the mathematical
modelling is accomplished on the level of the AMPK counterpart in the yeast Saccha-
romyces cerevisiae, the Snf1 pathway. The mathematical modelling of the Snf1 pathway
comprised at first the definition of a glucose regulated stimulus. For this reason, also the
process of glucose transport into the yeast cell is discussed. Furthermore, the proceeding
of fluorescence microscopy data of a Snf1 pathway component is discussed, separating the
information of interest from bleaching effects and background noises. The processed data
is then compared to the model simulations. In the second part of this work, quantitative
measures, which define properties such as the average time until a pathway component is
activated, are used to elucidate deviations between different model approximations as well
as to quantify differences between different pathway structures.
1.1. Signal transduction pathways
Cells realise and control the sensing, transduction, and response to a diversity of signals
via networks of interacting proteins, groups of which are organised into signalling path-
ways. The specificity of the cellular response to a certain stimulus is encoded by the
spatial and temporal dynamics of signalling networks [Kholodenko 2006]. By this means,
cellular processes are regulated, e.g. development, tissue function, and immune response
[Asthagiri and Lauffenburger 2000; Wolkenhauer 2007]. Figure 1.1 illustrates the main
steps of cellular signalling. The first step in cellular signalling is the recognition of the
signal by signal specific plasma membrane receptors, such as G protein-coupled receptors
(GPCRs) and receptor tyrosine kinases (RTKs). The specificity of the signal is a precon-
1
1. Introduction
1.) The recognition of the 
      signal by a receptor
2.) The transmission of
      the signal to the interior
3.) Passing on the signal  ...
4.) Signal reaches its final
      destination, e.g. nucleus
5.) The appropriate
      respone, e.g.
      control of 
      gene expression
environmental signals
receptor receptor
cell membrane
signalling
molecules
DNA
nuclear envelope
Figure 1.1.: Simplification summarising the main steps of signal transduction: An extracellular
stimulus is transduced by a membrane receptor into the intracellular environment. The signal is
translated and passed on in a series of biochemical reactions towards its destination to precipitate
the appropriate response, for example the transcription of certain genes.
dition to ensure the correct cellular response. The second step comprises the transmission
of the signal to cytoplasmic proteins. In a third step, the signal is passed on to a series of
complex biochemical circuits of protein interactions and modifications, often referred to
as cascades, that leads the signal to a defined place within the cytosol or nucleus [Kholo-
denko 2006; Hancock 2010]. The transfer and processing of a signal can be accomplished
through biochemical reactions such as (de)phosphorylation, (de)methylation, ubiquitina-
tion, or complex associations and dissociations. The final step includes the arrival of the
signal at its destination resulting in the appropriate cellular response. In the simplest case,
regulatory signalling pathways are of linear structure, but more often, their structure in-
clude feedback and feedforward mechanisms allowing for complex responses, e.g. sigmoidal
switches, transient responses, hysteretic switches, and oscillators [Tyson et al. 2003]. The
different outcomes are determined by the kinetic parameters of the components, the net-
work structure, and the input signal. For example, a sustained (long duration) activation
of ERK leads to differentiation, whereas a transient (short duration) activation of ERK
leads to proliferation [Marshall 1995]. The investigation of signal transduction pathways
is important to understand the functioning of intact cells and hence, to understand the
malfunctions of cells that lead to diseases, such as cancer or diabetes [Hancock 2010].
Accordingly, the medical and drug developing research increasingly focus on gathering
2
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information on the dynamic interactions between the components of signalling pathways
[Levitzki 1996].
Three examples of signal transduction pathways, analysed in this thesis, will be intro-
duced in the following.
1.1.1. The AMP-activated kinase pathway
Given that most biological processes such as cell growth, division or movement require
energy, it is not surprising that cells and organisms have the ability to sense energy levels
in order to adapt their energy household to their current demands [Canto´ and Auwerx
2010]. The adenosine monophosphate activated protein kinase (AMPK) is a key energy
sensor in cells and well conserved among almost all eukaryotes [Carling et al. 1994; Woods
et al. 1994; Mitchelhill et al. 1994; Carling 2004]. In multicellular organisms, AMPK
regulates a variety of cellular and physiological responses including carbohydrate and lipid
metabolism and appetite regulation [Hardie et al. 2003; Carling 2004; Gruzman et al. 2009].
Activated by a low energy status, AMPK switches cellular metabolism from anabolic to
catabolic mode by turning on ATP-producing catabolic pathways (e.g. glycolysis, fatty
acid oxidation, and glucose uptake) and switches off ATP-consuming anabolic pathways
(e.g. lipogenesis, gluconeogenesis, and protein synthesis) [Hardie 2007; Canto´ and Auwerx
2010].
Malfunctions of the AMPK pathway have been associated with diabetes type two [Gruz-
man et al. 2009] and obesity [Kola et al. 2008], which are some of the presently most
prevalent diseases [Viollet et al. 2007; Steinberg and Kemp 2009], and more recently, also
with cancer [Zadra et al. 2010].
1.1.2. The AMPK counterpart in Saccharomyces cerevisiae: Snf1
The yeast S. cerevisiae is highly amenable to genetic, biochemical, and cell biological
studies, and was the first eukaryote to have its entire genome sequenced [Chen and Thorner
2007]. Thereon, it has been used as a reference for comparison to sequences of humans and
animals. Many pathways are conserved between eukaryotes, hence allowing for studies of
pathways in model organisms that are easier to manipulate than in mammalian systems
[Petranovic et al. 2010]. For this reason, the investigation of interrelations between the
components of the Snf1 pathway, which is the AMPK counterpart in yeast, are of huge
interest.
The enzyme kinase Snf1 plays a crucial role in regulating cellular metabolism under
changing glucose conditions by controlling gene expression and regulating metabolic en-
zymes [Celenza and Carlson 1986; Gancedo 2008; Hedbacker and Carlson 2008]. Upon
glucose limitation, Snf1 is activated adapting gene expression to provide the metabolic
equipment for the usage of other carbon sources than glucose [Gancedo 1998; Carlson 1999;
3
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McCartney and Schmidt 2001; Santangelo 2006; Hong and Carlson 2007]. Upon glucose
presence, the Snf1 pathway is inhibited [Wilson et al. 1996; McCartney and Schmidt 2001].
Snf1 is activated by other stress signals as well, e.g. sodium ion stress, alkaline pH, and
oxidative stress [Hong and Carlson 2007], which leads to its involvement in various pro-
cesses, such as thermotoleration, sporulation, phospholipid synthesis, aging, and meiosis
[Thompson-Jaeger et al. 1991; Hedbacker and Carlson 2008; Smets et al. 2010] adapting
the cell to the corresponding type of stress.
Cells lacking Snf1 are unable to use sucrose, galactose, or nonfermentable carbon sources,
and display sporulation defects [Carlson et al. 1981; Celenza and Carlson 1986]. Cells
overproducing Snf1 have been shown to display accelerated aging [Hedbacker and Carlson
2008].
1.1.3. MAPK cascades
Ubiquitous among eukaryotes, mitogen-activated protein kinase (MAPK) pathways relay
extra- or intracellular stimuli to the nucleus controlling a plethora of cellular processes,
such as growth, proliferation, differentiation, migration and apoptosis [Rubinfeld and Seger
2005; Shaul and Seger 2007]. There are at least six groups of MAPKs identified in mam-
mals [Dhillon et al. 2007]. The central intracellular building blocks of all MAPK cascades
are composed of three to five tiers of protein kinases, which sequentially activate each
other by phosphorylation [Shaul and Seger 2007]. Three tiers (i.e. MAPK, MAPKK, and
MAPKKK) are considered to be the core cascade, whereas the components in the other
tiers are not always involved [Rubinfeld and Seger 2005]. Such a simple sequential ki-
nase cascade allows for sensitive responses towards a signal [Kholodenko 2000]. MAPK
cascades can also be embedded in positive or negative feedback loops [Kholodenko 2000].
An example for the structure of a MAPK pathway is depicted in Figure 1.2. The ERK
kinase was the first MAP kinase to be elucidated [Seger and Krebs 1995]. Their ability
to regulate a wide range of cellular processes is due to different mechanisms including
signal duration and strength, interaction with scaffold proteins, subcellular localisation,
and crosstalk [Shaul and Seger 2007].
Dysfunctions of these pathways contribute to the development of cancer [Dhillon et al.
2007] and various metabolic disorders, such as insulin resistance, obesity, and hypertension,
which are collectively known as metabolic syndrome [Gehart et al. 2010].
1.2. Mathematical modelling of signal transduction pathways
Systems biology [Ideker et al. 2001; Kitano 2002; Wolkenhauer et al. 2003; Kohl et al. 2010]
aims at understanding cellular functioning as a well organised system of dynamic processes.
Combining experimental data with mathematical models is a promising approach to gain
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Figure 1.2.: Schematic representation of a three level MAPK cascade. Upon activation via an
extracellular stimulus, sequential phosphorylation/activation is conducted: MAPKKK phospho-
rylates its downstream target MAPKK at two phosphorylation sites. The activated MAPKK
thereon acts by double phosphorylating MAPK, which initiates diverse responses involving cell
growth, differentiation, and stress responses. Kinase cascades allow for sensitive responses to-
wards a signal [Kholodenko 2000]. The activated MAPK protein is denoted the most downstream
component. This figure was designed using CellDesigner [Funahashi et al. 2003].
insights into those complex systems. This so called systems biology approach [Kohl et al.
2010] provides a powerful foundation from which to address critical scientific questions
that are fundamental to our understanding of living cells [Materi and Wishart 2007; Voit
and Kemp 2011].
Systems are called ‘complex’ if their behaviour cannot be understood from the laws that
govern their subsystems. According to Voit et al. [Voit et al. 2008], this mainly is due to
three reasons: i) a large number of components that are either unknown or only partly
understood, ii) the network structure, allowing for several different interactions among
the components, and iii) the occurrence of invisible thresholds, i.e. strikingly different
behaviour of the system as the parameter values change. Hence, modelling is needed where
we cannot make reliable predictions about the biological system with intuition alone.
One of the first steps of the modelling process is the determination of the mathemati-
cal framework. This decision depends on practical or experimental considerations, such
as the goal and purpose of the model, the available experimental data, mathematical
conveniences, and personal preferences [Materi and Wishart 2007; Voit et al. 2008]. For
choosing the appropriate framework, one should consider the following aspects: Do we
seek to establish a
• dynamic model (e.g. a signalling pathway model) or a static model (e.g. a metabolic
pathway model that is restricted to a steady-state)
• a deterministic model (e.g. a model describing the average behaviour is sufficient) or
a stochastic model (e.g. a model determining how far the system could deviate from
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its normal value) [Voit et al. 2008]?
A common approach for deterministic models is based on ordinary differential equations,
denoted ODEs [de Jong 2002]. Thereby, it is assumed that the components are present in
large amounts and that fluctuations do not generate a different behaviour. In other words,
the average value is a sufficiently good description of the components’ behaviour.
In contrast to stochastic approaches, simulations can be conducted with less computa-
tional time, and the tools of analyses, such as parameter estimations, are better developed.
However, eventually, the question that is to be addressed will be pivotal in deciding about
the mathematical framework. If the average behaviour is a sufficient description for the
dynamics of the components, a deterministic model may comply with the requirements
while allowing for less technical effort [Voit et al. 2008]. Focusing on a dynamic system
with transient continuous changes and assuming that the average value is sufficient to
describe the system’s behaviour, we use a deterministic approach for our mathematical
models.
Once the model, based on a certain framework and assumptions about the biological
system, has been defined, values for rate constants and other parameters have to be
determined. This can be achieved by fitting the model to experimental data. Thereby, for
a predictive character of the model, identifiability of the parameters should be guaranteed
[Balsa-Canto et al. 2010]. The next step it to test and analyse the model. Due to its
simplified nature, a model will never be able to respond to all possible scenarious correctly.
It is only defined to respond reasonably in relevant situations.
Experimental techniques, which generate data on the spatio-temporal interactions of
cellular components, are essential in order to allow for identification, selection, and char-
acterisation of the components of a pathway [Wolkenhauer 2007]. In the following para-
graphs, technologies used for experimental data generation of this thesis will be presented.
1.3. Technologies for data generation
Systems biology is on the rise because of developments in molecular biology and biophysics,
i.e. techniques to isolate, sequence, or manipulate proteins, characterise their biochemical
activities, and determine their structural properties [Vidal 2009]. Thus, experimental
data are generated in diverse forms ranging from quantitative dynamic time series data
to qualitative static data.
To generate the data for the experimental system in this thesis (i.e. the Snf1 pathway),
the well established technologies Western blotting and fluorescence microscopy were used.
They are explained in the following paragraphs.
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1.3.1. Western blotting
The technique of Western blotting provides measurements of relative changes of protein
levels detecting the protein of interest by means of separation by gel electrophoresis and
antibody labeling [Alberts et al. 2002]. In some cases there exist antibodies that are
specific to an antigenic region in the protein structure allowing for direct detection of
different proteins. More often, the antibody is specific towards a tag that is attached to
the protein of interest. For these experiments presented in this thesis, a protein specific
antibody for Snf1 and a second antibody that specifically recognises the phosphorylated
Snf1 were commercially available. However, for another protein of interest, Mig1, no
protein specific antibody for phosphorylated Mig1 was available. Thus, another way of
data generation had to be chosen as is introduced in the next part.
1.3.2. Fluorescence microscopy
Fluorescence microscopy in combination with optical tweezers and microfluidics has be-
come a powerful tool to assay biological structures and processes in the physiological
context of intact living cells [Pepperkok and Ellenberg 2006; Fujioka et al. 2006; Ishii
et al. 2010]. It can be used to acquire images with high spatial and temporal resolution
that allow quantitative information regarding the response of single cells to environmental
changes to be extracted as demonstrated in [Eriksson 2009].
The data generated using this technique and presented in this thesis are intensity data
of the protein Mig1 in the nucleus under changing glucose concentrations. Tagging the
brightly glowing green fluorescent protein GFP to the invisible protein of interest (Mig1)
allowed the observation of the movements and positions of Mig1-GFP.
1.4. Glucose uptake and metabolism in yeast
The Snf1 kinase is essential for the yeast cell to adapt to glucose limiting conditions and
to utilise other carbon sources than glucose, e.g. sucrose. The identity of the glucose
signal as well as the mechanisms, by which it is transduced to Snf1, have remained elusive
[Rubenstein et al. 2008]. However, it is assumed that the signal is related to the first step
of glycolysis, converting intracellular glucose into glucose-6-phosphate. For describing the
Snf1 dynamics, a glucose-regulated stimulus needs to be derived. As a basis for this
derivation, the rate of glucose consumption of yeast cells needs to be taken into account.
This rate depends on the extracellular glucose concentrations and the hexose transporters
composition within the cell membrane.
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1.4.1. Hexose transport
Lipid bilayers, such as cell membranes, allow for the passage of water and nonpolar molecu-
les (CO2, O2, etc.) down their concentration gradients due to random thermal movements,
a process termed diffusion [Elliott and Elliott 2005]. In contrast to that, the passage of
various polar molecules, such as sugars and ions, is accomplished by special membrane
transport proteins classified into ion channels and carrier proteins [Alberts et al. 2002].
Channel proteins form a pore across the membrane through which specific molecules can
diffuse down their concentration gradient, a process termed passive transport or facilitated
diffusion [Alberts et al. 2002]. Carrier proteins, unlike ion channels, undergo a series of
conformational changes in order to transport a molecule across the membrane. Some car-
rier proteins do so by passive transport, but there are also special carrier proteins (pumps)
to transport molecules actively against their concentration gradient, a process called ac-
tive transport. Active transport requires a source of energy such as ATP to catalyse these
energetically unfavourable movements [Alberts et al. 2002].
The yeast S. cerevisiae preferably subsists on glucose and fructose, which are transported
into the cell by passive, energy-independent facilitated diffusion [Romano 1982; Bisson and
Fraenkel 1984; Zaman et al. 2008] mediated by a large hexose transporters family [Boles
and Hollenberg 1997]. In its natural habitat, yeast is exposed to wide ranges of glucose
levels. Due to that, not only the sensing of the presence or absence of glucose is a crucial
property but also to determine the amount [Bisson and Kunathigan 2003]. Equipped with
several kinds of hexose transporter proteins, which differ in their affinity towards glucose
[Lagunas 1993], yeast is able to grow under variable conditions from approximately 0.1% to
over 40% glucose [Greatrix and Vuuren 2006]. The glucose induction pathway transmits a
signal in the presence of glucose that eventually leads to the induction of hexose transporter
genes [Johnston 1999; O¨zcan and Johnston 1999; O¨zcan 2002]. Thereby, in response to
certain glucose concentrations, yeast cells express hexose transporters that are of low,
mediate, or high affinity towards glucose, allowing for a highly specialised and efficient
glucose transport system [Kruckeberg 1996; Boles and Hollenberg 1997]. The family of
hexose transporters has been defined on the basis of sequence similarity and consists of at
least 20 members including Hxt1-Hxt17, Gal2, Snf3, and Rgt2.
1.4.2. Respiration and fermentation
S. cerevisiae utilises glucose as main carbon and energy source for biosynthesis. Glycol-
ysis is the metabolic pathway to break down glucose into pyruvate, thereby generating
the nucleotide ATP and the coenzyme NADH. S. cerevisiae is able to utilise pyruvate in
different ways [Zaman et al. 2008; Smets et al. 2010]. At high glucose concentrations, it
prefers fermentation with the release of ethanol and CO2 rather than respiration. This
process allows rapid cell growth [Bisson and Kunathigan 2003]. At low glucose concentra-
8
1.5. Quantitative measures
tions and in the presence of oxygen, S. cerevisiae uses the most efficient way to generate
ATP molecules at the expense of the maximal speed of yeast cell growth. This is ac-
complished in the process of respiration, which includes as the first step the conversion of
pyruvate into acetyl CoA (coenzyme A), followed by the citric acid cycle and the oxidative
phosphorylation.
1.5. Quantitative measures
As recent experimental and theoretical studies have shown, key parameters for the cellular
response are timing and order of events [Rensing et al. 2001; Murphy and Blenis 2006],
signal duration [Marshall 1995; Ferrell Jr. 1996; Sabbagh et al. 2001; Vaudry et al. 2002;
Millat et al. 2008] as well as signal strength (thresholds) [Behar et al. 2008]. On the one
hand for example, cells that do not react quickly enough to changing nutrient conditions
risk being overgrown by competitors that are more efficient on the uptake rates. On the
other hand, cells that respond too quickly risk wasting energy on the response itself and
being overgrown by more efficient competitors [Kalisky et al. 2007]. Additionally, the
duration should be long enough to be distinguishable from noise, while not expanding
the duration of signal transmission longer than needed. For example, it was observed in
cells of the neuroendocrine cell line PC12 that the duration of signalling through ERK
may hold the key to the very different outcomes of EGF and NGF stimulation [Sabbagh
et al. 2001; Vaudry et al. 2002]. As reported in [Marshall 1995], the duration of ERK
activation determines whether cells can trigger either proliferation or differentiation. The
characterisation of dynamic features of signal transduction pathways is therefore crucial
to describe cellular adaptation.
The meaningful determination of quantitative properties for dynamic signals is not
simple. In this work, the definitions by Heinrich et al. [Heinrich et al. 2002] are applied.
They defined measures to quantify the average signalling time, average signal duration,
and the signal amplitude using three different integrals over a dynamic signal.
1.6. Aims and objectives
In the first part of this thesis, the biological background and the mathematical model-
ling of the Snf1 pathway is discussed (Chapters 2 and 3, respectively). To gain deeper
understanding of the interrelations within the Snf1 pathway components, coincided with
the need for derivation of a glucose-regulated input signal controlling Snf1 regulation and
the processing of fluorescent microscopy data. Thereafter, several alternative ODE-based
models were established describing different hypotheses about the underlying network
structures. The simulations were compared to experimental time course data generated
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by the groups of Stefan Hohmann1, Mattias Gokso¨r2, and Goutham Vemuri3 from the
University of Gothenburg. The questions of focus are as follows:
i) How can the still unknown signal, which leads to the regulation of the Snf1 pathway,
be described and incorporated into the Snf1 pathway model?
ii) How can fluorescent microscopy data, exposed to bleaching and affected by back-
ground noise, be processed to extract the information of the protein of interest?
iii) Is the regulation of Mig1, which is a target of Snf1, controlled by glucose, or could it
be constitutive?
iv) Is the involvement of the Snf4-subunit required for explaining the experimental ob-
servations?
v) Is the regulation of Snf1 mediated by a glucose-regulated kinase or a glucose-regulated
phosphatase, or even both?
The second part of this thesis comprises the introduction and application of quantitative
measures to signalling pathways (Chapters 4 and 5, respectively). Here, the questions of
focus are:
i) Which parameter values do still allow for a sensible description of the biological system
while applying a weakly activated system?
ii) How to define a plausible optimisation criterion for comparing different pathway struc-
tures?
iii) What are the consequences of three different model approximations with respect to
time and duration describing the same pathway structure?
iv) Is the characteristic structure of a MAPK pathway, comprising two double phospho-
rylations, of advantage for signal transmission with respect to the average time and
average duration of active signal?
1.7. Outline of this thesis
This work is structured as follows:
Chapter 2 reviews the biological background of this thesis by introducing the AMPK
pathway and its homologue pathway in S. cerevisiae, the Snf1 pathway. This information
1Department of Cell and Molecular Biology, University of Gothenburg, SE-40530 Go¨teborg, Sweden.
2Department of Physics, University of Gothenburg, SE-41296 Go¨teborg, Sweden.
3Department of Chemical and Biological Engineering, Chalmers University of Technology, SE-41296
Go¨tborg, Sweden.
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provides the basis to follow the assumptions of network structures, which lead to a stepwise
Snf1 model development in Chapter 3. Moreover, the importance for investigating the
interrelations of the Snf1 pathway components for medical research is emphasised.
Chapter 3 comprises the steps of data processing and Snf1 pathway model develop-
ment. First, the derivation for a suitable definition of the glucose-regulated signal, which
leads to the regulation of Snf1, is discussed. This work has been submitted for publica-
tion [Frey et al. 2011a]. Then, the processing of fluorescent microscopy data for the Snf1
pathway component Mig1-GFP is presented. The data suffer from bleaching effects and
background noises. A mathematical model is established that allows for the extraction
of Mig1-GFP intensities by taking bleaching effects and background noises into account.
This work has been published in [Frey et al. 2011b]. In a final step, those results are
combined with Snf1 Western blot data and compared to alternative network structures
underlying Snf1 pathway.
Chapter 4 begins by introducing quantitative measures, as defined by Heinrich et
al. [Heinrich et al. 2002]. These definitions build the basis for the onward analyses. An
optimality criterion is defined as a measure for the optimal cascade length (i.e. the number
of tiers) concerning average time and average duration of active cascade components. This
is followed by an analysis of limits for a weakly activated system by determining those
parameter value sets that lead to biological nonsensical results, exemplarily for a cascade
with one phosphorylation cycle as published in [Frey et al. 2008].
In Chapter 5, the optimality criterion of Chapter 4 is applied to three MAPK path-
way models, which differ in their underlying approximations, discussing consequences of
approximations. These models are extended for hypothetical cascade structures varying
in tiers and number of phosphorylations in order to address the question of focus: Is the
characteristic structure of a MAPK pathway, comprising two double phosphorylations,
of advantage for signal transmission with respect to time and duration? This chapter
includes the main contents published in [Frey et al. 2008] and [Frey et al. 2009].
Chapter 6 concludes this work by summarising the main results and by giving an
outlook on future research topics.
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2. Biological background of the
AMP-activated kinase pathway
In this chapter, a review of the biological background of this thesis is given by introducing
the AMPK pathway and its homologue in yeast, the Snf1 pathway. This information pro-
vides the basis to follow the assumptions of network structures, which lead to a stepwise
Snf1 model development discussed in Chapter 3. Moreover, malfunctions of the AMPK
pathway are briefly discussed. At the end, a summary of glucose transport into the yeast
cell is given.
Given that most biological processes such as cell growth, division, or movement require
energy, it is not surprising that cells and organisms have the potential to sense energy levels
in order to adapt their energy household to their current demands [Canto´ and Auwerx
2010]. The adenosine monophosphate activated protein kinase (AMPK) is a key energy
sensor of the cell controlling metabolic pathways and appears to be highly conserved
between vertebrates, plants, and yeasts [Carling et al. 1994; Woods et al. 1994; Mitchelhill
et al. 1994; Carling 2004]. In yeast, AMPK regulates gene expression under changing
glucose conditions [Gancedo 1998; Carlson 1999; Johnston 1999; Gancedo 2008; Hedbacker
and Carlson 2008]. In multicellular organisms, it is involved in maintaining whole body
energy balance [Hardie et al. 2003; Carling 2004; Canto´ and Auwerx 2010]. Therefore, it is
not surprising that defects in this pathway are responsible for the development of metabolic
diseases. In particular, the malfunction of the AMPK pathway has been associated with
some of the presently most rapidly advancing diseases, such as diabetes type two and
obesity [Towler and Hardie 2007; Viollet et al. 2007; Kola et al. 2008; Gruzman et al.
2009; Steinberg and Kemp 2009]. Recent findings implicate malfunctions in the AMPK
pathway in cancer [Huang et al. 2008; Shackelford and Shaw 2009; Zadra et al. 2010;
Fogarty and Hardie 2010]. Gathering information on the dynamic interactions between the
components of signalling pathways has become a focus of the medical and drug developing
research [Levitzki 1996], in particular, gaining insights into the AMPK/Snf1 pathway aims
at tackling diabetes type two and obesity.
A detailed overview of the involvement of AMPK in cellular processes and its regulation
is depicted in Figure 2.1 and described in the following section.
The AMPK complex: The mammalian AMPK is a heterotrimeric serine/threonine
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kinase, which is composed of a catalytic subunit (α) and two regulatory subunits (β and γ)
[Davies et al. 1994; Hardie 2007]. Each subunit is encoded by at least two genes, i.e. there
are two isoforms for the α-subunit (denoted α1 and α2), two for β-subunits (β1 and β2),
and three for γ-subunits (γ1, γ2, and γ3), yielding 12 heterotrimeric combinations [Carling
2004]. The different isoforms display tissue-specific expression and activity [Steinberg and
Kemp 2009].
2.1. The adenosine monophosphate activated protein kinase
(AMPK)
P
P
P
P
P
P
P
P
P
Figure 2.1.: Overview of the involvement of AMPK into metabolic and signalling processes.
For further explanation please see Section 2.1. This figure was designed using the software
CellDesigner [Funahashi et al. 2008] and Adobe Illustrator Cs5.
Regulation of AMPK activation: Phosphorylation of the threonine residue 172
(Thr-172) within the catalytic α-subunit is essential for AMPK activation [Hawley et al.
1996; Stein et al. 2000]. Furthermore, the enzyme activity is affected by post-translational
modification of the β-subunit through myristoylation1 and phosphorylation at three ser-
ine residues (Ser-24 or Ser-25, Ser-108, and Ser-182) [Warden et al. 2001; Hamilton et al.
2002]. The β-subunit acts as a scaffold bridging the α- with the γ-subunit [Woods et al.
1996]. One of the critical features of the enzyme is contained in its regulatory γ-subunit
1Myristoylation is a protein modification binding a myristoyl group.
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[Xiao et al. 2007] comprising an interface for interaction with two AMP or ATP molecules
in a mutually exclusive way and a third AMP molecule in a non-exchangeable fashion
[Xiao et al. 2007; Canto´ and Auwerx 2010]. The exchange of ATP for AMP promotes an
approximately five-fold activation of AMPK via an allosteric mechanism [Hawley et al.
1996]. The mechanisms of rising AMP levels triggering AMPK phosphorylation are not
completely understood yet [Oakhill et al. 2010]. However, it was shown that AMP bind-
ing to the γ-subunit stimulates phosphorylation of AMPK (at Thr-172), provided that the
β-subunit is myristoylated [Oakhill et al. 2010] and protects the enzyme against dephos-
phorylation [Sanders et al. 2007; Xiao et al. 2011]. AMP binding also causes allosteric
activation [Sanders et al. 2007; Xiao et al. 2011]. Both AMP-promoted effects, i.e. the
allosteric and phosphorylation effects, increase the activation of AMPK approximately
1000-fold [Suter et al. 2006; Canto´ and Auwerx 2010]. The compound AICAR can be
used as an experimental tool to activate AMPK. Upon intake into the cell, it is converted
to an AMP analogue called ZMP. ZMP mimics the effects of AMP on AMPK.
Once activated by metabolic stresses, e.g. hypoxia, ischaemia, muscle contraction, or sim-
ply glucose deprivation causing depletion of ATP [Corton et al. 1994], AMPK changes
the mode of metabolism by switching off ATP-consuming anabolic processes that are not
essential for the immediate survival of the cell and by stimulating catabolic processes that
generate ATP [Corton et al. 1994; Hardie 2007]. It thus keeps an appropriate balance
between the energy-producing catabolic and energy-consuming anabolic processes.
So far, two upstream kinases of AMPK are identified, LKB1 [Hawley et al. 2003; Woods
et al. 2003; Shaw et al. 2004] and CaMKKβ [Hawley et al. 2005; Woods et al. 2005; Hur-
ley et al. 2005], whereas the exact identity of the phosphatase remains elusive [Canto´ and
Auwerx 2010]. LKB1 activity requires the formation of a complex with two additional
proteins, STRAD and MO25 [Hawley et al. 2003; Boudeau et al. 2003]. Upon complex
formation, it is transported from the nucleus to the cytosol, where it performs its biolo-
gical function [Boudeau et al. 2003]. Whereas the LKB1 complex is constitutively active
[Sakamoto et al. 2004; Lizcano et al. 2004], the LKB1 subunit achieves only weak activa-
tion [Hawley et al. 2003]. LKB1 serves as an upstream kinase for different AMPK-related
kinases [Lizcano et al. 2004]. Substrate specificity for AMPK is created through binding
of AMP to AMPK making it a better substrate for LKB1 [Hawley et al. 2003]. The other
upstream kinase of AMPK identified yet is the Ca2+/calmodulin-dependent kinase kinase
(CaMKK) [Hawley et al. 2005; Woods et al. 2005; Hurley et al. 2005]. Phosphorylation
of AMPK by CaMKKβ is stimulated by a rise in Ca2+-ions, independent of a rise in
AMP levels [Hawley et al. 2005; Hurley et al. 2005; Woods et al. 2005; Suter et al. 2006].
Tak1 (transforming growth factor-β-activated kinase 1) has been reported to be capable
of phosphorylating AMPK in vitro and is thus suggested to be a candidate for a third
AMPK kinase [Momcilovic et al. 2006; Canto´ and Auwerx 2010].
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AMPK is a multisubstrate enzyme. Targets of activated AMPK range from lipid- and
carbohydrate- to protein-metabolism.
Targets of activated AMPK in lipid-metabolism: The first targets for AMPK
to be identified were acetyl-CoA carboxylase (denoted ACC) [Carlson and Kim 1974] and
3-hydroxy-3-methylglutaryl-CoA (denoted HMG-CoA) reductase [Beg et al. 1973], which
play a key role in fatty acid synthesis and cholesterol synthesis, respectively. AMPK in-
hibits by phosphorylation both isoforms of the acetyl-CoA carboxylase, denoted ACC1
(cytoplasmic) and ACC2 (primarily mitochondrial) [Hardie and Pan 2002]. Both isoforms
of ACC catalyse the reaction forming malonyl-CoA from acetyl-CoA. Malonyl-CoA pro-
duced by ACC1 is used in lipid synthesis, malonyl-CoA produced by ACC2 is exclusively
involved in regulation of fatty acid oxidation [Hardie and Pan 2002]. Thus, the inactiva-
tion of ACC1 through AMPK leads to inhibition of fatty acid synthesis conserving ATP
under cellular stress. Inactivation of ACC2 leads to increasing the uptake of fatty acids
into mitochondria via the carrier CPT-1b, which is no longer blocked by ACC2 [Mills et al.
1983]. Thus, AMPK induces β-oxidation stimulating ATP synthesis [Merrill et al. 1997].
Targets of activated AMPK in carbohydrate-metabolism: Animals compensate
for long periods of fasting by converting sugars (and also fats) into special forms of storage
such as glycogen in a process called glycogenesis [Alberts et al. 2002]. Glycogen is a short-
term energy storage composed of glucose subunits. AMPK deactivates glycogen synthase,
the enzyme that mediates the production of glycogen. This results in the inhibition of
glycogenesis [Carling and Hardie 1989; Jørgensen et al. 2004]. Thus, glucose is available
for energy production. On the other hand, the AMPK-induced phosphorylation of PFK-2
(6-phosphofructo-2-kinase) results in an increased synthesis of fructose-2-6-bisphosphate, a
potent stimulator of PFK1 (phosphofructokinase 1), which has a key role in the regulation
of glycolysis. Thus, AMPK promotes ATP production also via the metabolic pathway
glycolysis [Marsin et al. 2000].
In skeletal muscles, AMPK stimulates glucose uptake [Merrill et al. 1997] by translo-
cation of the glucose transporter GLUT4 to the plasma membrane [Kurth-Kraczek et al.
1999] and by increasing its expression [Holmes et al. 1999] in order to provide ATP as
a fuel. However, the exact events that link AMPK activation to GLUT4 translocation
are not fully understood yet [Canto´ and Auwerx 2010]. In contrast to that, in adipocytes
(fat cells), AMPK stimulation inactivates insulin-stimulated glucose transport, inhibiting
triacylglycerol synthesis, to conserve ATP under conditions of cellular stress [Salt et al.
2000].
Binding of the hormone insulin to an insulin receptor (IR) is followed by the binding and
phosphorylation of an insulin receptor substrate (IRS-1) that trigger various mechanisms,
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such as activation of the glycogen synthase and the translocation of a glucose transporter
(GLUT4) to the cell membrane [Muoio and Newgard 2008].
Targets of activated AMPK in protein-metabolism: Protein synthesis utilises
cellular energy. Thus, in order to maintain sufficient cellular ATP levels under metabolic
stress, inhibition of translation of proteins, which are evitable for the immediate survival
of the cell, is a crucial property. The phosphorylation and inactivation of eEF-2K (eu-
karyotic elongation factor 2 kinase) by AMPK leads to a temporary pausing of translation
at elongation [Horman et al. 2002]. Translation can resume quickly upon normal ATP
levels [Horman et al. 2002]. AMPK also inhibits translation by phosphorylation of TSC2
(tuberous sclerosis 2) [Inoki et al. 2003] that functions as a key player in the regulation
of the mTOR pathway. The mTOR (mammalian target of rapamycin) pathway controls
protein synthesis, glucose homeostasis, and fat metabolism [Steinberg and Kemp 2009]. It
can also be inhibited through direct phosphorylation of the raptor subunit of the mTOR
complex by AMPK [Gwinn et al. 2008]. The inhibition of the mTOR pathway leads to
attenuation of protein biosynthesis and to the induction of protein degradation [Polak and
Hall 2009].
2.2. Malfunctions of the AMPK pathway
Malfunctions of the AMPK pathway, i.e. AMPK is not activated upon metabolic stress,
are associated with the metabolic syndrome, which comprises diseases as diabetes type
two, insulin resistance, cardiovascular disease and fatty liver disease [Winder and Hardie
1999; Steinberg and Kemp 2009; Fogarty and Hardie 2010]. However, it is still unclear
whether they are causes or consequences of the pathological conditions [Kola et al. 2008].
In addition to the metabolic syndrome, it increasingly is becoming clear that AMPK rep-
resents a link between energy homeostasis and cancer, in particular, prostate cancer [Zadra
et al. 2010]. Thus, treatments applying AMPK activators are a promising target in the
medical research [Zadra et al. 2010].
Whereas diabetes type one is characterised by the complete absence of insulin, due to
autoimmune destruction of the pancreatic islet β-cells, the primary factors causing di-
abetes type two are poorly understood [Savage et al. 2007; Muoio and Newgard 2008].
Due to the presence of insulin sensitivity in patients with diabetes type two several years
before the onset of diabetes type two and its consistent occurrence, is is assumed to play
a major role in the development of diabetes type two [Shulman 2000]. Insulin resistance
is characterised by an impaired insulin secretion or a non-insulin-dependent defect (i.e.
insulin is present while not effective). In consequence, insulin might be present or even
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elevated, but cells do not respond to it due to insensitivity caused by the downregulation
of the insulin receptors. Hence, blood glucose cannot be transported into the cells to be
stored for energy. Insulin resistance might be caused by lipotoxicity, which describes the
accumulation of lipids in other cell types than the target adipose tissue [Schaffer 2003;
Savage et al. 2007]. Whereas adipose tissues have a high capacity for storing lipids, cells
of non-adipose tissues have limited capacity. Thus, exceeded capacity leads to cellular
dysfunctions or even cell death [Schaffer 2003]. Adiponectin is a plasma protein exhibit-
ing anti-diabetic properties [Zhou et al. 2009]. Promoting LKB1 translocation out of the
nucleus into the cytosol, it stimulates the activation of AMPK, enhancing fatty-acid oxida-
tion, and therefore decreasing insulin resistance [Yamauchi et al. 2001; Zhou et al. 2009].
It also activates CaMKK by subsequently inducing Ca2+-release from the endoplasmic
reticulum [Zhou et al. 2009].
Metformin is a widely used drug for reducing the blood glucose levels in diabetes type
two mainly through inhibiting hepatic gluconeogenesis [Towler and Hardie 2007; Fogarty
and Hardie 2010]. The mechanism by which it leads to AMPK activation is still being
debated [Fogarty and Hardie 2010]. Positive effects of AMPK on insulin sensitivity can
be explained by findings that AMPK might be a potential modifier of insulin signalling
through phosphorylation of IRS-1 in vitro [Jakobsen et al. 2001]. AMPK also appears as
a promising target for cancer prevention and therapy [Luo et al. 2011]. AMPK performs
its function in various organs, especially in skeletal muscles (stimulation of glucose trans-
port and fatty acid oxidation) and liver (increase of fatty acid oxidation and decrease of
glucose output, decrease of cholesterol and triglyceride synthesis) [Gruzman et al. 2009].
The widespread cellular functioning of AMPK, ranging from metabolic effects through
appetite regulation, cell growth and differentiation to vascular functions [Gruzman et al.
2009], hamper drug target specificity and might cause unwanted and harmful side effects,
e.g. the biguanide phenformin was withdrawn as anti-diabetic drug due to the emergence
of lactic acidosis [Fogarty and Hardie 2010]. Furthermore, negative effects of consistent
AMPK activation include glycogen accumulation in the heart, inhibition of insulin secre-
tion, and increases in body weight due to appetite stimulation [Viollet et al. 2007; Kola
et al. 2008]. Accordingly, an ideal drug agent would only affect AMPK activity in periph-
eral tissues, such as the liver, while at the same time, not affect AMPK activity in the
hypothalamus, a portion of the brain which controls appetite. Thus, the agent enhances
fatty acid oxidation and glucose uptake and prevents cholesterol and triglycerides biosyn-
thesis, while reducing food intake and body weight [Viollet et al. 2007]. In addition to
side effects, resistance towards a drug agent due to genetic variations, which may alter
responsiveness, is a widely known challenge.
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2.3. The AMPK counterpart in Saccharomyces cerevisiae: Snf1
An introduction into the characteristics and functioning of Snf1 is given below and can be
retraced in Figure 2.2.
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Figure 2.2.: Overview of the Snf1 pathway and crosstalk to the Rgt2/Snf3 and PKA signalling
pathways. For further explanation see Section 2.3. The images were designed using the software
CellDesigner [Funahashi et al. 2008].
The Snf1 complex: Like AMPK, Snf1 is a heterotrimeric enzyme complex compris-
ing a catalytic α-subunit Snf1, a regulatory γ-subunit Snf4 [Celenza and Carlson 1989;
Celenza et al. 1989], and either of three alternative regulatory β-subunits Sip1-, Sip2-,
and Gal83-subunit [Erickson and Johnston 1993; Yang et al. 1994]. The proteins Sip1,
Sip2, and Gal83 serve as alternate members of the kinase complex [Erickson and Johnston
1993; Yang et al. 1994] leading to three possible alternative isoforms of the complex. The
β-subunit determines the localisation of the complex within the cell: in a glucose rich
medium, all three subunits are cytosolic, while in poor glucose conditions, Sip1 changes
its location to the vacuole, and Gal83 to the nucleus [Vincent et al. 2001], Sip2 staying
cytosolic [Vincent et al. 2001]. All three β-subunits are essential for the response to star-
vation for nutrients, such as glucose [Schmidt and McCartney 2000]. In homology to the
mammalian β-subunit, also the Sip1/Sip2/Gal83-subunit acts as a scaffold in the complex
and bridges Snf1 and Snf4 via two distinct conserved domains [Jiang and Carlson 1997].
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Furthermore, a crucial role performed by the β-subunit lies in targeting Snf1 to specific
substrates [Schmidt and McCartney 2000].
Regulation and stimulation of Snf1: Snf1 is activated by glucose limitation through
phosphorylation of the threonine residue 210 (Thr-210) located in the activation loop
segment [Jiang and Carlson 1996; Wilson et al. 1996; McCartney and Schmidt 2001].
Unlike the mammalian counterpart, Snf1 does not bind AMP in vitro [Woods et al. 1994;
Mitchelhill et al. 1994; Stapleton et al. 1994; Wilson et al. 1996] and allosteric activation
by AMP binding to Snf1 could not been detected [Woods et al. 1994; Steinberg and Kemp
2009]. The Snf1 complex undergoes glucose-regulated conformational changes: Interaction
of the Snf1- and Snf4-subunit is inhibited by high levels of glucose and induced in low levels
of glucose [Jiang and Carlson 1996]. When glucose is depleted, Snf4 binds to Snf1 and
counteracts an autoinhibitory interaction among the catalytic and the regulatory domain
of Snf1 [Celenza and Carlson 1989; Jiang and Carlson 1996]. In addition to this mechanism,
the protein Std1 has been implicated in regulatory functions on Snf1 [Kuchin et al. 2003].
It stimulates Snf1 activity by interacting with the catalytic domain promoting an active
conformation of Snf1 [Kuchin et al. 2003]. The involvement of Std1 in the glucose induction
pathway is described in Section 2.4 and in Figure 2.3.
Snf1 is phosphorylated by the kinases Sak1 [Nath et al. 2003; Momcilovic et al. 2008],
Elm1 [Sutherland et al. 2003], and Tos3 [Hong et al. 2003], and dephosphorylated by
the phosphatase complex Glc7/Reg1 [Tu and Carlson 1995; Sanz et al. 2000]. The three
kinases have overlapping functions in vivo, and all three genes must be deleted to abolish
Snf1 catalytic function [Hong et al. 2003; Sutherland et al. 2003]. They do not show a
preference to specific isoforms of the Snf1 complex [McCartney et al. 2005]. Instead, the
different isoforms of the Snf1 complex display stress-dependent preferences for the kinases
[McCartney et al. 2005]. The three activating kinases make distinct contributions to Snf1
activation in response to different type of stress, e.g. Sak1 is the major activating kinase
under glucose-limiting conditions [McCartney et al. 2005].
The phosphatase complex Glc7/Reg1 functions antagonistically to the upstream kinases
of Snf1 [Tu and Carlson 1994]. In response to a glucose signal, it dephosphorylates and
thus inactivates Snf1 [Ludin et al. 1998; Sanz et al. 2000]. Apart from its role in glucose
repression, the subunit Glc7 also fulfills tasks in the regulation of translation, cell cycle
progression, chromosome segregation, and glycogen accumulation [De Wever et al. 2005].
Thereby, it achieves substrate specificity through binding to a certain regulatory subunit
[Tu and Carlson 1995; Tu et al. 1996]. Cells lacking the Reg1-subunit showed constitutive
phosphorylation of Snf1 [McCartney and Schmidt 2001]. There is still uncertainty con-
cerning the regulatory mechanisms of the phosphatase and kinases of Snf1. It is unknown,
whether they are constitutively active or whether they are (de)activated in response to
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glucose availabilities. Upon glucose uptake into the cell, the enzymes Hxk1, Hxk2 (hex-
okinase 1 and 2), and Glk1 (glucokinase 1) catalyse the phosphorylation of glucose into
glucose-6-phosphate (G-6-P). It is assumed that the signal leading to glucose-induced Snf1
inactivation is related to the rate of this first step of glycolysis, but more details on the
molecular signals responsible for Snf1 regulation still remain elusive [Rubenstein et al.
2008; Hedbacker and Carlson 2008]. In general, Snf1 activity is negatively regulated by
glucose [Jiang and Carlson 1996], i.e. Snf1 is activated upon glucose limitation and inhib-
ited upon glucose presence [Wilson et al. 1996; McCartney and Schmidt 2001]. In glucose
presence, inactivation of Snf1 is essential for the repression of those genes that are not
needed during fermentative growth on glucose, such as genes encoding enzymes involved
in gluconeogensis, respiration, Citric acid cycle, and metabolism of alternative carbon
sources [Santangelo 2006; Smets et al. 2010]. Snf1 is also activated by other stress sig-
nals, such as salt stress, alkaline pH, or oxidative stress [Hong and Carlson 2007; Ye et al.
2008] leading to its involvement in various processes, such as thermotoleration, sporula-
tion, phospholipid synthesis, aging, and meiosis [Thompson-Jaeger et al. 1991; Hedbacker
and Carlson 2008].
Targets of activated Snf1 in lipid-metabolism: The Snf1 protein kinase complex
and its mammalian counterpart AMPK have at least one substrate in common: both can
directly inactivate ACC1 (acetyl-CoA carboxylase) by phosphorylation inhibiting fatty
acid synthesis during glucose-limiting conditions [Mitchelhill et al. 1994; Woods et al.
1994].
Targets of activated Snf1 in carbohydrate-metabolism: The primary role of Snf1
is to relieve the repression mediated by Mig1 and other regulators of genes that are not
required for fermentative growth on glucose. In response to glucose stress, Snf1 is activated
through phosphorylation and thereon phosphorylates Mig1 at four sites [Treitel et al.
1998; O¨stling and Ronne 1998; Smith et al. 1999]. Mig1 binds promoters of many glucose-
repressed genes, such as GAL1, SUC2, and MAL [Klein et al. 1998; Carlson 1999] encoding
the enzymes galactose, sucrose and maltose, respectively, for utilisation of alternative
carbon sources. Mig1 activity is controlled by a glucose-regulated nuclear import-export-
mechanisms [DeVit et al. 1997]. The phosphorylation of Mig1 promotes its recognition
by the nuclear exportin Msn5 and thereon, the transport of Mig1 into the cytosol [DeVit
et al. 1997; DeVit and Johnston 1999]. In msn5 mutants, it was shown that Mig1 was
constitutively located to the nucleus, while gene expression was derepressed. Thus, Msn5
only partially regulates Mig1 function [DeVit and Johnston 1999]. The export of Mig1
to the cytosol relieves transcriptional repression, leading to expression of the target genes
described above. Inversely, dephosphorylation of Mig1 might be the signal for the transport
back into the nucleus [Tu and Carlson 1995; DeVit et al. 1997]. Cells lacking the γ-subunit
of the Snf1 complex exhibit normal regulation of Thr-210 phosphorylation in response to
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glucose limitation, but are unable to efficiently phosphorylate Mig1, both in vitro [Elbing
et al. 2006] and in vivo [McCartney and Schmidt 2001]. Nevertheless, deletion of Snf4
results in a partially active Snf1, able to phosphorylate Mig1 to some extend [McCartney
and Schmidt 2001]. In the absence of Snf4, cells are unable to grow on alternative carbon
sources, such as ethanol or raffinose, despite the partially active Snf1. In response to salt
stress, Snf1 is phosphorylated but phosphorylation of Mig1 could not be observed [Ye et al.
2008].
Glc7/Reg1 is suggested to be the phosphatase not only for Snf1 but also for Mig1 [Treitel
et al. 1998; McCartney and Schmidt 2001]. There are also other phosphatases, e.g. Sit4,
which function in dephosphorylating Mig1 [Jin et al. 2007].
Snf1 activates glycogen synthase [Thompson-Jaeger et al. 1991] and is required for the
accumulation of glycogen [Hedbacker and Carlson 2008] for glucose storage.
Similarities between the AMPK and the Snf1 pathway: Mammalian AMPK
and yeast Snf1 are structurally and functionally related [Woods et al. 1994; Mitchelhill
et al. 1994].
Both are heterotrimeric enzyme complexes sharing 59% identity in their amino acid
sequences within the catalytic domains [Carling et al. 1994; Mitchelhill et al. 1994]. The
similarity among the catalytic domains of the three kinases Elm1, Sak1, and Tos3 to those
of CaMKKs and LKB1 led to the identification of LKB1 as a candidate kinase of AMPK
[Hong et al. 2003] and its verification [Woods et al. 2003].
Both regulate gene expression, and both affect the activity of metabolic enzymes and
transporters in response to metabolic stress [Hong et al. 2005]. For example, Snf1 and
AMPK inhibit fatty acid synthesis through targeting ACC1 during glucose-limiting con-
ditions [Mitchelhill et al. 1994; Woods et al. 1994; Hardie and Pan 2002] and control
glycogenesis [Carling and Hardie 1989; Jørgensen et al. 2004]. As activity of Snf1 in S.
cerevisiae is regulated by glucose [Jiang and Carlson 1996], also AMPK in pancreatic
β-cells of multicellular eukaryotes responds to a glucose signal: activated by glucose and
inhibited by high glucose concentrations to control hormone release and feeding behaviour
[Salt et al. 1998].
The kinases display cross-species functionality, LKB1 and CaMKK functioning in yeast
cells as Snf1-activating kinases [Woods et al. 2005; Hong et al. 2005] and Tos3 and Elm1
were shown to activate AMPK in vitro [Hong et al. 2003; Sutherland et al. 2003].
2.4. Glucose consumption in yeast: Hexose transporters
The glucose-sensing mechanisms for Snf1 regulation are poorly understood [Rubenstein
et al. 2008; Hedbacker and Carlson 2008], but it is assumed that it is related to the rate of
22
2.4. Glucose consumption in yeast: Hexose transporters
the fist step in glycolysis. However, its proper derivation is crucial for modelling Snf1 reg-
ulation. To provide the biological background for the mathematical representation of the
glucose-regulated stimulus, a summary of glucose transport into the cell of S. cerevisiae
is given. The derivation of a glucose-regulated stimulus will then be shown in Section 3.1.
Glucose is the main energy and carbon source for the yeast S. cerevisiae. The abun-
dance of this sugar is carefully monitored by the cells, adapting the mode of metabolism
accordingly. In addition to initiating metabolism, glucose also triggers a signal that regu-
lates gene expression via two different pathways, known as the glucose repression and the
glucose induction pathways [Santangelo 2006]. At high glucose availabilities, yeast mainly
ferments sugars, while repressing utilisation of alternative carbon and energy sources, a
phenomenon named glucose repression. The repression pathway inhibits a large group of
genes involved in catabolism of alternative carbon sources, respiration, and mitochondrial
functioning. In addition, another group of genes is strongly upregulated (e.g. encoding
glycolytic enzymes, glucose transporters, etc.) [Santangelo 2006]. Concomitantly, the in-
duction pathway ensures that the genes and proteins required for glucose metabolism are
activated. Those genes comprise the family of hexose transporters, which consists of at
least 20 members, including Hxt1-Hxt17, Gal2, Snf3, and Rgt2 [Kruckeberg 1996].
In yeast, glucose is transported into the cell by passive, energy-independent facilitated
transport [Romano 1982; Bisson and Fraenkel 1984]. In its natural habitat, baker’s yeast
is exposed to a wide range of glucose levels from approximately 0.1% to extreme conditions
of over 40% glucose [Greatrix and Vuuren 2006]. Yeast possesses a number of transporters
with different affinities in order to operate optimally in this broad range of extracellular
glucose concentrations [Lagunas 1993; Boles and Hollenberg 1997]. They can be classified
as transporters of low (HXT1 and HXT3 ), high (HXT2, HXT6, and HXT7 [Kruckeberg
and Bisson 1990]), and medium (HXT5 [Diderich et al. 2001]) affinity towards glucose
[Kruckeberg 1996; Boles and Hollenberg 1997]. In the presence of low glucose concentra-
tions (of about 0.1 % to 0.5 %), high affinity transporters are most abundant, while low
affinity transporters are not expressed [Bisson and Fraenkel 1984]. At high glucose con-
centrations (of more than 1 %), the reverse situation has been observed. In that case, low
affinity transporters are widely expressed [Reifenberger et al. 1997; O¨zcan and Johnston
1999].
The presence of extracellular glucose is sensed by two membrane-bound sensors, Rgt2
with low, and Snf3 with high affinity for glucose [O¨zcan et al. 1996, 1998; Santangelo 2006].
They initiate a signalling cascade that regulates expression of the hexose transporter genes
[O¨zcan and Johnston 1999; Johnston 1999; O¨zcan 2002] involving the proteins Std1 and
Mth1 [Flick et al. 2003; Moriya and Johnston 2004] via the transcription factor Rgt1
[Johnston and Kim 2005], as shown in Figure 2.3. During glucose presence, Rgt1 dis-
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Figure 2.3.: Glucose sensing and signalling in S. cerevisiae. Snf3 is responsible for the regulation
of high affinity sugar transporters, e.g. HXT2, HXT4, and HXT6, whereas Rgt2 regulates the low
affinity transporters, e.g. HXT1 and HXT3. In the presence of glucose, Rgt1 dissociates from
the repressor complex with Mth1 and Std1 and acts as a transcriptional activator for expression
of low affinity transporter genes. During glucose absence, Rgt1 associates with the repressor
complex and acts as a transcriptional repressor for HXT genes by binding their promoters
[O¨zcan and Johnston 1996, 1999; Mosley et al. 2003]. Yck1/2 provides an essential function in
triggering the degradation of Mth1 and Std1.
sociates from the repressor complex including Mth1 and Std1 while activated Yck1/2
phosphorylates Mth1 and Std1, which are thereon recognised by the SCFGrr1 complex for
degradation via a proteasome [Gancedo 2008]. The phosphorylation of Rgt1 in response to
glucose converts it to an activator by inhibiting its DNA-binding ability, thereby relieving
repression of HXT gene expression [Flick et al. 2003; Kim et al. 2003; Moriya and Johnston
2004]. During glucose absence, Rgt1 associates with Mth1 and Std1 in a complex acting
as a transcriptional repressor for the HXT1 to HXT4 genes by binding their promoters
[O¨zcan and Johnston 1996, 1999; Mosley et al. 2003]. It is assumed that Snf3 and Rgt2
generate the same signal regulating HXT gene expression and that their different roles in
high and low affinity glucose receptors is due to their affinity towards glucose [O¨zcan and
Johnston 1999].
2.5. Summary
Mammalian AMPK and yeast Snf1 are structurally and functionally related proteins that
play a crucial role in energy homeostasis of the cell. Activated by any stress that depletes
cellular ATP, AMPK switches off ATP-consuming biosynthetic pathways, while switching
on ATP-producing catabolic pathways. Snf1 regulates transcription of genes encoding
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enzymes for the use of alternative carbon sources to adapt to glucose limiting conditions.
A large family of hexose transporters with different affinities to glucose, allows yeast to
carefully monitor glucose in its environment and to control glucose uptake. Investigating
dysfunctions in the AMPK and Snf1 signalling pathways is a promising approach to tackle
one of the most prevalent diseases diabetes type two and obesity.
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3. Mathematical modelling of the Snf1
pathway
This chapter comprises the steps of model development for the Snf1 pathway. In Sec-
tion 3.1, the derivation of a glucose-regulated signal, which leads to the regulation of
the Snf1 pathway, is discussed. The experimental data were generated by Goutham Ve-
muri1 and the group of Stefan Hohmann2. This work has been submitted for publication
[Frey et al. 2011a]. In Section 3.2, a mathematical approach is presented that allows for
the processing of fluorescent microscopy data of Mig1-GFP (a downstream Snf1 pathway
component) generated by the group of Mattias Gokso¨r3. This work was published in
[Frey et al. 2011b]. In Section 3.3, the results of Sections 3.1 and 3.2 are then combined
with Snf1 Western blot data, generated by the group of Stefan Hohmann, University of
Gothenburg, to enter an iterative cycle between data-driven modelling and model-driven
experimentation to investigate the interrelations of Snf1 pathway components, which is
part of unpublished collaborative work (Manuscript in preparation [Garcia Salcedo 2009]).
In a final part (Section 3.4), the overall results are summarised.
3.1. Dynamics of hexose transporters in S. cerevisiae upon
glucose pulses
The research in the following section is motivated by the question:
How can the still unknown signal, which leads to the regulation of the Snf1
pathway, be described and incorporated into the Snf1 pathway model?
It is assumed that the signal leading to glucose-induced Snf1 inactivation is connected to
the rate of the first step of glycolysis, but more details on the molecular signals responsible
for Snf1 regulation still remain elusive [Rubenstein et al. 2008; Hedbacker and Carlson
2008]. In order to investigate the dynamics of Snf1 (de)phosphorylations upon glucose
availabilities, the derivation of a glucose-regulated input function is essential.
1Department of Chemical and Biological Engineering, Chalmers University of Technology, SE-41296
Go¨tborg, Sweden.
2Department of Cell and Molecular Biology, University of Gothenburg, SE-40530 Go¨teborg, Sweden.
3Department of Physics, University of Gothenburg, SE-41296 Go¨teborg, Sweden.
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S. cerevisiae utilises glucose as its main carbon and energy sources. Its glucose uptake
transport system consists of a family of hexose transporters, able to ensure efficient uptake
in a wide range of concentrations. Pulsing glucose to exponentially growing yeast cells, we
measured and modelled the dynamics of glucose consumption. We find that the carrier
model, which assumes a constant contribution of glucose transporters, is not able to re-
produce the experimentally observed dynamics of glucose consumption. We attribute this
discrepancy between the simulations and the experimental data to the overly simplified
model. We therefore established an advanced model that considers the dynamic contribu-
tion of low and high affinity glucose transporters. Our results show that the model, which
describes the dynamic contribution of high and low affinity transporters appropriately,
leads to an improved agreement of the simulations and the experimental data of glucose
consumption. Our findings reveal substantial changes in the degree of utilization of the
membrane transporters upon pulsing with nutrients in order to maintain an efficient up-
take. Our model is suitable to study glucose triggered signalling pathways, in this work
demonstrated for the Snf1 pathway.
Various studies of sugar transport across the plasma membrane have resulted in a deeper
understanding of its mechanisms [Bisson et al. 1993; Boles and Hollenberg 1997; O¨zcan
and Johnston 1999; Carlson 1999; Diderich et al. 1999]. Modelling approaches for trans-
membrane glucose transport comprised carrier models [Steinmeyer and Shuler 1989; Rizzi
et al. 1996; Teusink et al. 2000; Hynne et al. 2001; Bertilsson et al. 2008], which are for-
mally identical to the Michaelis-Menten equation for enzyme kinetic reactions. Carrier
models describe the glucose uptake by facilitated diffusion [Hoppe et al. 1983; Teusink
et al. 2000] and include the following properties: i) Transport of glucose to the interior
of the cell occurs only in the presence of a concentration gradient. ii) The transport is
substrate selective. iii) For high glucose concentrations, a maximal flow of glucose into
the cell is reached and saturation occurs [Hoppe et al. 1983; Weiss 1996].
3.1.1. Materials and methods
Yeast strains and growth conditions
The yeast strain used in this work is YSH1715 (MATa ura3-52 snf1::KanMX), derived
from W303-1A (MATa ade2-1 can1-100 his3-∆1 leu2-3,112 trp1-289 ura3-52) [Wallis et al.
1989] and made prototrophic by transformation with the plasmid pRS316-SNF1-HA [Mc-
Cartney and Schmidt 2001]. Cultivations were conducted in a Braun Biostat A fermentor
(Braun, Melsungen, Germany), using 2x concentrated defined minimal medium [Verduyn
et al. 1992] containing 2 % or 4 % glucose as carbon source (see Table 3.1) and 0.1mL/L
polypropylene glycol as anti-foaming agent. The medium (2 L) was inoculated with an
overnight culture to an optical density (OD600nm) of 0.05 and cells were grown with an aer-
ation of 0.5L/min, at 30◦C, 1000 rpm and pH 5. In some of the fermentations, two hours
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after sugar depletion the cultivation was pulsed with glucose to a final concentration of 2%
or 4 % (Table 3.1). Carbon Dioxide production was measured on-line (one measurement
per minute) using a photoacoustic gas analyser (type 1308; Bru¨el and Kjaerum, Denmark).
Samples were withdrawn during the experiment for the determination of extracellular glu-
cose and the measurement of the optical density. For our analysis, we included data from
eight different experiments. An overview of the experiments is given in Table 3.1.
Experiment A B C D E F G H
Glucose concen-
tration [g/L] at 16
hours before time
zero
40 20 20 40 40 40 - -
Initial glucose con-
centration [g/L] at
time zero
32.99 0 0 28.41 36.1 19 24 10.82
Amount of glucose
pulse [g/L]
34.89 40.59 43.18 19.09 34.46 - 87.32 88.55
Time of added glu-
cose pulse
8.55[h] 1.13[h] 1 [h] 6.36[h] 9.30[h] - 1[min] 1[min]
Duration of glucose
depletion
3.18[h] 1.13[h] 1 [h] 2.02[h] 2.61[h] - - -
Table 3.1.: Overview of the different glucose pulse experiments. Cells were inoculated in a
medium with initial glucose concentration as listed. After sugar depletion, some of the fermentors
were pulsed with glucose (denoted as ‘Amount of glucose pulse’).
Determination of extracellular glucose
Duplicate samples of 1 ml were sterile-filtered (0.22µm pore size), frozen in liquid nitrogen
and stored at −40◦C. Glucose was determined using an enzyme kit (Boehringer-Mannheim
GmbH, Mannheim, Germany).
Numerical simulations
Numerical simulations were carried out in Matlab (MathWorks, Inc.). Parameter estima-
tion was done with the Systems Biology Toolbox2 [Schmidt and Jirstrand 2006] using the
pswarm-algorithm [Vaz and Vicente 2007].
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3.1.2. The carrier model for glucose transport
S. cerevisiae thrives in environments with wide variations of glucose concentrations due
to a family of hexose transporters specialised in uptake through their affinities towards
glucose [O¨zcan and Johnston 1999]. In order to explain our experimental data from
batch cultivations, we present different models. To begin with, we use the established
carrier model and show its inadequacy in Section 3.1.2. Then, we extend this model
in Section 3.1.3 and 3.1.4 to improve the agreement of the model simulations with the
experimental data. In Section 3.1.5, we apply our model to derive a glucose-regulated
stimulus to model the dynamics of Snf1 (de-)phosphorylation.
Yeast consumes glucose using facilitated transport [Fuhrmann et al. 1976], mediated by
several hexose transporters [Boles and Hollenberg 1997]. It incorporates a saturation that
rises from a limited number of transporters in the membrane. Hence, there is a threshold
rate beyond which the cells cannot consume glucose any faster. The uptake of glucose
from the extracellular to the intracellular medium can thus formally be described by a
carrier model
d
dt
Glcext = −Vmax ·Glcext
KM +Glcext
·OD · kOD (3.1)
with Vmax = k · Hxttotal comprising all hexose transporters of a cell, thereby k denoting
a rate of transport efficiency. Due to the assumption that internal glucose is rapidly
transformed into glucose-6-phosphate and hence, cannot cross the membrane again [Becker
and Betz 1972], we consider only the influx of glucose not the efflux, as suggested in
[Rizzi et al. 1996]. The parameters Vmax = k · Hxttotal denoting the limiting rate of
glucose uptake and KM denoting the affinity constant, are estimated from our experimental
data using the SBToolbox2 [Schmidt and Jirstrand 2006]. The glucose consumption rate
d/dt Glcext considers the overall number of cells within the fermentor. Therefore, the
right hand side of Eq. (3.1) needs the incorporation of the factor OD · kOD. The OD
denotes the optical density (OD600) and kOD is a factor to convert the optical density to
the number of cells per litre. Since one unit of OD600 corresponds to approximately 10
10
cells per litre, we approximate kOD · OD ≈ 1010 · OD. In order to restrict the intervals
for reasonable parameter values, we use information from the literature: The limiting
transport rate Vmax of cells that are fermenting glucose rapidly was measured in ranges
up to 107 glucose molecules per cell per second [Kruckeberg 1996]. We relate this value
properly for our experimental data of extracellular glucose, since it is measured in hours
and g/L. Then, it results in approximately 36 · 109 glucose molecules per cell per hour,
which is approximately equal to 10−11 gram per cell per hour. The model described
above is not sufficient to describe the data of glucose consumption under the experimental
conditions studied (Figure 3.1(a)). There is no unique set of Vmax and KM values, which
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Figure 3.1.: Simulation of glucose consumption Eq. (3.1) compared to experimental data from
Experiment A (see Table 3.1). (a) The simulation is too slow for the first consumption (≈ hour
0 to hour 6) and too fast for the second consumption (≈ hour 8 to end of experiment). The
estimated parameters are: Vmax = 1.9 · 10−10 gram per litre per hour and KM = 8.3 g/L. (b) It
is possible to simulate the experimental data of the first glucose consumption or the second, but
not both at the same time. Fitting the first glucose consumption curve (≈ hour 0 to hour 6)
is possible through changing, e.g. the value for KM to 3.2 g/L (dotted line), fitting the second
glucose consumption curve (≈ hour 8 to end of experiment) is possible through changing, e.g.
the value for KM to 36 g/L (dashed line), but there is no unique set of parameters to fit both
at the same time.
explains the time course of the whole experiment. Considering two different value sets of
the parameters, we can either reproduce the first glucose consumption (within the first six
hours of Figure 3.1(b)), or the second glucose consumption (time after the given pulse in
Figure 3.1(b)). This clearly suggests the need to include at least one additional factor to
account for the deviations between the experimental data and the simulation of Eq. (3.1).
A summary of all parameter values is given in Table 3.2.
So far, the glucose consumption rate has been described assuming a constant contribu-
tion of transporters (Eq. (3.1)). However, in the course of our experiments, the yeast cells
face extreme glucose conditions, varying from 0 % up to 4 % glucose concentrations. The
sudden exposure to high glucose concentrations is accomplished by adding a pulse. We
reason that the composition of high and low affinity transporters in the cell membrane
differs significantly, comparing cells in high to cells in low glucose concentrations. Hence,
the consequence is a different glucose uptake rate. Thus, we hypothesise that the deviation
between simulation and experimental data is due to the neglected dynamic contribution
of high and low affinity transporters in the cell membrane. Consequently, we now estab-
lish a model that considers the contribution of the transporters in response to glucose
availabilities in the following section.
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Figure 3.2.: Simulations of glucose consumption (blue line) and the consolidated contribution
of hexose transporters (green line). (a) Simulation of Eq. (3.2) for glucose consumption (blue
line) compared to experimental data for glucose (blue dots) and simulation of Eq. (3.3) for the
hexose transporters in the membrane (green line), for Experiment A. (b) Analogous to (a) for
Experiment B, respectively. Experiments are listed in Table 3.1. Parameter values are shown
in Table 3.2.
3.1.3. Dynamic contribution of hexose transporters
Since the model assuming a constant contribution of hexose transporters, as described in
Eq. (3.1), does not simulate the experimental data accurately, we consider the contribution
of transporters that varies with glucose availabilities. We therefore extend Eq. (3.1) to
incorporate the contribution of the hexose transporters
d
dt
Glcext = −k ·Hxt(t) ·Glcext
KM +Glcext
·OD · kOD (3.2)
In contrast to the constant contribution of hexose transporters in Eq. (3.1), the term
Hxt(t) captures their dynamic contribution on glucose transport. Since Vmax is denoted
as the limiting transport rate for a constant total amount of transporters, we replace Vmax
with k ·Hxt(t) to emphasise the dynamics. The rate of change of the hexose transporters
is formalised as
d
dt
Hxt = ksynth · Glcext
K +Glcext
− kdegr ·Hxt (3.3)
In this equation, the synthesis term comprises the increase of the hexose transporters in
the presence of extracellular glucose [O¨zcan and Johnston 1999]. The synthesis includes
among others also the expression and the recruitment of the transporters into the cell
membrane. Analogously, the degradation term is composed of the removal from the mem-
brane and the degradation within the cytosol. In addition, we define a limit upon which
the rate of synthesis of transporters is saturated. The estimated values of the parameters
of Eqs. (3.2) and (3.3) are listed in Table 3.2. This amendment results in a significant
improvement for explaining the experimental data of glucose consumption as shown in
Figure 3.2.
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However, as can be seen in Figure 3.2(b) for Experiment B (specified in Table 3.1),
rapidly after the glucose pulse (time 1.5 hours), glucose is first consumed faster, and
then slowed down. This can also be observed for Experiment A (Figure 3.2(a)) but to a
much less extend. This behaviour cannot be described assuming transporters with a single
affinity (KM) to glucose as in Eq. (3.2). This difference between the two experiments might
be a consequence of different experimental setups. Prior to starting the experimental
measurements of Experiment B (Table 3.1), the cells were exposed to low and zero glucose
concentrations before the beginning of the experiment (from time 16 hours before the
start of the experiment until time zero). Furthermore, the duration of glucose repression in
Experiment A was much shorter (from time five to time eight, shown in Figure 3.2(a)) than
in Experiment B. Taken the observation and the different experimental setup together, this
might indicate that the composition of high and low affinity transporters in Experiment
B (after several hours exposed to glucose poor medium) is highly adapted to transport
glucose in glucose poor conditions, whereas their composition in Experiment A (after only
≈ 3 hours exposed to glucose poor medium) has not yet reached the same level. Thus
the deviation immediately after the glucose pulse might be interpreted as an abundance
of high affinity transporters that were produced and recruited by the cells during the
glucose poor condition. During glucose absence that precedes the pulse, the high affinity
transporters were active, while the low affinity transporters were repressed. Upon pulsing
with glucose, the low affinity transporters need to be synthesised and transported to the
cell membrane. Through the addition of the glucose pulse, the high affinity transporters,
still located within the cell membrane, face high glucose concentrations. This leads to a
too fast uptake and consumption of glucose by the cells, which results in the accumulation
of waste products of the electronic transport chain, glycolysis and fermentation. Those
waste products include toxic molecules, e.g. super oxide ions, or oxygen peroxides. Thus,
to maintain a healthy intracellular environment, the cells have to slow down the uptake
rate by adapting the transporters composition.
Based on our analysis and the discussion above, we further improve the model by con-
sidering both, high and low affinity transporters, in a more detailed manner. This is
accomplished by using two separate differential equations instead of just one for the hex-
ose transporters.
3.1.4. Dynamic contribution of high and low affinity transporters
There is previous evidence [Bisson and Fraenkel 1983] that glucose uptake in yeast involves
at least two different types of systems, which differ in their affinities to glucose. For
the high affinity uptake system, KM values of ca. 1 mM (≈ 0.2 g/L) for glucose were
measured and for the low affinity uptake system, KM values of ca. 20 mM (≈ 5 g/L)
[Bisson and Fraenkel 1983; O¨zcan and Johnston 1999]. The high affinity transporters
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are repressed in cells grown with high glucose concentrations and are derepressed in cells
grown on low glucose concentrations, whereas the low affinity transporters appear to be
largely constitutive [O¨zcan and Johnston 1999]. Extending Eq. (3.1), we now define two
terms for the consumption of glucose: one responsible for the glucose transport in glucose
rich medium, the other dominating the transport process in glucose poor medium. In
contrast to Rizzi et al. [Rizzi et al. 1996], we consider the dynamics of high and low
affinity transporters as shown in the following three equations:
d
dt
Glcext = −
(
klow ·Hxtlow(t) ·Glcext
K lowM +Glcext
+
khigh ·Hxthigh(t) ·Glcext
KhighM +Glcext
)
·OD · kOD . (3.4)
The degradation of the transporters occurs on the one hand to be constitutively and on
the other hand to be influenced by the availability of affinity transporters of the opposite
type. Hence, we establish the rate of change for low affinity transporters
d
dt
Hxtlow = klowsynth ·
Glcext
K low +Glcext
− klowdegr1 ·Hxtlow − klowdegr2 ·Hxtlow ·Hxthigh (3.5)
and for high affinity transporters
d
dt
Hxthigh = khighsynth ·
1
Khigh +Glcext
− khighdegr1 ·Hxthigh − khighdegr2 ·Hxthigh ·Hxtlow (3.6)
For high affinity transporters, we define an inhibition term for the synthesis depend-
ing on glucose concentrations. The inhibition term ensures high affinity transporters to
be available in glucose poor conditions. The simulations of glucose consumption are in
good agreement with the experimental data as shown in Figure 3.3(a). The simulations
of Eqs. (3.5) and (3.6) for low and high affinity transporters, respectively, are shown in
Figure 3.3(b). During glucose absence, the sensitive high affinity transporters increase
and eventually approach their maximum (Figure 3.3(b)). With the addition of the glucose
pulse, an instant reorganisation of the transporters composition begins, in order to adapt
to the new extreme glucose conditions and to avoid an accumulation of waste products.
Consequently, before this reorganisation has been completed, a noticeably faster consump-
tion rate of glucose is observed (Figure 3.3(a)). This result points towards a significant
reorganisation of the membrane transporters upon pulsing with nutrients in order to main-
tain an efficient uptake. Note that the simulations of glucose consumption for all other
experiments of Table 3.1 are shown in Figure 3.4.
Given the model of high and low affinity transporters, we show the changes in their
composition with respect to changes in glucose concentrations in Figure 3.5. A recipro-
cal relationship between the high and low affinity transporters as reported in [Ramos
et al. 1988] is supported by our simulations (Figure 3.3(b) and Figure 3.5). As glucose
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Figure 3.3.: Simulations of the dynamics of glucose concentration for Experiment A (see Ta-
ble 3.1) considering high and low affinity transporters. (a) Simulation of Eq. (3.2) (line) and
experimental data of external glucose (dots). The simulation is in good agreement with the
experimental data. The noticeably faster consumption rate of glucose following a pulse can be
reproduced by the model. (b) Simulations of Eqs. (3.5) and (3.6) describing the dynamic change
in composition of low (blue line) and high (green line) affinity transporters. In high glucose
concentrations, the low affinity transporters increase, whereas in low glucose concentrations, the
high affinity transporters increase. A maximum has been reached here, since the cells have been
exposed to glucose poor conditions.
concentrations increase, the low affinity transporters reach a limit of saturation at the
value Hxtlow = klowsynth/k
low
degr1 ≈ 1.1961 as shown in Figure 3.5. Vice versa, as glucose con-
centrations decrease, the high affinity transporters reach a saturation limit, at the value
Hxthigh = khighsynth/
(
khighdegr1 ·Khigh
)
≈ 0.1688. The derivations of these numbers are shown
in detail in the next paragraph. Interestingly, the estimated value of the parameter khigh
for high affinity transporters reveals an about 30-fold higher value compared to the value
of its analogical parameter klow for low affinity transporters (Table 3.2). This indicates,
that the lower concentration of high affinity transporters (about 10-fold lower, as shown
in Figure 3.5) is compensated through a higher efficiency of the transporters, whereas in
comparison the highly concentrated low affinity transporters operate less efficiently.
Derivation of the transporters concentrations in steady state
For derivation of the concentration of high and low affinity transporters at steady state as
shown in Figure 3.5, we use Eqs. (3.5) and (3.6), setting these equations equal to zero. In
general, this system can be solved numerically only. However, for limiting cases, a solution
can be calculated analytically. In the following, the steps are shown.
• The limiting case Glcext << Klow,Khigh
◦ For low affinity transporters, the case Glcext << K low leads to the cancellation
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Figure 3.4.: Comparison of simulations of Eq. (3.4) representing glucose consumption to data
of extracellular glucose (dots) for all experiments (in order: A, B, C, D, E, F, G, H, compare
Table 3.1).
36
3.1. Dynamics of hexose transporters in S. cerevisiae upon glucose pulses
10−3 10−2 10−1 100 101 102 103
0
0.25
0.5
0.75
1
1.25
1.5
1.75
2
extracellular glucose [g/L]
lo
w
 a
ni
ty
 tr
an
sp
or
te
rs 
[g/
L]
 
 
0
0.025
0.05
0.075
0.1
0.125
0.15
0.175
0.2
hi
gh
 a
ni
ty
 tr
an
sp
or
te
rs 
[g/
L]
Hxt low
Hxt high
Figure 3.5.: High and low affinity transporters as function of glucose concentration at steady-state
conditions. A reciprocal relationship between the high and low affinity transporters as reported
in [Ramos et al. 1988] as glucose concentrations increase, the low affinity transporters reach
a limit of saturation at the value Hxtlow ≈ 1.1961 g/L. Vice versa, as glucose concentrations
decrease, the high affinity transporters reach a saturation limit, at Hxthigh ≈ 0.1688 g/L.
of the synthesis term, with only the degradation terms remaining
−klowdegr1 ·Hxtlow − klowdegr2 ·Hxthigh ·Hxtlow = 0
⇔ Hxtlow
(
−klowdegr1 − klowdegr2 ·Hxthigh
)
= 0 .
This equation can only be fulfilled for Hxtlow = 0.
◦ For high affinity transporters, the case Glcext << Khigh results in
khighsynth
Khigh
− khighdegr1 ·Hxthigh − khighdegr2 ·Hxthigh ·Hxtlow = 0
and inserting the expression Hxtlow = 0 g/L derived above, leads to
Hxthigh =
khighsynth
khighdegr1 ·Khigh
.
Taking the estimated parameter values, which are shown in Table 3.2, we obtain
the value for amounts of high affinity transporters
Hxthigh =
khighsynth
khighdegr1 ·Khigh
≈ 0.1688 g/L.
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• The limiting case Glcext >> Klow,Khigh
◦ For high affinity transporters, the caseGlcext >> Khigh leads to the cancellation
of the synthesis term, with only the degradation terms remaining
−khighdegr1 ·Hxthigh − khighdegr2 ·Hxthigh ·Hxtlow = 0
⇔ Hxthigh
(
−khighdegr1 − khighdegr2 ·Hxtlow
)
= 0 .
This equation can only be fulfilled for Hxthigh = 0 g/L.
◦ For low affinity transporters, the case Glcext >> K low results in
klowsynth − klowdegr1 ·Hxtlow − klowdegr2 ·Hxthigh ·Hxtlow = 0
and inserting the expression Hxthigh = 0 derived above gives
klowsynth − klowdegr1 ·Hxtlow = 0
⇔ k
low
synth
klowdegr1
= Hxtlow .
In contrast to the value for high affinity transporters, this term is independent
of the affinity constants K low and Khigh, respectively. Taking the estimated
parameter values from Table 3.2, we obtain the value for the amount of low
affinity transporters
Hxtlow =
klowsynth
klowdegr1
≈ 1.1961 g/L.
3.1.5. Applications of the model
The model including the dynamics of high and low affinity transporters can be used
to deduce a stimulus for a glucose dependent signalling pathway. We assume that the
difference between the rate of glucose consumption per cell and its conversion to glucose-
6-phosphate (rate of glycolysis) is proportional to the rate of change of internal glucose
concentration. Whereas the external glucose consumption was related to all cells in the
fermentor (OD·kOD), we now relate the internal glucose concentration to an average single
cell by dividing by the approximate number of all cells per litre, OD · kOD
d
dt
Glcint =
khigh ·Hxthigh(t) ·Glcext
KhighM +Glcext
+
klow ·Hxtlow(t) ·Glcext
K lowM +Glcext
− k̂glycolysis ·Glcint . (3.7)
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Assuming steady-state conditions, we obtain an approximation for the glycolytic rate
coefficient
kglycolysis ≈ Glcext
Glcint
·
(
khigh ·Hxthigh(t)
KhighM +Glcext
+
klow ·Hxtlow(t)
K lowM +Glcext
)
. (3.8)
The rate of glycolysis depends on the ratio of extra- and intracellular glucose concen-
trations and the contribution of the high and low affinity transporters. Under standard
conditions, the intracellular glucose concentration in wild-type cells consuming glucose
has been taken to be very, if not negligibly, low [Teusink et al. 1998]. This rate can then
be used as an input in glucose signalling, e.g. as the signal controlling the Snf1 pathway
[Gancedo 1998; Santangelo 2006]. Snf1 is activated through phosphorylation upon glu-
cose limitation and inhibited through dephosphorylation upon glucose presence [Wilson
et al. 1996; McCartney and Schmidt 2001]. We establish a mathematical model for Snf1
dynamics by integrating the variable for the glycolytic rate, kglycolysis, derived from the
model for high and low affinity transporters
d
dt
Snf1P = a · Snf1− kglycolysis · Snf1P
with the total number of molecules staying constant:
Snf1total = Snf1
P + Snf1 .
The Snf1 Western blot data are composed of phosphorylated Snf1 divided by the total
concentration:
Snf1Pratio = Snf1
P/Snf1total .
Implementing this model into the SBToolbox2 [Schmidt and Jirstrand 2006] and per-
forming a parameter estimation with the pswarm-algorithm [Vaz and Vicente 2007], we
achieve the simulations shown in Figures 3.6(a) and 3.6(b). The good agreement of the
data and simulation support our model development to the point of high and low affinity
contribution and the derivation of the glycolytic rate following thereon.
3.1.6. Conclusions
Glucose is the main energy and carbon source for the yeast, S. cerevisiae. The abundance
of this sugar is carefully sensed by the cells, adapting the mode of metabolism accordingly.
In its natural habitat, yeast is exposed to a wide range of glucose concentrations [Greatrix
and Vuuren 2006]. In order to control glucose uptake rate, yeast features transporters
with high and low affinities towards glucose. Modelling approaches for transmembrane
glucose transport comprise carrier models. We demonstrated that a carrier model, which
assumes a constant contribution of high and low affinity transporters, is not sufficient to
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Para-
meter
Unit Values for the
carrier model
(Eq. (3.1))
Values for the
dynamic
transporter
model
(Eqs. (3.2)+(3.3))
Values for the
dynamic high
and low affinity
model
(Eqs (3.4)–
(3.6))
kOD − 1010 1010 1010
KM g/L 5 1 −
Vmax g/(L · h) 1.6 · 10−10 − −
k 1/h − 1 · 10−10 −
ksynth g/ (L · h) − 0.27 −
kdegr 1/h − 0.19 −
K g/L − 8.86 −
K lowM g/L − − 5
KhighM g/L − − 0.2
klow 1/h − − 1.2 · 10−10
khigh 1/h − − 30.8 · 10−10
Hxtlow g/L − − dynamic
Hxthigh g/L − − dynamic
klowsynth g/ (L · h) − − 0.36
khighsynth g
2/
(
L2 · h) − − 7.52
klowdegr1 1/h − − 0.3
klowdegr2 L/ (g · h) − − 6 · 10−6
khighdegr1 1/h − − 5
khighdegr2 L/ (g · h) − − 57
KhighHxt g/L − − 2.9
K lowHxt g/L − − 8.8
Table 3.2.: Overview of the parameters, units, and their estimated values of the models described
in the text. The values in bold style highlight parameter values taken from literature.
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Figure 3.6.: Simulation of phosphorylated Snf1 (denoted Snf1P) compared to Snf1 Western blot
data for (a) Experiments B and (b) Experiment D, as detailed in Table 3.1.
describe the glucose uptake in yeast for different batch experiments. We hypothesised
that these poor agreements are a consequence of neglecting the dynamic changes of the
transporters composition in the cell membrane. We showed the need to account for both,
high and low affinity transporters. While high affinity transporters enhance the uptake
of glucose in very low glucose concentrations, their pronounced presence in high glucose
concentrations can be harmful to the cell. A too fast uptake of glucose can result in an
accumulation of toxic waste products during glycolysis. Thus, high affinity transporters
must be downregulated in high glucose concentrations in order to keep a healthy intracel-
lular environment. Our results show that the consideration of the dynamic contribution of
high and low affinity transporters leads to an explanation of the experimental data. These
results point towards a significant reorganisation of the membrane transporters upon puls-
ing with glucose, in order to achieve an efficient glucose uptake while maintaining a healthy
intracellular environment. Our analysis of high and low affinity transporters as function of
glucose concentration at steady-state conditions supports the finding of a reciprocal rela-
tionship between the high and low affinity transporters as reported in [Ramos et al. 1988].
As glucose concentrations increase, the low affinity transporters reach a limit of saturation
and vice versa as glucose concentrations decrease, the high affinity transporters reach a
limit of saturation. We calculated these limits analytically. Our estimated value for the
rate of transport efficiency in a high affinity transporter reveals an about 30-fold higher
value compared to the value of its analogical parameter in low affinity transport. This
indicates that the lower concentration of high affinity transporters (about 10-fold lower)
is compensated through a higher efficiency of the transporters, whereas in comparison the
highly concentrated low affinity transporters operate less efficiently. For mathematical
models of glucose-regulated signalling pathways in yeast, such as the Snf1 pathway, our
model serves as a template for the input function, i.e. glycolytic rate.
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3.2. Data processing for the Snf1 pathway component Mig1
The hereon following text has been published in [Frey et al. 2011b]. The data were gen-
erated by the group of Mattias Gokso¨r2 from the University of Gothenburg.
How can fluorescent microscopy data, exposed to bleaching and affected by
background noise, be processed to extract the information of the protein of
interest?
In systems biology, mathematical modelling of signal transduction pathways aims at
understanding of biological networks. Therefore, high quality quantitative time course
data are necessary [Phillips and Milo 2009]. Fluorescence microscopy and related imaging
techniques have, together with the development of fluorescent probes, become a powerful
tool to assay biological structures and processes in the physiological context of intact
living cells [Pepperkok and Ellenberg 2006]. However, the imaging process induces both
reversible quenching and irreversible photobleaching of the fluorophores. Consequently,
the target molecule is still present but not detectable. Shaner et al. [Shaner et al. 2008]
addressed this problem by developing highly photostable fluorophores of mOrange and
TagRFP. Yet, those derivates are not always useful nor available. In order to address the
problem of photobleaching, we use mathematical modelling. In our case study we compare
the model to experimental data on Mig1-GFP shuttling. Acting as a transcription factor
in the Snf1-pathway, Mig1 plays a crucial role in the energy metabolism of S. cerevisiae
during the regulation of glucose [Carlson et al. 1984]. Mig1 is controlled by its kinase
Snf1 and its phosphatase Glc7/Reg1. As introduced in Chapter 2.3, in the presence of
glucose, Snf1 is in an inactive dephosphorylated state and Mig1 represses genes such as
SUC2, which encode for proteins converting other carbon sources than glucose as the
primary source of energy. In this state, Mig1 resides in the nucleus. If glucose is absent,
Snf1 is activated through phosphorylation and in turn phosphorylates Mig1 [O¨stling and
Ronne 1998; Treitel et al. 1998; Smith et al. 1999]. Mig1 is then transported out of the
nucleus into the cytosol [DeVit and Johnston 1999] so that alternative carbon sources can
be used in the metabolism of the cell [Santangelo 2006]. Our model describes Mig1-GFP
shuttling into and out of the nucleus when the cells are repeatedly deprived and exposed to
glucose. This procedure gives us an insight into the shuttling of fluorescently tagged Mig1
proteins using time lapse microscopy [Eriksson et al. 2010]. Our method of analysis allows
for a stepwise extraction of the information on the background and Mig1-GFP bleaching
rates, the background-to-Mig1-GFP ratio, and the rates of Mig1-GFP phosphorylation
and dephosphorylation. Hereby, it is possible to predict Mig-GFP shuttling as it would
occur without bleaching. Our analysis demonstrates how data acquired using an optical
2Department of Physics, University of Gothenburg, SE-41296 Go¨teborg, Sweden.
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microscope can be processed and used for mathematical modelling of signal transduction
pathways.
3.2.1. Materials and methods
Microscope setup
The microscope used in the experiments was an inverted epi-fluorescence microscope, Le-
ica DMI6000B, equipped with a motorised xy stage and a motorised microscope objective.
The images were acquired using a 14 bit dynamic range EMCCD camera (C9100-12, Hama-
matsu Photonics) together with a fluorescence light source, EL 6000 (Leica Microsystems),
a GFP filter cube (472/30 nm exciter, 520/35 nm emitter and 495LP, Semrock IDEX Cor-
poration) and an mCherry filter cube (560/40x exciter, 630/75m emitter and 585LP, ET
-TexRed, Chroma). The optical tweezers were formed by expanding a laser beam (λ =
1070 nm, IPG Photonics) to slightly overfill the back aperture of the microscope objective
(100x, NA1.3 oil, HCX PL FLUOTAR, Leica Microsystems). The same objective was also
used to image the yeast cells. The trapping laser beam was introduced to the microscope
via a dichroic mirror (Omega Optical Inc.) inserted between the microscope objective and
the filter cube cassette (for details regarding our optical tweezers setup see Sott et al. [Sott
et al. 2009]). The power in the laser focus was calculated to be 240 mW by measuring
the transmission through the microscope objective using the dual-objective technique as
described by Misawa et al. [Misawa et al. 1991]. The flow rates in the microchannels
were controlled by syringe pumps (CMA 400, CMA Microdialysis AB). The microscope,
the camera, and the microfluidic pumps were all controlled from the computer through
the software OpenLab (Improvision Inc.) with custom written programs in the extension
OpenLab Automator.
Microfluidic device
In order to allow for precise and reversible changes of glucose concentration around sin-
gle yeast cells, a microfluidic device was constructed, on which three inlet channels were
merged into one single channel containing the measurement region wherein the cells were
positioned (depicted in Figure 3.7). The lower inlet channel was used to introduce cells
suspended in growth medium into the system. The medium flowing in the middle channel
was the same growth medium as the cells were suspended in, while the medium flowing in
the top channel was pure growth medium without glucose (except for the GFP bleaching
experiments, see below). The two lower inlets were connected to the same syringe pump,
while the upper inlet was connected to a second pump. Thus, the flow rate could be
controlled independently, enabling environmental changes of the cells positioned in the
measurement region. Two different flow settings were used, referred to as flow configu-
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Figure 3.7.: Schematic representation of the microfluidic flow system. The lowermost channel
introduces the cells, the middle channel neutral medium, and the uppermost stress medium, in
this case medium without glucose. FC1 and FC2 denotes flow configuration 1 and 2, respectively.
ration 1 (FC1) and flow configuration 2 (FC2), respectively, as shown in Figure 3.7. In
FC1, the flow rate in the larger inlet was set to 40 nl/min, while the flow rates in the two
smaller inlets were set to 80 nl/min. This configuration was used when positioning the
cells on the surface and whenever glucose should be present in the measurement region.
In FC2, the flow rates were instead 480 nl/min in the larger inlet and 40 nl/min in each
of the two smaller inlets. This configuration was used to expose the cells positioned in the
measurement region to stress, i.e. to remove glucose.
Fabrication and preparation of the microfluidic device
The microfluidic device was fabricated using soft lithography. For specific details regard-
ing the fabrication process, we refer to Sott et al. [Sott et al. 2009]. The microfluidic
device was moulded in poly(dimethylsiloxane), PDMS, and sealed to a cover glass by
exposing both the PDMS and the cover glass to oxygen plasma using a plasma cleaner
(Harrick Scientific). Holes were punched in the PDMS structure allowing the channels to
be connected to polytetrafluoroethylene (PTFE) tubings, which in turn were attached to
250µl glass syringes (Hamilton Company). To enable attachment of cells, Concanavalin A
(ConA), dissolved in buffer (10 mM Tris-HCl and 100 mM NaCl at pH 8.0) at a concen-
tration of 1 mg/ml, was allowed to adsorb to the cover glass surface for one hour before
the experiments.
Yeast strain, plasmid and growth conditions
The yeast strain used in all experiments was YSH2346 (BY4741 125 MATalpha NRD1-
mCherry-hphNT1), transformed with the plasmid BM3315 [DeVit et al. 1997]. The strain
carries its native copy of the MIG1 gene and its only genomic alteration is the insertion of
a mCherry-hphNT1 fragment, constructed using plasmid pBS35 (gift from Prof. Roger Y.
Tsien) as PCR template, behind the NRD1 gene. The NRD1-mCherry construct allows
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for detection of the nucleus in experiments using fluorescence microscopy. BM3315 is a
centromeric, URA3 plasmid for expression of Mig1-GFP, driven by the endogenous MIG1
promoter. Cells were grown in synthetic drop-out medium (Yeast Nitrogen Base, YNB,
6.7 g/l, Complete Supplement Mixture (CSM-Uracil) 0.77 g/l pH 6), supplemented with
either glucose 4%m/v plus ethanol 3 % v/v or with ethanol 3 % v/v as sole carbon source
[DeVit et al. 1997]. Yeast cultures were grown to OD600 = 0.6−1.0, corresponding to mid
log phase, at 30◦C in an 15 incubation shaker (220 rpm), collected and concentrated by
centrifugation (30 s, 6000 rpm).
Positioning the cells
To position the cells inside the measurement region of the microfluidic device, the micro-
scope stage and the objective were controlled by an OpenLab automation [Eriksson et al.
2010]. The coordinates of the first positioned cell, the total number of cells and the spac-
ing between the cells were all determined by the user. Then, the automation positioned
the trapped cells in an array one by one, by bringing them down towards the bottom sur-
face at the desired positions in order to get attached to the coated surface. The program
also allowed the user to visually approve the trapped cell before it was positioned in the
measurement region. Here, only morphologically deviating cells and cells in clusters were
discarded in the experiments. For each experiment, approximately 25 cells were imaged.
However, some cells had to be excluded from further analysis, since they showed lack of
GFP, looked unhealthy or dead, or were lost during the course of the experiment. This
resulted in approximately 20 succesfully analysed cells for each experiment.
Image analysis
For each time point an image stack with seven optical sections was aquired. Each optical
section was imaged using three different filter settings in order to acquire the brightfield,
Mig1-GFP (green) and mCherry (red) signal. In order to keep the fluorescent labeling
to a minimum, we used brightfield images to find the cell contours, while the size and
position of the nuclei were determined using the fusion protein Nrd1-mCherry, which is
always localised in the nucleus independent of the level of stress. The image analysis was
performed using our own software, CellStress [Smedh et al. 2010], written in MATLAB
(MathWorks, Inc.). The contours of the nuclei were found using the mCherry images,
while the contours of the cells were identified from the brightfield images using the plug-in
tool CellStat [Kvarnstro¨m et al. 2008]. The fluorescence intensity of the Mig1-GFP inside
the nucleus was finally measured for each individual cell (see Figure 3.8).
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Figure 3.8.: S. cerevisiae cells expressing Mig1-GFP and Nrd1-mCherry in 4% glucose media.
The image segmentation is performed on (a) the bright field image just below the focal plane and
(b) the maximum intensity projection of the mCherry fluorescence channel. In (c) a maximum
intensity projection of the GFP channel is shown. (d) and (e) show the segmentation of the
bright field and the mCherry images, respectively. In (f) the contours of the cell objects and
nuclear objects from the segmenations are shown as an overlay in the GFP image.
Background bleaching experiment
Every cell has autofluorescence, which arises from naturally occurring molecules, such as
flavins, NADH and other fluorescing biomolecules [Smedh et al. 2010]. The exact mecha-
nism and nature of the background molecules are not known in this case, but bleaching is
a widely familiar problem resulting in the destruction of the fluorophore and a decrease in
emission intensity over time [Rost 1995]. A background bleaching experiment yields infor-
mation regarding the bleaching rate of naturally existing fluorescing molecules in the cell.
Thus, the experiment was done using the strain BY4741 without the plasmid expressing
Mig1-GFP. All other parameters, such as glucose concentration and pulse duration (in-
tervals of 10 minutes only) are as described in the environmental change experiment (see
below). Axial stacks (seven images with a spacing of 0.8µm) of brightfield and fluorescence
images (GFP and mCherry, respectively) were acquired at intervals of 30 seconds.
GFP bleaching experiment
In order to distinguish between changes in signal intensity due to bleaching of GFP and
those due to shuttling kinetics, experiments were performed where cells either remained
in a glucose rich medium or in a glucose free medium during the whole course of the
experiment. The aim of this experiment was to determine the background-to-Mig1-GFP
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Figure 3.9.: Experiments with a changing environment. (a) Schematic of the change in glucose
concentration and the change in GFP signal in the nucleus versus time, respectively. (b) The
corresponding microscope images of a selected cell, showing the shuttling of Mig1-GFP into and
out of the nucleus as a response of these changes. The leftmost image is a brightfield image and
the others are fluorescence images.
ratio and to analyse the rate, by which bleaching of the GFP molecules occurs and how
this bleaching rate might differ from that of the naturally occurring fluorescing molecules.
Axial stacks (seven images with a spacing of 0.8µm) of brightfield and fluorescence images
(GFP and mCherry, respectively) were acquired at intervals of 30 seconds.
Environmental change experiment
Prior to the experiment, cells positioned in the flow chamber were exposed to growth
medium containing 3% ethanol and 4% glucose to ensure that they are far away from
starvation. Hence, one can assume that the maximum number of Mig1-GFP molecules in
the nucleus has been reached prior to the initiation of the experiment. In the course of the
experiment, the microfluidic flow settings were shifted such that the cells were exposed to
medium containing 3% ethanol as sole carbon source, to only stress the cells by glucose
starvation, but not an overall starvation, causing Mig1-GFP to shuttle from the nucleus
into the cytosol (see Figure 3.9). Then, shifts between the two media were repeated at
different time intervals (5, 10 or 20 minutes) in different experiments. In all cases, the
full duration of an experiment was 40 minutes, hence four, two or one complete cycle(s)
of shifting could be monitored. Axial stacks (seven images with a spacing of 0.8µm) of
brightfield and fluorescence images (GFP and mCherry, respectively) were acquired at
intervals of 30 seconds. In order to evaluate the correctness of the model, additional
experiments (see Figure 3.15) with image acquisition every 60 seconds were done.
Processing of raw data
Whereas some technologies, like Western blotting, report the average response of a popula-
tion during the experiment, single cell experiments can instead provide data on individual
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cells. To obtain the average dynamic behaviour, it requires an averaging over all cells after
the experiment. From all three types of experiments described above, we use the intensity
data measured in the nuclei. We first normalise the time series of every cell to its average
value over time. The time courses now all share the same average value, which equals
one. In a second step, we take the average over all normalised cells at each time point
and calculate the standard deviation, thus combining approximately 60 cells out of three
experiments. In a last step, we scale this averaged time course to a range between zero
and one by dividing with its initial intensity. Hence, for all experiments, the initial time
point has the intensity value one.
3.2.2. Results
The intracellular response to the environmental changes results in a shuttling of Mig1-
GFP between the nucleus and cytosol and can thus be monitored using fluorescence mi-
croscopy. For the mathematical model we used data acquired from time lapse fluorescence
microscopy where yeast cells were exposed to repetitive environmental changes between
glucose rich and glucose free media. The model takes into account the decrease in intensity
over time due to bleaching of Mig1-GFP and autofluorescent molecules. It is based on
ODEs and describes the experimental data glucose concentration, background intensities,
Mig1-GFP intensities and the sum of background and GFP intensities in a dynamic envi-
ronment.
Parameter estimation
Numerical simulations were carried out with Matlab (MathWorks, Inc.) and the Systems
Biology Toolbox2 [Schmidt and Jirstrand 2006], using the particle-swarm-algorithm [Vaz
and Vicente 2007] for parameter estimation. A list of all parameter values is given in
Table 3.3.
Background bleaching model
In this experiment, cells without the capability of expressing GFP were used. We describe
the bleaching of fluorescing molecules by a decreasing exponential function, implying that
the bleaching impact is proportional to the fluorescing molecules available (Figure 3.10a).
The experimental data of the background show a rapid initial decline within the first three
minutes followed by an almost constant level, as shown in Figure 3.11. Hence, one can
assume that the bleaching process of the background molecules is a combination of mainly
two different processes: a fast and sensitive process and a slow and insensitive process.
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Figure 3.10.: Schematics illustrating the different contributions to the fluorescent signal of the
nucleus. (a) Background bleaching with λ1 denoting the bleaching rate of a fast and sensitive
process and λ2 of a slow and insensitive process. (b) GFP bleaching for cells residing in glu-
cose free media with λ3 denoting the bleaching rate and BGprop1 denoting the proportion of
background to the overall intensity. (c) GFP bleaching for cells residing in glucose rich media,
λ3 and BGprop1 analogously to (b). (d) Nuclear intensity of Mig1-GFP for cells in a dynamic
environment, where the surrounding media change between glucose rich and glucose free media,
α and β denoting the shuttling rates for Mig1-GFP.
The background noise (BG), described as the sum of two exponentially decaying functions,
can be expressed as
BG = BG1(0) · e−λ1·t +BG2(0) · e−λ2·t ,
where
d
dt
(BG1) = −λ1 ·BG1 ,
d
dt
(BG2) = −λ2 ·BG2 ,
and λ1 and λ2 are determined through experimental measurements. The simulation is
shown in Figure 3.11. The values for the estimated parameters are given in Table 3.3.
The only parameter difference among the background bleaching experiment and the en-
vironmental change experiment was the absence of Mig1-GFP. All other parameters were
kept constant. The purpose of the background bleaching experiments is to determine the
bleaching effect of the autofluorescence, which for normal experiments is hidden in the
sum of intensities of GFP and autofluorescence. The change in medium is, however, not
considered in the background model. This simplification is reasonable because it is not
expected that background molecules are affected by changes in the medium.
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Figure 3.11.: Comparison of simulation and experimental data (intensities in the nucleus) of the
autofluorescence in cells without GFP. Images were taken every 30 seconds. Parameter values
are listed in Table 3.3.
GFP bleaching model
To analyse GFP bleaching, two different experiments were designed: on the one hand,
cells were continuously exposed to a glucose poor medium (0 g/L) resulting in Mig1-GFP
residing in the cytosol (Figure 3.10b), on the other hand, cells were continuously exposed
to a glucose rich medium (40 g/L) resulting in Mig1-GFP residing inside of the nucleus
(Figure 3.10c). The intensity data measured is equal to the sum of the background and
Mig1-GFP intensity. The contribution of the background to the overall intensity in the
nucleus will be higher when Mig1-GFP is located in the cytosol, and lower when it is
located in the nucleus. Since no confocal laser scanning imaging technique is applied, the
intensity of the excitation light is assumed to be equal throughout the entire volume of
the cell, resulting in a similar bleaching rate λ3 of Mig1-GFP, regardless of Mig1-GFP
localisation within the cell. According to Song et al. [Song et al. 1995], one can assume
an exponential decay of the Mig1-GFP intensity, when exposed to excitation light as il-
lustrated in Figure 3.10b and Figure 3.10c. Any qualitative differences between the two
experiments is thus explained by the different contribution of the background to the mea-
sured intensity. Furthermore, the decrease of the total excited Mig1-GFP concentration
within a cell under bleaching effects can be defined as
d
dt
(Mig1GFPtotal) = −λ3 ·Mig1GFPtotal
such that
BGGFP = Mig1GFPtotal(0) · e−λ3·t +BGprop ·BG
where BGGFP is the intensity composed of background (BG) and Mig1-GFP fluorescent
intensity, both decreasing due to bleaching. We define BGprop as the local parameter
accounting for the background-to-Mig1-GFP ratio (Figure 3.12a and Figure 3.12b). The
comparison between the simulation and the experimental data can be seen in Figure 3.12c
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Figure 3.12.: (a), (b) Background (dashed red line) and Mig1-GFP (dotted green line) intensities.
Their sum represents the overall measured intensity in the nucleus (solid blue line) in glucose
poor medium (left column) and glucose rich medium (right column) as described in the model
for the GFP bleaching. Note that under glucose poor conditions the background intensity has
a higher portion of the overall measured intensity in the nucleus, since Mig1-GFP is located to
the cytosol, compared to glucose rich conditions when Mig1-GFP is located in the nucleus. (c),
(d) Comparison of simulation and experimental data of Mig1-GFP and background intensities.
Images were taken every 30 seconds. Parameter values are listed in Table 3.3. The GFP
bleaching model is described in Section 3.2.2.
and Figure 3.12d. Therefore, it is possible to extract the bleaching rate for Mig1-GFP by
using the information from the background bleaching data. Applying this information, it
is now possible to start analysing the Mig1-GFP shuttling data.
Environmental change model
This model analyses changes in Mig1-GFP localisation under glucose starvation stress.
Fitting the model to the experimental data, the phosphatase and kinase rate constants for
Mig1-GFP were determined (Figure 3.10d). As shown in the previous section, the decrease
in excited Mig1-GFP concentration due to bleaching can be described as the exponentially
decreasing function:
Mig1GFPtotal(t) = Mig1GFPtotal(0) · e−λ3·t
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where λ3 is the bleaching rate of Mig1-GFP. Then, we finally insert this degradation term
into the model for Mig1-GFP shuttling:
d
dt
(Mig1GFP ) = α · (A+ θ1) ·Mig1PGFP − β · (B + θ2) ·Mig1GFP , (3.9)
where
Mig1PGFP = Mig1GFPtotal −Mig1GFP ,
and α and β are parameters representing the rate of Mig1-GFP dephosphorylation and
phosphorylation, respectively. The term within the brackets of Eq. (3.9) is a switch func-
tion representing the presence of active phosphatase and kinase of Mig1, respectively.
Hence, it can be assumed that the activation of Mig1’s kinase and phosphatase is faster
than the activation and deactivation of Mig1 itself. The parameters A and B indicate a
basal phosphorylation and dephosphorylation of Mig1 regardless of the glucose concentra-
tion, respectively. The Heaviside step functions θ1 and θ2 [Bracewell 1999] represent the
switches among glucose rich and glucose free media:
θ1 =
0 for glucose free medium1 for glucose rich medium
θ2 =
1 for glucose free medium0 for glucose rich medium
The experimental data of the environmental change experiments can be described as the
composition of background and Mig1-GFP shuttling:
BGGFPshuttling = Mig1PGFP +BGprop ·BG
as shown in Figure 3.13(a) to 3.13(c) for the comparison of experimental data and simu-
lation. Figure 3.13(d) shows the composition of background and Mig1-GFP resulting in
the overall intensity. Since BGprop is a local parameter, it needs be included into a new
estimation for the environmental change experiments. The result of the parameter esti-
mation for A and B indicates that there is in addition to the glucose depending regulation
a basal Mig1 (de)phosphorylation, since A,B 6= 0. This result is supported by findings
in Western blot data indicating that Snf1 is never fully dephosphorylated [Garcia Salcedo
2009]. The values can be found in Table 3.3.
Due to the bleaching process and unlike the Mig1 concentration, the total concentration
of excited Mig1-GFP is not constant but decreases over time. In order to predict the rate
of change for Mig1 (regardless of GFP-tagging), we use the above equation of Mig1-GFP
for Mig1 by replacing Mig1GFPtotal with a constant total concentration of Mig1:
d
dt
(Mig1) = α · (A+ θ1) ·Mig1P − β · (B + θ2) ·Mig1
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Parameter Unit BG GFP
eth
GFP
glc
5min 10min 20min
λ1 1/min 0.92 “ “ “ “ “
λ2 1/min 0.0002 “ “ “ “ “
BG1(0) norm.in. 0.12 “ “ “ “ “
BG2(0) norm.in. 0.88 “ “ “ “ “
λ3 1/min - 0.022 0.022 “ “ “
Mig1GFPtotal(0) norm.in. - 0.30 0.54 0.55 0.55 0.48
BGprop - - 0.63 0.47 0.57 0.56 0.49
Mig1GFP (0) n.i. - - - 0.41 0.49 0.46
α norm.i.min - - - 0.35 0.35 0.35
β norm.i.min - - - 0.50 0.50 0.50
A norm.in. - - - 0.03 0.03 0.03
B norm.in. - - - 0.06 0.06 0.06
Mig1total
molec.
cell - - - 19 000 19 000 19 000
Table 3.3.: Overview of the parameters and values used in the model ordered by the different
models in the columns. The parameter values for the background bleaching experiment were
taken in order to estimate the parameters for the GFP bleaching experiment, and those values
are finally used for the 75 environmental change experiments. The handing down of parameter
values is indicated by the quotation marks. The non-existence of a parameter in the model
is denoted by a minus. A,B 6= 0 indicate a constant level of Mig1 (de)phosphorylation. The
gray fields highlight parameter values taken from unpublished data [Garcia Salcedo 2009]. The
units for A, B, and the initial conditions are normalised intensities (concentrations), denoted
norm.in. the unit of Mig1total is molecules/cell taken from unpublished data [Garcia Salcedo
2009]. BGprop is a scaling factor.
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Figure 3.13.: (a) to (c) Comparison of simulation (BGGFP shuttling) and experimental data of
the environmental change experiment, for pulse durations of (a) 5 minutes, (b) 10 minutes, and
(c) 20 minutes, respectively. Images were taken every 30 seconds. (d) Simulation of the intensity
in the nucleus of a 10 minutes environmental change experiment. The intensity (solid blue line)
is defined as the sum of background (dashed red line) and Mig1-GFP shuttling (dotted green
line) both undergoing photobleaching during imaging.
where Mig1P = Mig1total −Mig1 and Mig1total represents a constant. So far, our model
simulated the normalised data. A more natural view on Mig1 and Mig1-GFP shuttling
dynamics is obtained by scaling Mig1GFPtotal to 19 000 ± 3800, which is an approximate
number of Mig1 molecules per cell [Garcia Salcedo 2009]. The simulation can be seen in
Figure 3.14(a) for Mig1 and in Figure 3.14(b) for Mig1-GFP.
Model validation
The model was validated using new experimental data acquired at 60 seconds intervals.
Hence, a two-fold slower bleaching rate is expected while the values for parameters α, β,
A, and B remain the same. Therefore, we divide the bleaching rates λ1, λ2, and λ3 by two.
New estimates for the local parameter BGprop and the initial conditions are required. As
presented in Figure 3.15, the simulation is in good agreement with the experimental data.
This supports the assumption that the decrease in the intensity data is due to bleaching
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Figure 3.14.: Simulation of Mig1 (solid blue line) and Mig1P (dotted green line). The total
concentration (dashed red line) is constant and set to 19 000 molecules per cell. (b) Simulation
of Mig1-GFP (solid blue line) and Mig1P-GFP (dotted green line). The total concentration
(dashed red line) is decreasing due to photobleaching.
effect during image acquisition.
3.2.3. Discussion
All fluorophores undergo photobleaching during excitation. The lack of photostability
is therefore a limiting factor during imaging, especially for time series and single cell
experiments. We have developed a mathematical model that successfully describes the
decrease of total excited Mig1-GFP due to photobleaching and the shuttling of Mig1-
GFP. Our mathematical model takes bleaching and background noise into account and
can thus extract the information on Mig1-GFP shuttling in order to predict the dynamic
behaviour of Mig1 during changing environmental conditions. The estimated parameter
values suggest that the basal phosphorylation and dephosphorylation of Mig1 occur both
independently of glucose levels, thereby supporting the findings of Western blot data
[Garcia Salcedo 2009]. Furthermore, the estimated parameter values suggest that the
kinase has a greater influence on the activation status of Mig1 than the phosphatase. The
image acquisition every 60 seconds supports the assumption that the decrease in total
excited Mig1-GFP is sufficiently explained by the occurrence of bleaching: Exclusively by
dividing the estimated values for bleaching rates by two (since only half the number of
images were taken) and assigning the local parameters for background-to-Mig1-GFP ratio,
we obtain a satisfying reproduction of the data. Our model suggests that mathematical
modelling can be a complement to the extensive development of highly photostable variants
of mOrange and TagRFP. It thereby demonstrates how raw data, that were generated in
an optical microscope, can be processed and used for mathematical modelling of signal
transduction pathways.
The model allows for a stepwise extraction of the information on the background and
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Figure 3.15.: Comparison of simulation and experimental data of the environmental change
experiment for pulse durations of (a) 5 minutes, (b) 10 minutes, and (c) 20 minutes. Images
were taken every 60 seconds. Dividing the bleaching rates for background and GFP by two and
resuming parameters α, β, A, and B as estimated before leads to the successful reproduction of
the data.
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Mig1-GFP bleaching rates, the background-to-Mig1-GFP ratio, and the rates of Mig1-
GFP phosphorylation and dephosphorylation. Hereby, it is possible to predict Mig-GFP
shuttling as it would occur without bleaching. The analysis demonstrates how data ac-
quired using an optical microscope can be processed and used for mathematical modelling
of signal transduction pathways as shown in Chapter 3.3.
3.3. Snf1 pathway modelling
In order to elucidate regulatory mechanisms that comprise interrelations of Snf1 pathway
components, in particular, Snf1 and Mig1, we first derived the glucose-regulated stimulus
(shown in Section 3.1.5), followed by the processing of Mig1-GFP intensity data (discussed
in Section 3.2.2). Experimental data was available generated by the group of Stefan
Hohmann1, University of Gothenburg. Within data-driven modelling and model-driven
experimentation cycles, we establish the ODE-based mathematical models describing the
Snf1 pathway to investigate the following questions:
• Is the regulation of Snf1 mediated by a glucose-regulated kinase or a
glucose-regulated phosphatase, or even both?
• Is the involvement of the Snf4-subunit essential for explaining the exper-
imental observations?
• Is the dephosphorylation of Mig1 controlled by glucose, or could it be
constitutive?
This Section is part of an unpublished collaborative manuscript [Garcia Salcedo 2009].
3.3.1. Alternative Snf1 pathway models
We now analyse alternative pathway structures of the Snf1 pathway, which include the
three hypotheses that Snf1 is regulated through
a) a constant kinase (UK) and a glucose-regulated phosphatase (PP1),
b) a constant phosphatase (PP1) and a glucose-regulated kinase (UK), and
c) both, phosphatase (PP1) and kinase (UK), being glucose-regulated
As described in [McCartney and Schmidt 2001], it was observed that sodium stress lead to
Snf1 phosphorylation on the Thr-210 residue, while at the same time Snf1 was unable to
phosphorylate Mig1 efficiently. Hence, we also consider two alternative model structures
with a glucose-controlled step, that was added to our initial, simple model:
1Department of Cell and Molecular Biology, University of Gothenburg, SE-40530 Go¨teborg, Sweden.
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I) initial model (illustrated in Figure 3.16)
II) a conformational rearrangement that is mediated by the Snf4-subunit (described in
[McCartney and Schmidt 2001], network sketched in Figure 3.22)
III) a complex formation of Mig1 and Hxk2, protecting Mig1 from phosphorylation by
Snf1 in glucose presence (suggested in [Ahuatzi et al. 2007], network outlined in
Figure 3.23).
After describing the integration of the glucose-regulated signal (derived in Section 3.1)
and the fluorescence microscopy data for Mig1 (processed in Section 3.2) into the Snf1
models, a detailed discussion and presentation of the nine (Ia), Ib), Ic), IIa), IIb), IIc),
IIIa), IIIb) and IIIc)) alternative Snf1 network structures is performed.
Integration of the glucose-regulated signal into the mathematical model
Since details of the glucose-regulated signal are still unknown, we do not introduce a
new variable, speculating on its degradation, synthesis, and (de)activation processes, but
introduce the signal directly into the differential equation system in form of the glucose-
dependent glycolysis rate derived in Section 3.1 Eq. (3.8), kglycolysis, as follows
d
dt
UKactive = −dUK · kglycolysis · UKactive + aUK · UKinactive (3.10)
d
dt
PP1active = aPP1 · kglycolysis · PP1inactive − dPP1 · PP1active . (3.11)
In this way, while the cell subsist on glucose, the upstream kinase of Snf1 (UK) is
deactivated and the phosphatase of Snf1 and Mig1 (PP1) is activated leading to the re-
sponse that genes encoding proteins for the utilisation of alternative carbon sources are
repressed via Mig1. In contrast, as glucose availabilities glucose decrease, inactivation
of UK slows down and its constant activation prevails, while activation of PP1 slows
down and its constant deactivation dominates. Alternative model structures, within ev-
ery iteration cycle discussed below, include the three different combinations of Eq. (3.10)
and Eq. (3.11): (a) a constant kinase and a glucose-regulated phosphatase by cancelling
kglycolysis of Eq. (3.10), (b) a constant phosphatase and a glucose-regulated kinase by
cancelling kglycolysis of Eq. (3.11), and (c) both, phosphatase and kinase, being glucose-
regulated without cancelling the rate kglycolysis.
Integration of the Mig1-GFP intensity data into the Snf1 pathway model
The definition of the glucose signal and the processed Mig1 data are now used for
modelling the Snf1 pathway. Recalling Eq. (3.9) from the Subsection 3.2.2
d
dt
(Mig1GFP ) = α · (A+ θ1) ·Mig1PGFP − β · (B + θ2) ·Mig1GFP ,
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the fluorescent microscopy data of Mig1 are comprised into the Snf1 model by adding the
following equation
d
dt
(Mig1) = α · PP1 ·Mig1P − β · Snf1P ·Mig1 ,
with the phosphatase Glc7/Reg1 (PP1) replacing (A+ θ1) and Snf1P replacing (B + θ2).
Since A and B have units molecules per cell for normalised Mig1 data, but PP1 and Snf1P
(SNF1P) are of units molecules per cell for Mig1 numbers per cell, we expect a scaling
factor of approximately the size of PP1total ≈ 28 000 and Snf1total ≈ 20 000 molecules per
cell to be balanced within the parameters α and β.
3.3.2. Snf1 pathway models
The corresponding pathway can be seen in Figure 3.16.
UK
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PP1PP1
Mig1 Mig1
Snf1Snf1
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glucose
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simple molecule
channel
activated protein
inactivated protein
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Figure 3.16.: A reaction network suggesting three alternative structures for the Snf1 pathway:
(a) a constant kinase and a glucose-regulated phosphatase, (b) a constant phosphatase and a
glucose-regulated kinase, as well as (c) a glucose-regulated kinase and phosphatase). In glucose
presence, Snf1 is dephosphorylated and Mig1 acts as a transcriptional repressor. In glucose
absence, Snf1 is phosphorylated, thereon phosphorylating Mig1, which thereon shuttles to the
cytosol. ‘UK’ summarises the three upstream kinases of Snf1. The rate equations are listed
in Table 3.4. The image was designed using CellDesigner [Funahashi et al. 2008] and Adobe
Illustrator.
The Snf1 Western blot data
The activation of Snf1, monitored via the phosphorylation state of the Snf1 Thr-210
residue, was studied during controlled batch cultivations (fermentor) as shown in Fi-
gure 3.17 and described in detail in Section 3.1.5.
The generated Western blot data present ratios of phosphorylated Snf1 to the overall
Snf1 protein. Therefore, we relate
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Figure 3.17.: Glucose simulations for Experiments C, D (see Table 3.1) and for a 10 minutes
Experiment as shown in Part 3.13(a). These glucose profiles in (a) and (b) are input signals for
the Snf1 simulation and the glucose profile in (c) is the input signal for nuclear intensity (taken
as a measure for Mig1 intensity).
Snf1Pratio = WBscaling factor ·
SNF1P
Snf1total
for a model that does not consider Snf1 complex formation, and for a model that does
take the complex formation into account
Snf1Pratio = WBscaling factor ·
Snf1P + SNF1P
Snf1total
.
The parameter WBscaling factor denotes the Western blot scaling factor, which is needed
to account for different intensities among different Western blot experiments, e.g. the
magnitude of antibody binding. We scale each time series of the different experiments to
its maximum value. Snf1 Western blot data of three different overexpression experiments
were generated: Overexpression of SAK1, the gene encoding the main kinase of Snf1,
overexpression of REG1, the gene encoding the regulatory subunit of the phosphatase
of Snf1, and overexpression of SAK1 and REG1 within the same strain. The data of the
Sak1 overproduction show, that Snf1 is constitutively phosphorylated, even in high glucose
concentrations. At the same time it is observed, that Mig1 remains unphosphorylated. It
appears that Snf1 can be activated and perform functions in the presence of glucose (such
as in salt tolerance) without targeting Mig1 through phosphorylation. Also overexpressing
REG1 did not alter Mig1 (de)phosphorylation dynamics compared to non-overexpressing
cells.
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Details of the materials and methods for the experimental setups are according to un-
published data [Garcia Salcedo 2009]. The findings of these experiments were as follows:
• For Sak1 overproduction:
– Constitutive Snf1 phosphorylation
– In presence of glucose, the artificial Snf1 activation does not have any effect on
Mig1 phosphorylation and localisation
• For Reg1 overproduction:
– In glucose limiting conditions, no significant decrease in the Snf1 phosphory-
lation level is observed
– This observation supports the idea that the phosphatase complex Glc7/Reg1 is
specifically active toward Snf1 when glucose is abundant
– Similarly to the conditions of Sak1 overproduction, overexpression of REG1
does not have impact on Mig1 regulation
• For both, Sak1 and Reg1 overproduction:
– Regulation of Snf1 phosphorylation in cells overexpressing SAK1 is partially
restored by overproduction of Reg1
According to unpublished data [Garcia Salcedo 2009], the kinase is approximately 10-fold
overexpressed relative to the basal level, whereas the phosphatase is about 35-fold over-
expressed. However, since only the gene REG1 encoding for the regulatory subunit was
overexpressed without the gene GLC7 encoding for the catalytic subunit, we only act on
the assumption that the overproduction is limited to the maximal number of the protein
Glc7.
Assumptions
Modelling is limited due to insufficient quantitative and qualitative data on concentra-
tions, reaction and degradation rates, as well as many other parameters that are delicate
to measure [Materi and Wishart 2007]. As a consequence, approximations and estimates
have to be used. We here assume for all nine model candidates the following:
• The upstream kinases of Snf1 (Elm1, Sak1, Tos3) can be summarised to one kind of
upstream kinase (UK).
• The different isoforms of each subunit of Snf1 do not need specification but can be
summarised and reduced to just one form.
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• All components, especially the Snf1 complexes are well mixed within the cell (no
spatial impact due to the β-subunit of Snf1).
• Phosphorylated Mig1, which is located to the nucleus, as well as dephosphorylated
Mig1, which is located to the cytosol, can be neglected.
The corresponding reaction rates, kinetic equations, and conservation relations are listed
in Table 3.4. We denote the model the Snf1-model. We translated the three alternative
Processes Reaction rates
UK (Upstream Kinase of Snf1) activation R1 = aUK · UKinactive
UK deactivation R2 = dUK · UKactive · kglycolysis
PP1 (phosphatase of Snf1) activation R3 = aPP1 · PP1inactive · kglycolysis
PP1 deactivation R4 = dPP1 · PP1active
Snf1 phosphorylation/activation R5 = aSnf1 · Snf1 · UKactive
Snf1 dephosphorylation/deactivation R6 = dSnf1 · Snf1P · PP1active
Mig1 phosphorylation/deactivation R7 = aMig1 ·Mig1 · Snf1P
Mig1 dephosphorylation/activation R8 = dMig1 ·Mig1P · PP1active
Kinetic equations Conservation relations
d/dt(UKactive) = R1−R2 UKtotal = UKactive + UKinactive
d/dt(PP1active) = R3−R4 PP1total = PP1active + PP1inactive
d/dt(Snf1P) = R5−R6 Snf1total = Snf1P + Snf1
d/dt(Mig1) = R8−R7 Mig1total = Mig1P +Mig1
Table 3.4.: Overview of the processes, reaction rates, kinetic equations and conservation relations
for models Ia), Ib), and Ic) as depicted in Figure 3.16. The corresponding parameter values are
given in Table A.1 in the Appendix.
pathway structures, depicted in Figure 3.16, into ODE-based models. Numerical simu-
lations for all models were carried out with Matlab (MathWorks, Inc.) and the Systems
Biology Toolbox2 [Schmidt and Jirstrand 2006], using the particle-swarm-algorithm [Vaz
and Vicente 2007] for parameter estimation. A comparison of the model simulations to
the experimental Snf1 Western blot data showed that all three investigated models explain
the Snf1 data, as can be seen in Figure 3.18.
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The results are:
• All three models ((a) a glucose-regulated phosphatase, (b) a glucose-regulated kinase,
or (c) both, kinase and phosphatase, glucose-regulated) reproduce the Snf1 Western
blot data for wild type cells (compare Figure 3.18).
• Estimating the parameter values for a model with a glucose-regulated phosphatase
and a glucose-regulated kinase leads to an optimum displaying almost a constant
kinase rate (see Figure 3.19), suggesting that a glucose-regulated phosphatase would
be sufficient to regulated Snf1.
These results displays the need for further experimental data.
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Figure 3.18.: Snf1 data and simulations of three alternative Snf1-models (Ia), Ib), and Ic)):
(a+d) a constant kinase and a glucose-regulated phosphatase, for two experiments respectively,
(b+e) a constant phosphatase and a glucose-regulated kinase, (c+f) a glucose-regulated kinase
and a glucose-regulated phosphatase). It can be seen that all pathway structures explain Snf1
(de)phosphorylation dynamics.
As can be seen in Figure 3.20, the Snf1 model introduced above does not explain the
mechanisms, that Mig1 phosphorylation and dephosphorylation dynamics remain unaf-
fected. Sak1 overproduction results in a decreased concentration of unphosphorylated
Mig1, due to an increased level of phosphorylated Snf1, even in glucose rich media, and as
a consequence, an increased process of Mig1 phosphorylation. Also for cells overproducing
Reg1, Mig1 is increasingly dephosphorylated but does not remain unaffected as observed
in experiments. In particular, the deviations among simulation and experimental data
for a Snf1 model with a glucose-regulated kinase (middle column of Figure 3.20) suggest
that the regulation of Snf1 alone is not strong enough to compensate for a constitutively
active phosphatase to afford the rapid (de)phosphorylation dynamic of Mig1. As follows,
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Figure 3.19.: Kinase and phosphatase rates of Snf1 for the Snf1 models Ia), Ib), and Ic). It
is notable that a model with both, kinase and phosphatase being glucose-regulated exhibits
a pronounced phosphatase rate (dSnf1 · PP1active) via the phosphatase and a modest, almost
constant kinase rate (aSnf1 · UKactive). First row: PP1 regulated model, second row: UK
regulated model, third row: both regulate. (a+d) a constant kinase and a glucose-regulated
phosphatase, for two experiments respectively, (b+e) a constant phosphatase and a glucose-
regulated kinase, (c+f) a glucose-regulated kinase and phosphatase).
we can exclude this model from the list of candidates. As will be shown in the next para-
graph, a constitutively active phosphatase may be possible in collaboration with another
glucose-stimulated component, such as Hxk2.
In the next two paragraphs, the establishment of two models is shown, which describe
the following mechanisms:
• Activation of the Snf1 kinase complex involves two steps: one that requires an
upstream kinase and one that is mediated by the γ-subunit of Snf1 [McCartney and
Schmidt 2001]. The corresponding regulatory network is shown in Figure 3.21. We
denote this model the two-step model for Snf1 regulation.
• Regulation of Mig1 involves a glucose-regulated complex formation with Hxk2. Thereby,
Hxk2 binds Mig1 in order to defend it from phosphorylation through Snf1 in glucose
presence [Ahuatzi et al. 2007]. The corresponding regulatory network is shown in
Figure 3.23. We denote this model the Two-step model for Mig1 regulation.
3.3.3. Snf1 pathway models with a two-step regulation for Snf1
McCartney and Schmidt found that while both, glucose stress and sodium ion stress,
caused a rapid increase in Snf1 phosphorylation on the residue Thr-210, only glucose
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Figure 3.20.: Experimental data and simulations of nuclear intensities, as a measure for Mig1, for
the Snf1 models Ia), Ib), and Ic). First row: normal conditions. Second row: UK overproduced
in silico. Third row: PP1 overproduced in silico. First column: glucose-regulated PP1. Second
column: glucose-regulated UK. Third column: both glucose-regulated. It can be seen that a
constant phosphatase hampers the abrupt (de)phosphorylation dynamics of Mig1, and thus leads
to a poor agreement of simulations and experimental data (see (e) to (h)). Glucose profile as
shown in Figure 3.9.
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stress triggered the phosphorylation of Mig1 protein [McCartney and Schmidt 2001]. This
suggests that activation of the Snf1 kinase complex involves two steps: one that requires
an upstream kinase and one that is mediated by the γ-subunit of Snf1 [McCartney and
Schmidt 2001], as depicted in Figure 3.21. We establish the corresponding differential
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Figure 3.21.: Two-step model for Snf1 regulation, as suggested by McCartney and Schmidt
[McCartney and Schmidt 2001] (models IIa), IIb), and IIc)). In glucose presence, Snf1 is de-
phosphorylated and Mig1 acts as a transcriptional repressor. In glucose absence, Snf1 is phos-
phorylated, thereon phosphorylating Mig1, which thereon shuttles to the cytosol. Since Snf1 can
also be phosphorylated during glucose presence, while Mig1 is not phosphorylated, an additional
regulatory step is assumed. In this figure, the Snf1 undergoes a conformational change with the
Snf4 subunit while glucose is absence, as suggested by [McCartney and Schmidt 2001].
equations, listed in Table 3.5, and compare the simulations to the experimental data
shown in Figure 3.22.
3.3.4. Snf1 pathway models with a two-step regulation for Mig1
In glucose presence, Snf1 is dephosphorylated and Mig1 acts as a transcriptional repressor.
In glucose absence, Snf1 is phosphorylated and thereon phosphorylates Mig1 causing the
release of transcriptional repression. It appears that Snf1 is phosphorylated during glucose
presence, activated by, e.g. salt stress, while Mig1 is not phosphorylated. The Snf1 model
neglecting a glucose-regulated step in addition to kinase and phosphatase regulation is not
successful in describing the mechanisms, that Mig1 remains unaffected by phosphorylated
Snf1 in glucose presence. Figure 3.23 schemes the regulatory network considering a glucose-
regulated complex formation of the hexokinase Hxk2 and Mig1, as described by Ahuatzi
et al. [Ahuatzi et al. 2007]. In the presence of glucose, the Mig1Hxk2 complex defends
Mig1 from phosphorylation by Snf1. In the absence of glucose, the Mig1Hxk2 complex
dissociates, allowing Mig1 to be targeted for phosphorylation by Snf1 [Ahuatzi et al. 2007].
The corresponding differential equations are listed in Table 3.6. The simulations are in
good agreement with the experimental data for both, normal conditions and in silico
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Processes Reaction rates
UK activation R1 = aUK · UKinactive
UK deactivation R2 = dUK · UKactive · kglycolysis
PP1 activation R3 = aPP1 · PP1inactive · kglycolysis
PP1 deactivation R4 = dPP1 · PP1active
Snf1 phosphorylation R5a = aSnf1 · Snf1 · UKactive
Snf1 activation R5b = aSnf1P · Snf1P
Snf1 dephosphorylation R6a = dSnf1 · Snf1P · PP1active
Snf1 deactivation R6b = dSnf1P · Snf1Pactive · kglycolysis
Mig1 phosphorylation/deactivation R7 = aMig1 ·Mig1 · Snf1Pactive
Mig1 dephosphorylation/activation R8 = dMig1 ·Mig1P · PP1active
Kinetic equations comprising the Snf1 pathway model
d/dt(UKactive) = R1−R2
d/dt(PP1active) = R3−R4
d/dt(Snf1P) = R5a−R6a
d/dt(Snf1Pactive) = R5b−R6b
d/dt(Mig1) = R8−R7
Conservation relations
UKtotal = UKactive + UKinactive
PP1total = PP1active + PP1inactive
Snf1total = Snf1
P + Snf1 + Snf1Pactive
Mig1total = Mig1
P +Mig1
Table 3.5.: Overview of the reaction rates for two-step models for Snf1 regulation (IIa), IIb), and
IIc)) considering an additional step in Snf1 activation towards Mig1 as described by McCartney
and Schmidt [McCartney and Schmidt 2001]. The corresponding network structure is depicted
in Figure 3.21 and the corresponding parameter values are listed in the Appendix Table A.2.
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Figure 3.22.: Experimental data and simulations of nuclear intensities, as a measure for Mig1, for
two-step models of Snf1 regulation (IIa), IIb), and IIc)). First row: normal conditions. Second
row: UK overproduced in silico. Third row: PP1 overproduced in silico. First column: glucose-
regulated PP1. Second column: glucose-regulated UK. Third column: both glucose-regulated.
It can be seen that in the same way as the Snf1 model introduced above (see Table 3.4), a
constant phosphatase hampers the abrupt (de)phosphorylation dynamics of Mig1, and thus
leads to a poor agreement of simulations and experimental data (see middle column). However,
in contrast to the Snf1 model, there is no difference between the Mig1 dynamics under normal
conditions compared to conditions with UK overproduction. This observation can be explained
by the glucose-regulated Snf1-Snf4 conformational rearrangement.
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overproduction of the kinase and phosphatase, as can be seen in Figure 3.24.
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Figure 3.23.: Two-step model for Mig1 regulation. In glucose presence, Snf1 is dephosphory-
lated and Mig1 acts as a transcriptional repressor. In glucose absence, Snf1 is phosphorylated,
thereon phosphorylating Mig1, which thereon shuttles to the cytosol. Since Snf1 can also be
phosphorylated during glucose presence, while Mig1 is not phosphorylated, additional regulatory
steps are assumed, e.g. the complex formation of Mig1 and Hxk2, which is provoked by glucose,
as suggested by Ahuatzi et al. et al. [Ahuatzi et al. 2007]. The Mig1Hxk2 complex defends
Mig1 from being phosphorylated by Snf1 while glucose is present. In the absence of glucose, the
Mig1Hxk2 complex dissociates, allowing Mig1 to be targeted and be phosphorylated by Snf1.
The results can be summarised as follows:
• All three mechanisms (i.e. (a) a glucose-regulated phosphatase, (b) a glucose-regulated
kinase, and (c) both, kinase and phosphatase, glucose-regulated) reproduce the Snf1
Western blot data for normal conditions (compare Figure 3.18).
• A comparison of the model allowing for glucose regulation of kinase and phosphatase
to the experimental data leads to a distinctive phosphatase rate for Snf1 and an
almost constant kinase rate. This indicates, that the regulation of the phosphatase
would be sufficient to regulate Snf1 dynamics (see Figure 3.19). However, it does
not imply that the kinase is likely to be constant.
• Considering the nuclear intensity data, the model with a constant phosphatase shows
only a poor agreement of the experimental data and the simulations. This supports
the existence of a glucose-regulated phosphatase. (see middle column of Figures 3.20
and 3.22)
• Including a two-step regulation for Snf1 improves the agreement of data and simu-
lations (see Figure 3.22).
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Processes Reaction rates
UK (Upstream Kinase of Snf1) activation R1 = aUK · UKinactive
UK deactivation R2 = dUK · UKactive · kglycolysis
PP1 (phosphatase of Snf1) activation R3 = aPP1 · PP1inactive · kglycolysis
PP1 deactivation R4 = dPP1 · PP1active
Snf1 phosphorylation/activation R5 = aSnf1 · Snf1 · UKactive
Snf1 dephosphorylation/deactivation R6 = dSnf1 · Snf1P · PP1active
Mig1 phosphorylation/deactivation R7 = aMig1 ·Mig1 · Snf1P
Mig1 dephosphorylation/activation R8 = dMig1 ·Mig1P · PP1active
Mig1 complex association R9 = k1 ·Mig1 ·Hxk2 · kglycolysis
Mig1 complex dissociation R10 = k2 ·Mig1Hxk2
Kinetic equations Conservation relations
d/dt(UKactive) = R1−R2 UKtotal = UKactive + UKinactive
d/dt(PP1active) = R3−R4 PP1total = PP1active + PP1inactive
d/dt(Snf1P) = R5−R6 Snf1total = Snf1P + Snf1
d/dt(Mig1) = R8−R7−R9 +R10 Mig1total = Mig1P +Mig1 +Mig1Hxk2
d/dt(Hxk2) = R10−R9 Hxk2total = Hxk2 +Mig1Hxk2
Table 3.6.: Overview of the processes, reaction rates, kinetic equations and conservation relations
for the two-step models for Mig1 regulation (IIIa), IIIb), and IIIc)), as depicted in Figure 3.23.
The list of parameter values is given in the Appendix Table A.3.
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Figure 3.24.: Experimental data and simulations of nuclear intensities, as a measure for Mig1,
for a two-step Mig1 regulation model (IIIa), IIIb), and IIIc)). First row: normal conditions.
Second row: UK overproduced in silico. Third row: PP1 overproduced in silico. First column:
glucose-regulated PP1. Second column: glucose-regulated UK. Third column: both glucose-
regulated. It can be seen that the model with a constant phosphatase reproduces the abrupt
(de)phosphorylation dynamics of Mig1 (see middle column). This is due to the interplay with
the glucose-regulated complex formation with Hxk2. In contrast, the Snf1 model without this
additional step as introduced above (see Table 3.4), displays poor agreement of simulations and
experimental data (see middle column of Figure 3.20). Glucose profile as shown in Figure 3.9.
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• Including a two-step regulation for Mig1 considerably improves the agreement of
data and simulations (see Figure 3.24).
3.4. Summary
Although the details on the mechanisms of the glucose signals responsible for Snf1 reg-
ulation remain to be elucidated, so far, it is widely assumed in the literature that the
signal leading to glucose-induced Snf1 inactivation is related to the rate of the first step
of glycolysis. Thus, in a first approach to modelling the Snf1 pathway, we present the
derivation of a glucose-regulated signal by means of the glucose consumption rate per
cell. As a basis for this approach, the mechanisms of glucose transport into a yeast cell
had to be reviewed. Yeast consumes glucose through facilitated diffusion accomplished by
a complex transport system consisting of several different kinds of hexose transporters.
Using experimental data for extracellular glucose, we find that for certain experimental
setups, the well-known carrier model, which assumes a constant dynamic contribution of
transporters, is not sufficient. We develop an ODE-based model considering the high and
low affinity contribution on the glucose uptake rate and find that this approach shows a
satisfying fit for both, the overall shape and the details comprised after a glucose pulse.
On this basis, we derive the glucose-regulated signal, which then is used as the regulatory
signal for Snf1 [Frey et al. 2011a].
Furthermore, the processing of fluorescent microscopy data of a downstream target of
Snf1, the transcriptional repressor Mig1, is presented. Fluorescence microscopy, in com-
bination with optical tweezers and microfluidics, can be used to acquire images with high
spatial and temporal resolution that allow quantitative information regarding the response
of single cells to environmental changes [Eriksson 2009]. The fluorescent microscopy data
for Mig1-GFP had to be processed in order to extract the data of interest (Mig1-GFP)
from bleaching effects and background noises. We establish an ODE-based mathematical
analysis for Mig1-GFP data processing, which allows a stepwise extraction of the infor-
mation on the background and Mig1-GFP bleaching rates, the background-to-Mig1-GFP
ratio, and the rates of Mig1-GFP phosphorylation and dephosphorylation. Eventually, it
is possible to predict Mig-GFP shuttling as it would occur without bleaching. Our analysis
demonstrates how data acquired using an optical microscope can be processed and used
for mathematical modelling of signal transduction pathways [Frey et al. 2011b].
Iterative cycles between data-driven modelling and model-driven experimentation were
carried out. The information of the glucose signal, the processed Mig1 data, and Snf1
Western blot data were used for modelling the Snf1 pathway. Additional information was
given through the finding, that upon overexpression of SAK1 (the main upstream kinase
of Snf1), Snf1 was highly phosphorylated even in high glucose media, while Mig1 remained
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unaffected. Also, Mig1 (de)phosphorylation was not influenced by REG1 overexpression.
In search of the regulatory mechanisms underlying the Snf1 pathway, several alternative
pathway structures are proposed, translated into ODE-based models, and tested by com-
paring the model simulations to the (processed) experimental data. The Snf1 Western blot
data can be reproduced for all model alternatives. In order to describe the Mig1 data, the
models comprising a two-step regulation for Snf1 are constricted to those models with a
glucose-regulated phosphatase. However, investigating the models comprising a two-step
regulation for Mig1 shows that all of them can explain the data. With the given data
and the current model assumptions, it is not possible to distinguish between simulations
of a pathway, where both, the kinase and the phosphatase of Snf1, are glucose-regulated
and where only the phosphatase transmits the glucose signal. Yet, the models show, that
Mig1 requires a glucose-regulated step for dephosphorylation, either in form of a directly
glucose-regulated phosphatase or a mechanisms involving an additional glucose-regulated
component. However, a model with a glucose-regulated kinase and a glucose-regulated
phosphatase show the best agreement to the experimental data with an almost constant
kinase rate while the phosphatase rate exhibited pronounced dynamics upon glucose avail-
abilities. Indeed, this does not lead to the conclusion that a glucose-regulated phosphatase
alone is more favourable or more likely. It would also be a feasible explanation if both,
a glucose-regulated kinase and a glucose-regulated phosphatase, are responsible for Snf1
regulation. This redundancy might allow for defending Snf1 from dysfunctions.
Modelling is limited due to insufficient qualitative and quantitative data on concentra-
tions, reaction and degradation rates, as well as many other parameters that are delicate
to measure [Materi and Wishart 2007]. With regard to further work, investigating the
mechanisms (such as including hexokinases into the model) that eventually lead to the
phosphatase activation or kinase deactivation appears to be a promising approach to con-
strict the remaining possible Snf1 network structures. The phosphatase of Snf1 and Mig1
is a complex, composed of the regulatory Reg1 and the catalytic Glc7 subunit. So far,
only REG1 was overexpressed, leading to only a slight increase in the total number of
complexes. For this reason, overexpression of both subunits at the same time seems more
promising to create a condition of high Snf1 phosphatase overproduction. Also, in order
to answer the question of Snf1 regulation, it might be useful to, in addition to the data
introduced here, generate different kinds of data, such as spectroscopic data elucidating
Snf1 complex formations or Reg1/Glc7 and Snf1 complex formations. Another challenge
certainly lies within not only temporal but also spatial considerations of the different lo-
cations of the Snf1 complex to the nucleus, cytosol, or vacuole, and the role of the three
different kinases of Snf1.
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4. Quantitative measures for signalling
pathways
In this chapter at first, an introduction to quantitative measures is given in Section 4.1.
Next, quantitative measures are established, as defined by Heinrich et al. [Heinrich et al.
2002] in Section 4.2 and 4.4. These definitions build the basis for the onward analyses:
In Section 4.3, extensions of those measures are discussed, which has been submitted for
publication in the collaborative manuscript Millat et al. [Millat et al. 2010]. In Section 4.5,
restrictions for a weakly activated system for a single phosphorylation cycle are addressed.
In Section 4.6, an optimality criterion as a measure of optimal cascade length concerning
average time and average duration of active cascade components is defined. Thereon,
consequences of model approximations are discussed in Section 4.7. Main parts of this
chapter are published in [Frey et al. 2009].
4.1. The need for quantitative measures
To ensure survival, cellular systems continuously need to adapt to changing environmental
conditions. The stimuli triggered by those changes are mediated via signalling pathways
from specified detection systems to the interior of the cell in order to cause changes in
gene expression or enzyme activity [Downward 2001]. As recent experimental and theo-
retical studies have shown, timing and order of events [Rensing et al. 2001; Murphy and
Blenis 2006], signal duration [Marshall 1995; Ferrell Jr. 1996; Sabbagh et al. 2001; Vaudry
et al. 2002; Millat et al. 2008] as well as signal strength (thresholds) [Behar et al. 2008]
are key parameters for the cellular response. On the one hand, cells that do not react
quickly enough to changing nutrient conditions risk being overgrown by competitors that
are quicker on the uptake [Kuttykrishnan et al. 2010]. On the other hand, cells that
respond too quickly risk wasting energy on the inappropriate response itself and being
overgrown by more efficient competitors [Kalisky et al. 2007]. This leads to the conclu-
sion that the specific structure of a pathway reflects its specific characteristic dynamical
requirements. Signal specificity is determined by the temporal and spatial dynamics of
signalling components [Kholodenko 2006]. It was observed in PC12 cells that the duration
of signalling through ERK may hold the key to the very different outcomes of EGF and
NGF stimulation [Sabbagh et al. 2001; Vaudry et al. 2002]. As reported in [Marshall 1995],
75
4. Quantitative measures for signalling pathways
the duration of ERK activation determines whether cells can trigger either proliferation
or differentiation. For the cellular response, and therefore, for the specific function of the
pathway, the properties of signals are crucial. However, an analysis for comparing different
pathway structures requires measures for quantification of properties, such as the timing
or duration of activated signal. The application of quantitative measures to components of
those pathways provides a tool for their characterisation. The characterisation of dynamic
features of signal transduction pathways is hence crucial to describe cellular adaptation.
This can also be determined by analysing experimental data without any knowledge about
the underlying network. Different attempts were made to define mathematical relations,
which extract this information from experimental and theoretical time courses. (For re-
cent reviews see [Klipp 2009; Kholodenko et al. 2010].) The meaningful determination of
quantitative properties for dynamic signals is not trivial. Over recent years, mathematical
theories have been developed to describe the regulation of signalling pathways as a function
of key parameters, i.e. phosphatase or kinase rate constants. The notion of characteristic
times is an approach frequently used to determine signal properties. Well-known examples
are the transition time [Easterby 1981, 1986; Llorens et al. 1997], and the t99 magnitude
[Easterby 1973; Storer and Cornish-Bowden 1974; Torres et al. 1991], which is the time
necessary to reach 99% of the final steady state. The t99 magnitude has the physical mean-
ing of the relaxation time of a system [Schwarz 1968; Atkins and de Paula 2002], which is
related to the eigenvalues of the system. This measure is well-defined from a theoretical
point of view, but difficult to determine from data and complex systems. For this reason,
Llore´ns et al. [Llorens et al. 1999] introduced a geometrical approach to estimate the mag-
nitude of the average time, taken by any observable of a metabolic pathway, to reach a
new state, when either a perturbation or a persistent variation was applied. Heinrich et al.
defined measures to quantify signalling time τ , signal duration ϑ, and signal amplitude S
using three different integrals over the dynamic signal X(t) [Heinrich et al. 2002]. These
integrals sum over the signal with different orders (order n = 0, 1, 2), with respect to time
tn. This approach excludes signals, which do not return to a zero basal level, and thus also
those, which are in non-phosphorylated protein forms. In the analyses following below,
we use the approach of Heinrich et al. [Heinrich et al. 2002], where integrals of different
orders are used to characterise signals for a general system (see Section 4.2) and a weakly
activated system (in Section 4.4).
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4.2. Quantitative measures for general systems
Heinrich et al. [Heinrich et al. 2002] introduced a general model1, denoted Hg model, that
describes a sequential kinase-phosphatase-cascade, as depicted in Figure 4.1. The change
of concentration of a phosphorylated protein XPi is described by the rate equation [Heinrich
et al. 2002]
d
dt
XPi = α˜i (Xi) (X
P
i−1)− βiXPi , (4.1)
where α˜i = αi/X
tot
i and X
tot
i denotes the total concentration, Xi the dephosphorylated
form of the proteins, X0 the receptor concentration, and α and β denote the kinase and
phosphatase rate constants, respectively. For a detailed derivation of this equation we
refer to [Heinrich et al. 2002] or the Appendix B.3.
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Figure 4.1.: The sequential kinase-phosphatase-cascade model of Heinrich et al. [Heinrich et al.
2002]. The dephosphorylated form of the proteins is denoted as Xi and the phosphorylated as
XPi . X0 denotes the receptor concentration, α and β denote the kinase and phosphatase rate
constants, respectively.
For such a system, Heinrich et al. [Heinrich et al. 2002] introduced the following quan-
titative measures: The signalling time of a pathway defined as
τi :=
∞∫
0
tXPi dt
∞∫
0
XPi dt
. (4.2)
The signalling time of a pathway is thus defined as the average time for the signal of the
i-th component X to become activated (Figure 4.2). The denominator integrates over the
entire signal XPi (t) and corresponds to the total amount of all X
P
i molecules generated
during the signalling period. More generally, it can be interpreted as signal power or
1The naming convention ‘general’ is chosen in contrast to a ‘weakly activated’ model discussed in Sec-
tion 4.4.
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dosage of the considered signal. The quantitative measure signal duration is defined as
ϑi :=
√√√√√√√
∞∫
0
t2XPi dt
∞∫
0
XPi dt
− τ2i (4.3)
and characterises for how long a signal of component XPi remains active. With quantitative
measures given in Eqs. (4.2) and (4.3), we can generate information about signal strength
and signal amplification. The quantitative measure signal amplitude is then given by
Si :=
∞∫
0
XPi dt
2ϑi
. (4.4)
Due to the averaging involved, the signal amplitude S is smaller than the maximal signal
strength. All three definitions include integrals that sum over the signal with different
orders with respect to time t. This approach therefore excludes signals, which do not
return to a zero basal level.
Finally, [Heinrich et al. 2002] define the amplification ratio A as
Ai,i−1 =
Si
Si−1
, i = 1, . . . , n
comparing the signal amplitude of the i-th component with its precursor. Thereby, A1
denotes the amplification of the stimulus and its successor. If Ai,i−1 > 1 the signal is
amplified, and damped for Ai,i−1 < 1. The overall amplification of a signalling pathway
can thus be measured as
An,0 ≡ An = Sn
S0
, (4.5)
where S0 denotes the signal amplitude of the stimulus and Sn of the most downstream and
phosphorylated protein. It describes the course of the signal amplitude S on its way from
receptors to the nucleus. Heinrich et al. found that in short pathways, signal amplification
can be achieved only with slow signal propagation and prolonged signal duration. This
might be biologically undesirable, and could explain why signalling cascades generally
consist of multiple steps. The series of components in a cascade can afford amplification
of the signal, e.g. binding of one hormone molecule to the cell can potentially lead to the
activation of hundreds of signalling molecules inside of the cell, so that relatively small
amounts of a certain extracellular signal can have drastic intracellular effects [Hancock
2010].
Within this study, we assume an exponential decreasing function for the stimulus
X0(t) = X0e−λt ,
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Figure 4.2.: Illustration of signalling time τ , signal duration ϑ, and signal strength S for a
hypothetical time-dependent signal [Heinrich et al. 2002]. Note that the signalling time τ does
not necessarily coincide with the maximum level of the signal. This would only be the case for
a symmetric function. By definition of S, the area under the curve is equal to the area of the
rectangle.
where X0 is the initial concentration, that is the ‘concentration’ of activated receptors.
How fast the stimulus decreases is determined by the rate constant λ. The greater λ the
faster the stimulus tends to zero. Due to this special choice, the integrals in Defs. (4.2)-
(4.4) can be solved analytically. The signalling time for the receptor is then τ0 = 1/λ,
which coincides with the relaxation time or characteristic time. The signal duration is
also ϑ0 = 1/λ. Finally, it is S0 = X0/2 for the signal amplitude as shown in Heinrich et al.
and in the Appendix B.5.
4.3. Extension to signals with a non-zero basal level
In previous studies [Heinrich and Rapoport 1975], the application of quantitative measures
was restricted to signals that eventually return to a value of zero. In [Millat et al. 2010],
we extend previous definitions in order to allow for signals approaching a non-zero basal
level, which will be presented here. The restriction to transient signals, which return to
zero, is a limitation that can be avoided by the measures based on Llorens [Llorens et al.
1999].
For example, the characteristics of non-phosphorylated proteins in a cascade, as shown
in Figure 4.1, cannot be computed using the definitions of [Heinrich et al. 2002]. This
case is illustrated with the simulations shown in Figure 4.3. For the simulations, we used
a sequential phosphorylation cascade (Figure 4.1), which is a simplified representation of
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Figure 4.3.: Time course of selected components of a sequential phosporylation cascade. The
behaviour of phosphorylated proteins (XP1 , X
P
2 , and X
P
3 (solid lines)) can be described with the
original approach of [Heinrich et al. 2002], the behaviour of the non-phosphorylated proteins
(X1, X2, and X3 (dashed lines)) with the approach of [Millat et al. 2010]. Exemplary, we show
the values for the quantitative measures τ , ϑ and S for protein X3. Figure from [Millat et al.
2010]. ‘a.u.’ denote arbitrary units.
the MAPK cascade [Seger and Krebs 1995; Schlessinger 2000; Avruch 2007].
For this case study, the integrals defining τ , ϑ, and S have to be redefined. To incor-
porate signals, which do not tend to zero but to a basal level X˜ for t → ∞, we replace
the integral kernel of the original representation [Heinrich et al. 2002] by the difference
X(t) − X˜. In contrary to the definitions in [Llorens et al. 1999; Klipp 2009], we do not
use the absolute value of the difference. As discussed below, the algebraic sign of the inte-
grals is important for the interpretation of quantitative measures and contains information
about the components of signalling pathways.
Using the extended integral kernels we obtain the zero-order integral
I =
∞∫
0
(
X(t)− X˜
)
dt , (4.6)
the first-order integral
T =
∞∫
0
t
(
X(t)− X˜
)
dt , (4.7)
and finally the second-order integral
Q =
∞∫
0
t2
(
X(t)− X˜
)
dt . (4.8)
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These integrals coincide with the original definitions of [Heinrich et al. 2002] if the basal
level is equal to zero. Due to the consideration of the basal level X˜, the integrals are finite
for signals tending to a non-zero final value for t→∞. The integrals for signals with a zero
basal level are always positive. However, signals with a non-zero basal level may result in
negative integrals because of the difference X(t)− X˜. A positive integral I represents the
total amount of produced/phosphorylated proteins [Heinrich et al. 2002] and a negative
integral describes the total amount of consumed/dephosphorylated proteins during the
dynamic signal transduction process.
Following the approach of [Heinrich et al. 2002] and inserting the extended integral
kernels, the signalling time is calculated as the ratio of the integrals (4.7) and (4.6):
τ =
T
I
=
∞∫
0
t[X(t)− X˜]dt
∞∫
0
[X(t)− X˜]dt
. (4.9)
The denominator integrates over the entire signal of phosphorylated protein XPi (t) and
corresponds to the total amount of all XPi molecules generated during the signalling period.
More generally, the area under the curve can be interpreted as the total amount of activated
protein XPi . This formula is an analogous to the mean value of a statistical distribution.
It may be interpreted as the average time required to activate or deactivate the considered
protein. Since for the same signal X(t) the integrals T and I always have the same
algebraic sign, the signalling time is positive definite.
The signal duration is given as
ϑ =
√
Q
I
− τ2 =
√√√√√√√
∞∫
0
t2[X(t)− X˜]dt
∞∫
0
[X(t)− X˜]dt
− τ2 (4.10)
and corresponds to a standard deviation. It indicates the average duration the signal is
active or inactive, respectively. The ratio of the integrals (4.8) and (4.6), as used in the
above definition (4.10), is always positive because the integrals are of the same algebraic
sign.
In order to develop the definition for the average signal concentration S, Heinrich et al.
consider the area under the curve XPi (t),
∞∫
0
XPi dt, (Figure 4.2). Then, the average concen-
tration S is chosen the way that 2ϑ · S spans a rectangle, such that its area has the same
size as the area under the curve [Heinrich et al. 2002]. Thus, combining the quantitative
measures as defined in Eq. (4.2) and Eq. (4.3), the signal strength or signal amplitude is
given by
S = X˜ +
I
2ϑ
. (4.11)
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Equations (4.9)-(4.11) coincide with the definitions in [Heinrich et al. 2002] for a basal
level equal to zero.
The application of the integrals defining the introduced quantitative measures of Eqs. (4.2)–
(4.4) is restricted to a special class of signal shapes: The signal has to be finite at initial
time t0 (in our investigations we assume a value of zero). In addition, the term
∞∫
0
t2XPi dt
of Eq. (4.3) requires that the limit of the signal disappears for t → ∞ faster than t−2.
According to these limitations, the introduced formalism can be applied to a cascade,
where the initial concentrations of the phosphorylated proteins, the non-phosphorylated
proteins, intermediates and the external stimulus are finite.
4.4. Quantitative measures for weakly activated systems
Heinrich et al. [Heinrich et al. 2002] apply a simplification of Eq. (4.1) that arises if one
assumes ‘weak activation’, i.e. only a small fraction of protein Xi is activated during the
process of signal transduction. This assumption implies that the concentration of the
phosphorylated form of protein X is much smaller than the concentration of the unphos-
phorylated form, i.e.
XPi
Xtoti
 1 (4.12)
for each component of the considered cascade, denoted as the Hw model. This occurs for
high phosphatase rates β̂i · Pi = βi, Pi = 1 and low kinase rates αi · XPi−1. We can then
neglect the contribution of the activated form of protein Xi in Eq. (4.1) and obtain the
simplified rate equation
d
dt
XPi = αiX
P
i−1 − βiXPi . (4.13)
Note that the law of conservation of mass is not considered here. Consequences of this
neglect are discussed in Section 4.5.
The linear differential equation (4.13) allows analytical solutions for the quantitative
measures signalling time τ in Eq. (4.2), signal duration ϑ in Eq. (4.3), and signal strength
S in Eq. (4.4), as shown in [Heinrich et al. 2002]. Thus, the signalling time for the activated
protein XPi in a weakly activated system is defined as
τi =
1
λ
+
i∑
j=1
1
βj
. (4.14)
Interestingly, the definition of the signalling time is independent of the kinase rate con-
stant. Since all summands are positive, the signalling time is an increasing function with
increasing number of cascade levels. This means that for the same set of kinetic parame-
ters, the more elements are combined in a cascade, the longer the transfer of information
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in terms of way and time. To reach the same signalling time of two cascades of diffe-
rent lengths (i.e. number of tiers), every step of the longer cascade has to be accelerated
through an appropriate choice of kinetic parameters. However, the range of those kinetic
parameters is restricted due to physical properties of the molecules. According to [Heinrich
et al. 2002], the signal duration of XPi is
ϑi =
√√√√ 1
λ2
+
i∑
j=1
1
β2j
. (4.15)
Also, the signal duration is independent of the kinase rate constant α. Both, signalling
time and signal duration, increase with longer signalling cascades. For the signal amplitude
of XPi one obtains [Heinrich et al. 2002]
Si =
S0
i∏
k=1
αk
βk√
1 + λ2
i∑
j=1
1
β2j
. (4.16)
S0 is equal to X0/2 with X0 describing the concentration of activated receptor at time
zero, as shown in the Appendix B.5. In contrast to the signalling time and signal duration,
the average concentration depends on all pathway components, i.e. receptor, kinases and
phosphatases [Heinrich et al. 2002]. The definition agrees with the intuitive idea that high
amplification can be reached through high kinase rates and low phosphatase rates.
In the next section, it is shown that a model for a weakly activated pathway does not
reflect the biological context appropriately, unless it is restricted to certain parameter com-
binations. Using a simple example of a cascade with one activation cycle, the parameter
value interval is calculated.
4.5. Restrictions for weakly activated systems
Which parameter values do still allow for a sensible description of the biological
system while applying a weakly activated system?
As introduced in Section 4.4, a sequential kinase-phosphatase-cascade is called ‘weakly
activated’ if there is a low level of phosphorylation and a high level of dephosphorylation.
The relevance for weak activation in natural systems is disputable. For adapting their
gene expression to actual demands, cells respond to environmental changes and stimuli. In
order to avoid responses towards noise, this process most likely requires strong activation.
However, several analyses, such as [Chaves et al. 2004] and [Nakabayashi and Sasaki 2004],
concerning optimal lengths and phosphorylation numbers are based on weakly activated
systems. Since the law of conservation of mass is not taken into account in Eq. (4.13),
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Figure 4.4.: Amplification An in the Hg and Hw model [Heinrich et al. 2002] as a function of the
phosphatase rate constant β and the kinase rate constant α (plotted in logarithmic scale). The
results are shown for cascade length three. (Hg model: 0 < β < 5.5 and 0 < α < 5.5, Hw model:
2.5 < β < 5.5 and 0 < α < 3). It can be seen in the Hg model that with an increasing kinase
rate constant the amplification converges to a limiting value. It is noticeable for the Hw model
that amplification increases as the kinase rate constant is increased. This cannot be achieved for
the Hg model and does not seem to be realistic since obviously the number of available proteins
in a biological system is finite.
the solutions of the ODEs describing non-phosphorylated proteins become negative for
certain values of the parameters α and β, while the phosphorylated proteins exceed the
overall total concentrations. In order to determine the exact limiting values, we analysed a
cascade of length one. The analysis described below stresses that weakly activated systems
are restricted to certain parameter combinations only and that beyond these values they
perform nonsensical behaviour from a biological point of view [Frey et al. 2008].
We compare the Hg model (Eq. (4.1)) and the Hw model (Eq. (4.13)) by applying the
quantitative measure signal amplitude of Def. (4.4) and Def. (4.16), respectively. More
precisely, we examine the amplification ratio (Def. (4.5)) as a function of kinase and
phosphatase rate constants.
A comparison of the Hg model and the Hw model examining the amplification An as a
function of kinase and phosphatase rate constants shows striking deviations between the
two models as can be seen in Figure 4.4. For real systems, the finite amount of molecules
available restricts the overall amplification. In the Hg model the amplification reaches
a limit, shown with the occurrence of a plateau in Figure 4.4 on the left. By contrast,
in the Hw model, a signal can theoretically be amplified up to infinity by increasing the
kinase rate constant as shown in Figure 4.4 on the right. We insert the signal amplitude
of Eq. (4.16) into the overall amplification Eq. (4.5), restricting the values to λ = 1,
β1 = β2 = ... = βn, and α1 = α2 = ... = αn. The limit as α→∞ leads to
lim
α→∞An = limα→∞
αn
βn
(
1 +
n
β2
)−1/2
= ∞ ,
which is practically not possible for biological systems. For a weakly activated system, the
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key parameters such as phosphatase or kinase rate constants can be calculated explicitly,
as can be seen in Defs. (4.14), (4.15), and (4.16).
We calculate the range of parameter values for α and β, for which a biologically nonsensi-
cal behaviour is avoided. For the sake of simplicity, we use a single activation/deactivation
cycle. This system can be described in the formalism of a weak activation as
d
dt
X1 = −λX1 ,
d
dt
X2 = −αX1 + βX3 ,
d
dt
X3 = αX1 − βX3 ,
where X1 is the receptor concentration, X2 the concentration of the unphosphorylated
protein, and X3 the phosphorylated protein. Again, the deactivation of the receptor is
determined by the time constant λ and the (de)activation of the protein by the kinase rate
constant α and the phosphatase rate constant β. This system of coupled differential equa-
tions can be solved analytically (for instance using DSolve function from Mathematica)
and we obtain
X1(t) = X1 · e−λ·t ,
X2(t) =
X1 · α
β − λ ·
(
e−β·t − e−λ·t
)
−X3 · e−β·t + X2 + X3 ,
X3(t) = −X1 · α
β − λ ·
(
e−β·t − e−λ·t
)
+ X3 · e−β·t .
For demonstration purposes, we choose the parameters as follows: rate constant λ = 1,
initial concentrations X1 = 1, X2 = 1, and X3 = 0, which leads to the following equations:
X1(t) = e
−t ,
X2(t) =
α
β − 1
(
e−β·t − e−t
)
+ 1 , (4.17)
X3(t) = − α
β − 1 ·
(
e−β·t − e−t
)
.
Note that this value choice for X1, X2, X3, and λ requires the phosphatase rate constant β
to have a value unequal to one. If the minimal values of X2(t) are smaller than zero, the
approximation of weakly activated cascades becomes unphysical. Therefore, we calculate
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the minimum of Eq. (4.17) as follows
X2(t) =
α
β − 1
(
e−β t − e−t
)
+ 1
d
dt
X2(t) =
α
β − 1 ·
(
e−t − β · e−β t
)
= 0
⇔ t = lnβ
β − 1
X2
(
lnβ
β − 1
)
=
α
β − 1
(
β
1
1−β − β β1−β
)
+ 1 . (4.18)
Eq. (4.18) contains the values for the minimum of X2 in dependency of α and β. Combi-
nations of the parameters leading to a minimum ≤ 0 are parameter combinations, which
are not possible in biological systems and therefore, are not allowed. We solve Eq. (4.18)
≥ 0 for kinase rate constant α and obtain the combination of parameters, for which the
minimum is non-negative:
α ≤ (β − 1)/(β1/(1−β) − ββ/(1−β)) .
For a cascade with one activation cycle, we found that the values of α and β must follow
the inequality α ≤ (β−1)/(β1/(1−β)−ββ/(1−β)) in order to allow for biological meaningful
considerations only.
4.6. An optimality criterion
How to define a plausible optimisation criterion for comparing different path-
way structures?
Previous works [Chaves et al. 2004; Nakabayashi and Sasaki 2004] investigated the
average time τ as a function of the number of phosphorylation steps. An optimal surviving
strategy might be to transmit a signal fast. Additionally, the duration should be long
enough to be distinguishable from noise, while not impeding the signal transmission longer
than needed. Since both, the signal duration as well as the signalling time are crucial for
the response of the system [Sabbagh et al. 2001; Vaudry et al. 2002], we include both into
our optimality criterion [Frey et al. 2008]. Assuming that the structure of a pathway is
the result of a multivariate optimisation process, an optimality criterion is defined using
the quantitative measures introduced above. We expect that structures, which enable a
fast response to a stimulus, by exerting a sufficiently long duration to be distinguishable
from noise, are of advantage. It is therefore reasonable to define the optimality criterion
86
4.7. Consequences of approximations
as follows:
On = min
n
(τn · ϑn) , (4.19)
τn = average time until a protein is activated,
ϑn = average duration a protein remains activated.
The level of the cascade is denoted with n. Thus, n represents the most downstream and
phosphorylated protein. τ and ϑ are defined by Defs. (4.2) and (4.3).
Based on these definitions, we test the hypothesis, whether the structure of the MAPK
cascade is the result of such an optimisation process. This analysis is presented in Chap-
ter 5.
4.7. Consequences of approximations
The analysis of signal transduction pathways often requires simplifying reductions. There
is an ongoing discussion how the applied approximations change the system’s behaviour.
Approximations can change the system’s behaviour qualitatively and quantitatively [Millat
et al. 2007]. Several studies [Blu¨thgen et al. 2006; Flach and Schnell 2006; Millat et al. 2007]
demonstrate that approximations can strongly influence the response of the considered
system. Therefore, the question arises:
What are the consequences of three different model approximations with re-
spect to time and duration describing the same pathway structure?
The different models to be compared here, are summarised in Table 4.1, introduced in
detail in the Appendix B, and briefly listed as follows:
1. The mechanistic model by Huang and Ferrell (hereafter denoted HF model) was
developed using an enzyme kinetic model of 18 non-linear ODEs [Huang and Ferrell
1996].
2. Assuming that the intermediate complexes operate at a quasi-steady state, this
model is reduced to nine ODEs, introduced by Heinrich et al. (denoted Hg model)
[Heinrich et al. 2002].
3. A further simplification leads to the the model by Kholodenko (denoted K model)
[Kholodenko 2000].
The starting point is the mechanistic HF model, for which we exemplarily chose six diffe-
rent sets of parameters. The compatible parameters for the Hg model and K model were
derived as described in [Millat et al. 2007], assuming a quasi steady state, a formal bimole-
cular reaction and constant concentration of phosphatase, as shown in Appendix B.4. For
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Model by Example equation Parameters
HF
[Huang and
Ferrell 1996]
d
dtX
P
i = {di+1 + ki+1} (Xi+1XPi )
+ki(XiX
P
i−1)− ai+1Xi+1XPi
ai, di, ki
K
[Kholodenko
2000]
d
dtX
P
i =
kiX
P
i−1Xi
KM+Xi
− ViXPi
KM+X
P
i
KiM =
di+ki
ai
Vi = ki P
Hg
[Heinrich et al.
2002]
d
dtX
P
i = αiX
P
i−1
{
1−XPi /Xtoti
}− βiXPi
αi =
ki
KiM
βi =
ki
KiM
P
Table 4.1.: Overview of the three models used for analysis in this chapter. The first column
indicates the reference of the literature, the second column shows one example equation of
each model, and the third column shows the specific parameters and their derivation from the
mechanistic HF model. Table from [Frey et al. 2009].
simplicity, the number of parameters is reduced by examining only cascades with identical
cycles.
In case the mechanistic interactions, approximations or intermediate steps of a signalling
pathway are still unknown or uncertain, modelling of the pathway becomes precarious.
Among others, quantitative measures can be used to characterise the effect of different
approaches, such as different mechanistic interactions, approximations and of different
intermediate steps. Here, a structural analysis is performed by comparing alternative
structures for signalling cascades, as shown in Figure 4.5, using the quantitative measures
described in Section 4.2. The different intermediate steps include single, double and triple
phosphorylations of a three level cascade.
Figure 4.5 shows that the Hg and K models, which both assume that intermediate
complexes operate at a quasi-steady state, have a similar behaviour, in contrast to the HF
model, which considers the formation of complexes. Interestingly, those parameter value
sets, where association constant a is bigger than dissociation constant d and catalytic
constant k, Figures 4.5(e), 4.5(f), 4.5(k), 4.5(l), show huge deviations of the HF model
compared to the Hg and K model. This can be explained by the increased complex
formation in the HF model, which emphasises the neglect of complexes in the Hg and
K models even more. For values of dissociation constant d bigger than a and k, the
concentration of complexes in the HF model is small. This fact leads to a similar behaviour
compared to the Hg and the K models, which both neglect the formation of complexes,
Figures 4.5(b), 4.5(h), and 4.5(i). When the sum of catalytic constant k and dissociation
constant d is much bigger than association constant a, this leads to small concentrations
of complexes in the HF model, and thus, to similar behaviour among the three model
approximations, Figures 4.5(a), and 4.5(g).
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Figure 4.5.: Comparing the different model approaches Hg, HF and K for a cascade with three
tiers over a range of single, double, and triple phosphorylation applying signalling time τ and
signal duration ϑ. Parameters, namely association constant a, dissociation constant d, and
catalytic constant k, are indicated above each subfigure. The quantitative measures unravel
deviations of the HF model (considering complex formation) on the one hand and of the Hg and
K model (both neglecting complex formations) on the other hand. Figures are taken from [Frey
et al. 2009].
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4.8. Summary
Once a model of signal transduction pathways has been determined fulfilling plausible
assumptions of the biological background and reproducing the experimental data, the
question still remains disregarded, why this specific kind of structure has evolved. The
application of quantitative measures to components of those pathways provides a tool
for their characterisation and can thus be used for comparison among different pathway
structures.
Definitions of quantitative measures by [Heinrich et al. 2002] are restricted to signals
that eventually approach zero. Depending on the kinds of signals, a redefinition for signals
with a non-zero basal level becomes necessary. We redefined quantitative measures to
make applicable for a broader class of signals [Millat et al. 2010]. We define an optimality
criterion that allows for a multivariate optimisation process.
Amplification as a function of the kinase rate constant α and phosphatase rate constant
β exposes huge deviations between the Hg model and the Hw model. The amplification
defined by the Hg model is limited to the overall concentration, the amplification of a Hw
model, however, is not. In order to satisfy the mass conservation in the Hw model, the
values of those parameters were determined for a single phosphorylation cycle.
Comparing three different model approximations, the quantitative measures mirror that
the underlying assumptions are more similar among the Hg and K model than between
them and the HF model. Interestingly, it depends on the choice of parameters, whether
or not the HF model shows faster responses to a stimulus than the Hg and K model. This
is a consequence of the used quasi-steady state approximation in the Hg and K model.
On the one hand, those two models neglect the time to establish the quasi-steady state
of the complexes, which is fully described in the HF model. On the other hand, if no
quasi-steady state is established, the quasi-steady state approximation used in the two
other models is not valid and adds an artificial bottleneck in the dynamics of the system.
Consequently, the more detailed HF model becomes faster than the Hg and K models. As
shown in investigations of enzyme kinetic reactions, the choice of parameters determines
the validity of the quasi-steady state assumption [Schnell and Mendoza 1997].
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the MAPK cascade
In this chapter, the optimality criterion of Eq. (4.19) is applied to three MAPK pathway
models, which differ in their underlying approximations, and consequences of approxima-
tions are discussed. Also, applying the optimality criterion, we compare the characteristic
MAPK structure to alternative structural designs. The work presented here includes main
contents published in [Frey et al. 2008] and [Frey et al. 2009].
5.1. The two double phosphorylations within the MAPK cascade
The ubiquitous Mitogen Activated Protein Kinase cascades (MAPK cascade) are well-
conserved from yeast to mammals [Widmann et al. 1999]. They relay signals from diverse
stimuli and receptors to the nucleus and are involved in many crucial processes of cellular
development [Pearson et al. 2001; Avruch 2007], e.g. proliferation, differentiation [Raman
et al. 2007] and apoptosis [Lamkanfi et al. 2007]. Many oncogenes have been shown to en-
code proteins that transmit mitogenic signals upstream of this cascade, so that the MAPK
pathway provides a simple unifying explanation for the mechanism of action of many non-
nuclear oncogenes [Seger and Krebs 1995]. Consequently, these signalling pathways play
an important role in many diseases [Kyriakis and Avruch 2001; Lawrence et al. 2008], e.g.
their role in cancer is of special interest.
The MAPK cascade consists of a system of at least three activation steps [Bardwell 2005]
as shown schematically in Figure 1.2. It is assumed that the corresponding kinase and
phosphatase activities do not depend on the number of added phosphate groups. The first
protein kinase (MAPKKK) activates the second kinase (MAPKK), the second one then
activates the third kinase (MAPK) through double phosphorylation [Anderson et al. 1990;
Alessi et al. 1994]. Active MAPK thus can enter the nucleus and regulate transcription
factors that control gene expression.
For about a decade, the MAPK cascade has been subject to mathematical modelling.
The mathematical analyses unravel many interesting features of this fundamental structure
in cellular signalling. The sequential alignment of (de)phosphorylation cycles amplifies
their inherent ultrasensitivity [Goldbeter and Koshland, Jr. 1981] in such a way that
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the cascades are presumed to be a very sensitive, highly nonlinear, biochemical switch
[Ferrell Jr. 1996; Ferrell and Machleder 1998]. Additional combination with positive and/or
negative feedback brings about further interesting nonlinear behaviour, as bistability and
oscillations [Kholodenko 2000; Xiong and Ferrel Jr. 2003; Wang et al. 2006]. Due to the
specific structure of the MAPK cascade, which consists of two double phosphorylations
and a cascade length three, the question arises: Do certain structures realise a design
principle with respect to the quantitative measures [Frey et al. 2008]?
5.2. Applying quantitative measures to the MAPK cascade
Is the characteristic structure of a MAPK pathway, comprising two double
phosphorylations, of advantage for signal transmission with respect to the av-
erage time and average duration of active signal?
There are more complex structures of MAPK pathways discussed in the literature, such
as single or multiple negative feedback loops [Dougherty et al. 2005; Dhillon et al. 2007].
However, for this study, the analysis is done for a sequential multi-stage phosphorylation
cascade, whereas the analyses of more complex structures are kept for future work. The
present work performs a structural analysis by comparing alternative structures for those
cascades by using quantitative measures for signalling time, signal duration and signal
amplitude. Such measures were first introduced in [Heinrich et al. 2002]. An analysis of
optimal cascade lengths was published in [Chaves et al. 2004] and [Nakabayashi and Sasaki
2004]. They performed their analysis based on a weakly activated system assuming the
structure of a cascade is the outcome of a univariate optimisation process. Simulating the
model for a weakly activated system, we found that certain parameter combinations led to
a violation of the mass conservation, as shown in Section 4.5. This can lead to solutions of
the differential equations with negative concentrations, which is obviously not possible in
biological systems. Therefore, we focus on a the general model, and compare alternative
structures with respect to a multivariate optimisation criterion introduced in Section 4.6.
We compare different lengths of a cascade keeping the amplification ratio at a constant
value.
The optimality criterion in Eq. (4.19) shows a minimum for structures with double
phosphorylations, as shown in Figure 5.1. This result matches the structure of the MAPK
cascade. For the parameter value sets of the second row, the products show a huge
deviation among a structure with single and structure with double phosphorylations. Here,
the optimum lies at a triple phosphorylation, but compared to the very large decrease
from a single to a double phosphorylation there is no noteworthy improvement of the
structure when changing a double to a triple phosphorylation. In addition, a structure with
three phosphorylations would imply an increased complexity and additional processes to
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Figure 5.1.: Product of signalling time and signal duration: Comparison over a range of single,
double, and triple phosphorylation of the Hg, K, and HF model for a cascade with three tiers.
Parameters are indicated above each figure. We consider the most downstream and phospho-
rylated protein of the cascade. The optimality criterion of Eq. (4.19) is fulfilled for double and
triple phosphorylated structures. Parameter values are indicated above each figure. The corres-
ponding τ and ϑ are shown in Figure 4.5. See text for further explanation or [Frey et al. 2009].
realise them compared to a structure with double phosphorylations. To allow a reasonable
comparison among different pathway structures of the Hg model, we kept the amplification
An at a constant value. This way, the pathways may differ in their structure, but still
realise the same function (amplification). We investigate the consequences of structural
changes within the Hg model under constant amplification and the consequences of changes
in amplification. Figure 5.2 shows the influence of the amplification An on the quantitative
measures τ , ϑ and their product for three amplification factors, An = 1, An = 2, and An =
6. The speed of the response τ correlates with its duration ϑ. Our optimality criterion
is satisfied for high amplifications (An = 2 and An = 6) and a cascade length of two and
three, respectively, which includes the case of the MAPK cascade structure. Nakabayashi
and Sasaki et al. [Nakabayashi and Sasaki 2004] found that the optimum number of kinase
cascade steps increases approximately linearly with the logarithm of the amplification.
They suggested that multi-step phosphorylations would have evolved to accelerate τ of
weak signals. For that purpose they focus on the speed of signal transduction (τ) as the
criterion for determining the optimal response. In our simulations not only τ , but also
our multivariate optimality criterion supports this idea, (compare Figure 5.2). The length
of the MAPK cascade is of at least three protein kinases [English et al. 1999] and its
amplification lies within three to ten [Blu¨thgen 2007]. An overview of the concentrations
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is given in [Fujioka et al. 2006] showing that the input signal of a MAPK cascade (Raf) is
a weak signal compared to the final product concentration (ERK).
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Figure 5.2.: Hg model for cascade lengths up to five. The number of phosphorylations is depicted
the following way: single (circle), double (triangle), and triple phosphorylation (diamond). Left
column: average time until a signal is activated τ . Middle column: average duration, which
a signal remains activated ϑ. Right column: optimality criterion τ · ϑ. An denotes the am-
plification factor of the cascade element located most downstream. Note that for an increased
amplification, the minimum according to our optimality criterion appears for longer cascades.
For an amplification An = 6, the minimum can be found at length three for double phosphory-
lation, which is the structure of the MAPK cascade. (The receptor concentration was chosen to
equal one, the concentration of the more downstream proteins to equal ten, α = 2; β was chosen
to obtain the specific amplification An).
Binder and Heinrich [Binder and Heinrich 2004] presented a first step towards an ap-
proach that investigates the interrelation between dynamics and the structural design of
pathways. In contrast to [Binder and Heinrich 2004], we here consider short cascades with
single, double, and triple phosphorylations.
We show how a double phosphorylated structure, which exists in MAPK cascades,
changes the properties of the transduced signal in a favourable way comparing it to single
phosphorylated structures. In general, the average time until a signal is activated (τ)
becomes slower with increasing number of phosphorylations and the average duration a
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signal remains activated (ϑ) becomes shorter. This means that multiple phosphorylations
could have evolved to generate slow signals of short duration. A signal with a fast response
might be of disadvantage because a biological system might need a certain time to proof
its validity. On the other hand, the proof of validation should be fast enough to realise
protection against damage or intake of nutrients when exposed to high availabilities. We
also considered the product of τ and ϑ. If a minimum of this product exists, it shows
an optimal trade-off between both. Indeed, as can be seen in Figure 5.1, a minimum
most often exists for structures with double phosphorylations. This structure matches
the design of the MAPK cascade, which suggests that the MAPK cascade is in favour to
trigger a fast response of short duration. For a few parameter combinations the product
of the average time τ (see Eq. (4.2)) and the average duration ϑ (see Eq. (4.3)) shows a
minimum at triple phosphorylation. Yet, in those cases, the minimal value of the triple
phosphorylation is similar to that of a double phosphorylation. Moreover, there is a huge
deviation among a structure with single compared to a structure with double or triple
phosphorylations. Although for some parameter value combinations, the minimum lies at
a triple phosphorylation, there is no noteworthy deviation and thus improvement compared
to a double phosphorylation. A double phosphorylated structure could still be favoured
since a structure with three phosphorylations would imply an increased complexity and
additional processes to realise and fuel them with energy, compared to a structure with
only double phosphorylations. Besides the importance of the timing and duration of the
transmitted signal, another crucial characteristic for the correct functioning of a pathway
lies in the ability to amplify signals.
5.3. Summary
Quantitative measures can be used to characterise the properties of signalling molecules,
and thus, of signalling pathways. Here, pathways of single, double, and triple phosphory-
lated structures of different model approximations are compared in terms of average time
and average duration of activation. The application of the previously defined optimality
criterion suggests, that a double phosphorylated structure, which matches the design of
the MAPK cascade, is in favour to trigger a fast response of short duration. A minimum
of the optimality criterion indicates an optimal trade-off between a fast signal response
accompanied with a sufficiently long duration, e.g. to be distinguishable from noise while
at the same time remain quickly responsive to changes in the environment or the interior.
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Cells are permanently exposed to changes in their environment. The process of adaption
has been proven to be a promising and necessary survival strategy of the cell realised by
signal transduction pathways of interacting proteins. They detect extracellular signals,
translate, and transmit their information to the interior of the cell and eventually trigger
the specific and appropriate response. One focus of this thesis comprises a systems biology
approach to dynamic modelling of the AMP-activated kinase pathway. This pathway plays
a key role in energy sensing and metabolism by keeping an appropriate balance between
the energy-producing catabolic and energy-consuming anabolic processes. Activated by
metabolic stresses that cause depletion of ATP, AMPK switches off ATP-consuming an-
abolic processes that are not essential for the immediate survival of the cell and stimulates
catabolic processes that generate ATP.
In this research, a systems biology approach is realised through an iterative cycle be-
tween data-driven modelling and model-driven experimentation. Using ordinary differen-
tial equations, mathematical modelling is established for the AMPK pathway homologue
in the yeast S. cerevisiae, the Snf1 pathway. As a basis for the model development, the
underlying biological background of both pathways is introduced in detail. Then, steps of
model developments including the derivation of the glucose-regulated signal, Mig1-GFP
data processing, and the analysis of the Snf1 pathway are presented and discussed.
So far, the mechanisms leading to Snf1 regulation upon glucose availabilities are still
elusive, however, it appears to be related to the first step of glycolysis. Therefore, a first
essential step for developing a mathematical model of the Snf1 pathway is the deviation
of a glucose-regulated stimulus [Frey et al. 2011a] that ultimately determines Snf1 regula-
tion. Thereby, we find that the carrier model, which describes the transport of molecules
through the cellular membrane and considers only a constant contribution of transporters,
is not able to explain the experimental data of glucose consumption in batch experiments.
We show, that the dynamics of high and low affinity hexose transporters within the cell
membrane of S. cerevisiae are essential and need to be considered and incorporated into
the model. Thereon, a meaningful and precise reproduction of the glucose data is accom-
plished. The derived glucose-regulated signal is then supplied to serve as input function
for Snf1 regulation.
Furthermore, Mig1-GFP fluorescence microscopy data, which suffer from bleaching ef-
fects and background noise, have to be processed in order to become suitable for modelling.
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Therefore, a mathematical approach is discussed. It allows for a stepwise extraction of
the data of interest (Mig1-GFP) by subtracting the background noise and accounting for
the decrease of intensity due to bleaching effects. Therefore, the bleaching rates of the
background noises and the Mig1-GFP itself and the background to Mig1-GFP ratios are
determined. Eventually, this approach allows for the extraction of information on Mig1-
GFP and for the prediction of Mig1 shuttling as it would occur without bleaching and
background noise during changing environmental conditions [Frey et al. 2011b].
The derived glucose-regulated signal and the processed Mig1-GFP data are then used,
combined with Snf1 Western blot data, to compare and analyse alternative pathway struc-
tures underlying the Snf1 pathway. We encode different hypotheses by ODE-based models.
Iterative cycles between data-driven modelling and model-driven experimentation are car-
ried out. We find that an additional glucose-regulated involvement is essential for explain-
ing the experimental observations of unaffected Mig1 (de)phosphorylation in SAK1 and
REG1 overexpressing cells. The models suggest, that Mig1 requires a glucose-regulated
step for dephosphorylation, either in form of a directly glucose-regulated phosphatase or
in case of a constantly active phosphatase, a mechanisms involving an additional glucose-
regulated component. With regard to the Snf1 data, all three model alternatives ((a)
regulation via the phosphatase, (b) regulation via the kinase, and (c) regulation via both)
lead to a good agreement of Snf1 Western blot data and simulations, and thus all un-
derlying mechanisms remain possible candidates for Snf1 regulation. The models also
indicate that the regulation of Snf1 can be realised by a glucose-regulated phosphatase
alone. However, a combination of both regulatory mechanisms allows for more subtle ways
to adapt to changing environmental conditions and cannot be excluded from the list of
Snf1 pathway candidates.
In order to describe the dynamic properties of signalling pathways, the application of
quantitative measures, such as the average time until activation or the average duration of
remaining in an activated state, can be used. They are useful to compare different pathway
structures, providing insights, why a certain structure is favoured to another one. Also,
the quantification of a signal might unravel crucial differences among healthy and diseased
cells. The second focus of this thesis lies on the analysis of the characteristic structure of
the MAPK cascade. Quantitative measures are assigned to investigate signalling pathway
structures that are optimal in terms of a fast signal propagation, which stays active only
for a short duration. Comparing single, double, and triple phosphorylated structures, we
find that an optimum of the optimality criterion appears for the double phosphorylated
structure of the MAPK cascade with respect to its characteristic amplification. For an
increased amplification, the optimum appears for longer cascades, supporting the idea that
multi-step phosphorylations could have evolved to accelerate the speed of weak signals.
With regard to further work, provided that additional data, as spectroscopic data,
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are available, the considerations of complex dynamics might be useful to constrict the
remaining candidates for Snf1 network structures. Another challenge certainly lies not only
within temporal but also spatial considerations, especially, as determined by the different
isoforms of the β-subunit of Snf1, the different locations of the Snf1 complex to the nucleus,
cytosol, or vacuole. For the conditions of the experiments considered here, the phosphatase
regulation might be sufficient to regulate Snf1, however, for other environmental conditions
the contribution of a glucose-regulated kinase might be essential. Thus, designing new
experiments might find a scenario that provides a way to distinguish between a glucose-
regulated phosphatase model and a model, in which kinase and phosphatase are glucose-
regulated. This raises new questions that require further research.
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A. Parameters for the Snf1 models
UK const. UK regul. UK regul.
Parameter PP1 regul. PP1 const. PP1 regul.
Model Ia) Model Ib) Model Ic)
aSnf1 1 · 103 1 · 104 1 · 102
dSnf1 6 · 103 2 · 103 3 · 103
aPP1 6 · 105 3 · 105 2 · 106
dPP1 3 · 106 1 · 103 3 · 105
dUK 1 · 106 5 · 106 5 · 106
aUK 1 · 104 4 · 103 1 · 106
dMig1 2 · 10−3 1 · 10−6 7 · 10−5
aMig1 2 · 10−5 4.7 · 10−5 2 · 10−5
WBs. f. (Exp. C) 0.97 1.08 1
WBs. f. (Exp. D) 0.97 1.39 0.97
UKtot 1.5 · 104 1.5 · 104 1.5 · 104
PP1tot 2.8 · 104 2.8 · 104 2.8 · 104
Snf1tot 2 · 104 2 · 104 2 · 104
Mig1tot 1.9 · 104 1.9 · 104 1.9 · 104
Table A.1.: Overview of the parameters and values used in models Ia), Ib), and Ic). The total
numbers of molecules per cell are taken from unpublished data [Garcia Salcedo 2009].
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A. Parameters for the Snf1 models
UK const. UK regul. UK regul.
Parameter PP1 regul. PP1 const. PP1 regul.
Model IIa) Model IIb) Model IIc)
aSnf1 1 · 103 1 · 104 1 · 102
dSnf1 6 · 103 2 · 103 3 · 103
aPP1 6 · 105 3 · 105 2 · 106
dPP1 3 · 106 1 · 103 3 · 105
dUK 1 · 106 5 · 106 5 · 106
aUK 1 · 104 4 · 103 1 · 106
aSnf1P 3 · 104 1 · 104 1 · 104
dSnf1P 4 · 107 8 · 107 6 · 106
dMig1 1.7 · 10−3 2 · 10−6 6 · 10−5
aMig1 2 · 10−5 2 · 10−5 2 · 10−5
WBs. f. (Exp. C) 0.97 1.08 1
WBs. f. (Exp. D) 0.97 1.39 0.97
UKtot 1.5 · 104 1.5 · 104 1.5 · 104
PP1tot 2.8 · 104 2.8 · 104 2.8 · 104
Snf1tot 2 · 104 2 · 104 2 · 104
Mig1tot 1.9 · 104 1.9 · 104 1.9 · 104
Table A.2.: Overview of the parameters and values used in the with a two-step Snf1 regulation
(models IIa), IIb), and IIc)). The parameter values for PP1 and UK were taken from models
Ia), Ib), and Ic). The total numbers of molecules per cell are taken from unpublished data
[Garcia Salcedo 2009].
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UK const. UK regul. UK regul.
Parameter PP1 regul. PP1 const. PP1 regul.
Model IIIa) Model IIIb) Model IIIc)
aSnf1 1 · 103 1 · 104 1 · 102
dSnf1 6 · 103 2 · 103 3 · 103
aPP1 6 · 105 3 · 105 2 · 106
dPP1 3 · 106 1 · 103 3 · 105
dUK 1 · 106 5 · 106 5 · 106
aUK 1 · 104 4 · 103 1 · 106
dMig1 1.72 · 10−3 2 · 10−6 6 · 10−5
aMig1 2 · 10−5 2 · 10−5 2 · 10−5
k1 4 · 104 2 · 103 2 · 106
k2 4 · 106 0.7 1 · 107
WBs. f. (Exp. C) 0.97 1.08 1
WBs. f. (Exp. D) 0.97 1.39 0.97
UKtot 1.5 · 104 1.5 · 104 1.5 · 104
PP1tot 2.8 · 104 2.8 · 104 2.8 · 104
Snf1tot 2 · 104 2 · 104 2 · 104
Mig1tot 1.9 · 104 1.9 · 104 1.9 · 104
Hxk2tot 1 · 105 1 · 105 1 · 105
Table A.3.: Overview of the parameters and values used in the models IIIa), IIIb), and IIIc).
The total numbers of molecules per cell are taken from unpublished data [Garcia Salcedo 2009].
The parameter values for PP1 and UK were taken from models Ia), Ib), and Ic).
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B.1. Huang and Ferrell
The MAPK cascade model developed by Huang and Ferrell [Huang and Ferrell 1996] (here
denoted HF model) analyzes the intrinsic ultrasensitivity of the stimulus response curve
of the cascade. It assumes that each activation/deactivation of proteins follows an enzyme
kinetic reaction [Segel 1993; Cornish-Bowden 2004]. For a protein Xi and its upstream
active kinase XPi−1, that catalyzes the phosphorylation of Xi to X
P
i , we have
Xi + X
P
i−1
ai−⇀↽−
di
(Xi X
P
i−1)
ki−→ XPi + XPi−1 . (B.1)
The bimolecular reaction of Xi and X
P
i−1 results in an intermediary complex (Xi X
P
i−1),
which can dissociate into the reactants or the activated form XPi and the unchanged
enzyme XPi−1. The three involved reactions are determined by rate coefficients: association
constant ai, dissociation constant di, and catalytic constant ki. X
P
i−1 is assumed to be an
ideal catalyst. Furthermore, it is assumed that all other participants, e.g. H2O, ATP, are
constant over the whole observation period, which leads to a formal equivalent reaction
scheme as for an enzymatic reaction [Millat et al. 2007]. Additionally, there are some
conservation laws for proteins and enzymes, see [Huang and Ferrell 1996]. This system of
differential equations describes the time course of the proteins and their different activation
states as well as the time course of the formed intermediary complexes as shown in the
example of complex formed in Reaction (B.1)
d
dt
(XiX
P
i−1) = ai (Xi) (X
P
i−1)− {di + ki} (XiXPi−1) .
Note that there is an additional equation for the time-dependent stimulus in comparison to
the original system in [Huang and Ferrell 1996] where the stimulus is a constant external
parameter. The term (XiX
P
i−1) denotes a complex. Note that for our investigation, we
introduce an additional equation for the time-dependent stimulus
X0(t) = X0 e−λt (B.2)
in comparison to the original system in [Huang and Ferrell 1996], where the stimulus
is a constant external parameter. This equation describes the receptor deactivation as
a consequence of a pulse-like stimulus. For the sake of simplicity we choose a simple
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monomolecular deactivation mechanism. We assume a receptor concentration of X0 at
initial time t0 = 0. This assumption guarantees that the final signal of the phosphorylated
protein approaches zero for t→∞, as required for calculating the quantitative measures.
B.2. Kholodenko
Also in the MAPK model by Kholodenko [Kholodenko 2000], all involved biochemical
reactions follow the enzyme kinetic reaction of Eq. (B.1). Again we use the quasi-steady-
state approximation to simplify the system of coupled differential equations. In contrast
to the above discussed models, the conservation law for the proteins is used to express the
level of upstream kinases. Due to this explicit transformation, the model is a simplification
of the Hg model (see Eq. (4.1)) [Millat et al. 2007]. The resulting rate equation for
activation/deactivation of a protein
d
dt
XPi =
kiX
P
i−1Xi
KM +Xi
− ViX
P
i
KM +XPi
(B.3)
contains two Michaelis-Menten like expressions and is similar to the result of Goldbeter
and Koshland [Goldbeter and Koshland, Jr. 1981]. The limiting rate Vi results again
from the assumption of a constant phosphatase concentration. Note that neglecting the
complex concentration within the model is crucial [Blu¨thgen et al. 2006; Millat et al. 2007].
The structure of the used differential equations and the required kinetic parameters and
their relation to the mechanistic constants are summarised in Table 4.1.
B.3. Heinrich et al.
The mechanistic model can be simplified if one assumes that the intermediate complexes
operate at a quasi-steady state. This assumption converts the differential equation of the
complexes into an algebraic equation, e.g.
0 = aiXiX
P
i−1 − {di + ki} (XiXPi−1) , (B.4)
which can be transformed with respect to the complex concentration (XiX
P
i−1). Insertion
into the enzyme kinetic reaction reduces it formally to a bimolecular reaction [Millat et al.
2007]. If one further assumes a constant phosphatase concentration, the dephosphorylation
reaction further reduces to a pseudo-monomolecular reaction [Millat et al. 2007]. The
change of concentration of a protein can then be described by the differential equation
d
dt
XPi = α˜iXi X
P
i−1 − βiXPi (B.5)
as introduced before in the main text as Eq. 4.1, where α˜i = αi/X
tot
i and X
tot
i denotes the
total concentration of protein Xi [Heinrich et al. 2002]. The rate equation Eq. (4.1) can
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be further simplified if we apply the conservation laws for the proteins and additionally
assume that the concentration of intermediate complexes is negligible with respect to the
concentration of proteins, which are not bound in a complex. Then, the conservation law
reduces to a simple relation between the protein concentrations
Xtoti = Xi +X
P
i . (B.6)
Insertion into Eq. (4.1) leads to the Hg model [Heinrich et al. 2002]
d
dt
XPi = αiX
P
i−1
{
1− X
P
i
Xtoti
}
− βiXPi . (B.7)
Applying the quantitative measures of signal properties (Defs. (4.2), (4.3), and (4.4))
introduced in Chapter 4, shows that a change in Xtoti does not change the values of
signalling time τ and signal duration ϑ but the signal strength S. Since Xtoti is the sum of
phosphorylated and non-phosphorylated form of protein Xi, it cancels out in the definitions
for signalling time (4.2) and signal duration (4.3). The signal strength (4.4), on the other
hand depends on the total concentration. This means that signalling time as well as signal
duration of a cascade, as in Figure (1.2), do not depend on the total concentrations of the
involved proteins. Nevertheless, the choice of the rate constants and a ratio of the initial
(receptor) concentration Xtot0 to the more downstream elements of the cascade X
tot
i affect
these quantitative measures as shown in Chapter 5.
The definitions of signalling time τ , signal duration ϑ, signal amplitude S and related
quantities depend on the existence of the involved definite integrals. This condition re-
stricts the approach to a special class of dynamic signals. At initial time t = 0, all
concentrations have to be finite, which is not a serious problem because it is fulfilled au-
tomatically by biological systems. A cell cannot produce an infinite amount of molecules
resulting in an infinite concentration. (Additionally, the cellular volume cannot be zero.)
Since the upper limit of integration is set to infinity it is required for the calculability of
the integral that all considered signals tend to zero. The definition of the signal duration,
Def. (4.3), further enforces the following requirement. An involved integral is proportional
to t2. Consequently, the investigated signal XPn has to decrease faster than t
−2 for t→∞.
This restriction excludes signals that tend to a steady state or produce stable oscillations.
Also, the inactive protein forms of the MAPK cascade, see left picture of Figure 1.2,
cannot be investigated using the introduced approach. However, this framework can be
generalised using a similar approach as in [Llorens et al. 1999].
B.4. Relation between the kinetic parameters
So far we introduced three models [Huang and Ferrell 1996; Kholodenko 2000; Heinrich
et al. 2002] and explained their structure and main assumptions. In our analysis, we
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examined cascades with identical cycles only. This assumption was made for reducing
the number of parameters in order to keep the model clearly arranged. An important
part of the models, which we have not yet discussed is: their different kinetic parameter
sets. For a systematic comparison of the behavior of the models it is required to relate
the rate constants. We derive the kinetic parameters of the models and show that the
parameters of the simplified models can be related to the mechanistic kinetic parameters.
The starting point is again the HF model. In this model the activation and deactivation
of a protein Xi is determined by the association constant ai, the dissociation constant di,
and the catalytic constant ki. Due to the quasi-steady state assumption in the Heinrich
model, we obtain new kinetic parameters, which contain a combination of the mechanistic
parameters of the HF model. The activation is determined by the rate constant αi, which
follows from the balance equation (B.4) as
αi =
ki
KiM
. (B.8)
Due to the assumed constant phosphatase, the rate constant of deactivation βi is an
effective rate constant [Atkins and de Paula 2002; Millat et al. 2007]
βi = P
ki
KiM
, (B.9)
which is the product of the concentration P of the phosphatase and the mechanistic rate
constants. Both rate constants are ratios of the corresponding catalytic constant ki and
the Michaelis constant
KiM =
di + ki
ai
. (B.10)
The Kholodenko model contains the limiting rate Vi, which is defined as usual as
Vi = ki P (B.11)
where P again is the phosphatase concentration.
By applying these equations the kinetic parameters of the different models are related
to each other. If one defines a set of mechanistic parameters ai, di, and ki the parameters
of the Heinrich model and the Kholodenko model are uniquely defined. Note that this is
not reversible [Millat et al. 2007]. Due to the generated relation between the parameters
we are now able to investigate the models’ behavior as done for the analysis shown in
Section 5. For practical purposes, we have to introduce further restrictions for these
models. Since the kinetic parameters are determined by physical constraints, e.g. the
atomic configuration of the molecules, temperature or pH-value, each rate coefficient is
unique. The parameters span an m-dimensional parameter space. This space is further
increased by the total protein concentrations, including signalling proteins, kinases, and
phosphatases, and the initial concentrations. A parameter space of this dimension is
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intractable for a systematical investigation of the behavior of MAPK cascades, especially
if one investigates different structural configurations. Therefore, we have to reduce the
dimension. We realise this by using cascades composed of identical activation/deactivation
cycles. Furthermore we assume that the coefficients of the deactivation are multiples of
the kinetic coefficients of the activation. This means that we have to consider the three
rate coefficients of the activation and a constant factor, which determines the coefficients
of the deactivation. Furthermore, we use the same total concentration for all involved
proteins, except if declared other. Last but not least, we assume that at t = 0 all proteins
are inactive or non-phosphorylated.
B.5. Properties of the external stimulus
The quantitative measures for the exponential input function can be derived as shown in
Heinrich et al. [Heinrich et al. 2002]:
X0(t) = X0 e−λt (B.12)
for modeling the external stimulus. X0 denotes the initial state at t = 0 and λ the
inverse time constant. For such a signal, the characteristic quantities can be calculated
analytically. The total amount is then simply
∞∫
0
X0 dt =
∞∫
0
X0 e−λt dt
= −X0
λ
[
e−λt
]∞
0
=
X0
λ
. (B.13)
The integral in the nominator of Def. (4.2) can be solved by partial integration
∞∫
0
tX0 dt = X0
∞∫
0
t e−λt dt
= −X0
λ
[
t e−λt
]∞
0
+
X0
λ
∞∫
0
e−λt dt
= −X0
λ2
[
e−λt
]∞
0
=
X0
λ2
. (B.14)
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Also by partial integration the last remaining integral is solved
∞∫
0
t2X0 dt = X0
∞∫
0
t2e−λt dt
= −X0
λ
[
t2e−λt
]∞
0
+
2X0
λ
∞∫
0
t e−λt dt
=
2X0
λ
∞∫
0
t e−λt dt
= −2X 0
λ2
[t e−λt]∞
0
+
∞∫
0
e−λt dt

= −2X0
λ3
[
e−λt
]∞
0
=
2X0
λ3
. (B.15)
With these results we then can calculate the characteristic quantities for the external
stimulus. Following from Def. (4.2) the signaling time is
τ0 =
X0
∞∫
0
te−λt dt
X0
∞∫
0
e−λt dt
=
X0
λ2
λ
X0 =
1
λ
. (B.16)
From Def. (4.3) follows
ϑ0 =
√√√√√√√
X0
∞∫
0
t2e−λt dt
X0
∞∫
0
e−λt dt
− τ20
=
√
2X0
λ3
λ
X0 −
1
λ2
=
1
λ
(B.17)
for the signal duration. Finally, we obtain from Def. (4.4)
S0 =
X0
∞∫
0
e−λt dt
2ϑ0
=
X0
λ
λ
2
=
X0
2
(B.18)
for the signal strength. Whereas signaling time and signal duration are determined only
by the inverse characteristic time λ, the averaged signal amplitude depends on the initial
concentration X0 only.
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Theses for the doctoral research
1. The carrier model, which describes the transport of molecules across the cell mem-
brane, assumes a constant contribution of high and low affinity transporters. It
is shown that the carrier model is not sufficient to describe the glucose uptake in
S. cerevisiae for different batch experiments due to the neglect of a dynamic con-
tribution of the transporter in the cell membrane. These results point towards a
significant reorganisation of the membrane transporters.
2. An analysis of high and low affinity transporters, as a function of glucose concen-
tration at steady-state, supports the finding of a reciprocal relationship between the
high and low affinity transporters as reported by Ramos and co-workers in 1988.
3. The estimated value for the rate of transport efficiency of a high affinity transporter
reveals a higher value compared to a low affinity transporter. The lower concentra-
tion of high affinity transporters compared to low affinity transporters thus indicates
a compensation through a higher efficiency of the transporters, whereas in compar-
ison the highly concentrated low affinity transporters operate less efficiently.
4. The identity of the glucose signal, which regulates Snf1 (de)phosphorylation, still
remains elusive. This work shows the derivation of a glucose-regulated stimulus,
which can be used as the input function of glucose-regulated signalling pathways,
such as the Snf1 pathway. It serves as a template to display and compare alternative
pathway structures.
5. Mig1-GFP data, generated by the technique fluorescence microscopy, suffers from
bleaching effects and background noises. This work introduces a mathematical ap-
proach, which allows for the prediction of Mig1 dynamics as they would occur with-
out bleaching and background noises. The processed data is thereon usable for
mathematical modelling of signal transduction pathways.
6. In this research, an iterative cycle of data-driven modelling and model-driven exper-
imentation for the Snf1 pathway was performed. It was found that, in addition to
regulation by the kinase and phosphatase, the consideration of a glucose-regulated
step is essential in order to explain the dynamics of Mig1 (de)phosphorylations.
7. In addition to establishing a signalling pathway model, the dynamic properties of
its pathway components, such as the average time or duration of activation, can be
determined. In order to compare different pathway structures, a two-dimensional
optimality criterion is defined. It signifies that a cell aims at a fast signal response
while keeping the duration of activated signal as short as possible. This strategy
may ensure a fast signal transfer while at the same time bordering from noise.
8. Signalling pathways occur in a huge variety of structural designs. Applying quan-
titative measures for comparison of different pathway structures suggests that the
characteristic design of the MAPK pathway favours a fast response to a stimulus in
combination with a sufficiently long duration.
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